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Thesis’ purpose 
The needed of new intermediates/products for screening mainly in the fields of drug discovery and 
material science is the driving force behind the development of new methodologies and technologies for the 
rapid synthesis of simple moieties or for the assembly of more complicated structures. Among organic 
scaffolds which constitute one of the privileged target of the organic chemists, a priority place has to be 
attributed to the organic compounds, cyclic as well as acyclic ones, containing the nitrogen atom. That said 
it is clear to the reader that any new methodology, which will allow the introduction of the nitrogen atom 
for the synthesis of an established target or for the curiosity driven research, will be welcome. 
The main research theme of the group joined by the Applicant during the thesis period, has been the 
development of new methodologies for the above.  
More in detail, the objectives of this PhD thesis are: 
(1). Preparation of new heterocycles, presenting the N-Heteroarylmethyl 3-carboxy-5-hydroxy 
piperidine scaffold, as potential and selective α-glucosidase Inhibitors. 
(2). Synthesis of enantiomerically pure 1, 4-dihydropyridine using “solid” ammonia (magnesium 
nitride). 
(3). Use of N-trialkylsilylimines in the synthesis of N-containing heterocycles via a Hetero Diels-Alder 
strategy. 
(4). N-Metallo-ketene imines (metallo= Si, Sn, Al) in the preparation of highly functionalized 
derivatives as possible building blocks in the preparation of nitrogen containing targets. 
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Chapter 1.  
N-Heteroarylmethyl 3-carboxy-5-hydroxy piperidine: A 
Novel Scaffold for the Design of Potent and Selective α-
glucosidase Inhibitors 
1.1 Introduction:  
Owing to the success of α-glucosidase inhibitors as antidiabetic agents and the postulated involvement 
of this enzyme in tumorigenesis1 and viral infection,2 the interest in the discovery and development of 
novel, structurally different inhibitors is much alive. Several of the compounds described in the literature 
are natural products from plants used in the folk medicine around the world as remedy against diabetes.3 
Fewer α-glucosidase inhibitors have originated through rational drug design and novel chemical 
synthesis.4,5 None has thus far supplanted the use of Acarbose or the other clinically tested inhibitors.  
Iminosugars are a rich fount of glycosidase inhibitors.6,7 Since the discovery in the mid sixties of 
nojirimicin,8 the first identified natural α-glucosidase inhibitor, a large number of synthetic mimetics based 
on the same scaffold or that of azasugars9 and aminocyclitols10, have been evaluated. As in nojirimycin, the 
prototypical iminosugar and transition state analogues, a protonated nitrogen in these compounds is 
responsible for the formation of a stable electrostatic interaction with the critical carboxylate ion located 
within the catalytic pocket of the α-glucosidase. It is postulated that the ammonium ion, by mimicking the 
positively charged oxycarbenium ion in the pyranose ring of the natural substrate during catalysis, accounts 
for the competitive mechanism of inhibition of the compounds.3 As a consequence of the fact that most 
glycosidases utilize the carboxylate ion as a catalytic group, the poor specificity of iminosugars and the 
related scaffolds toward α-glucosidase, is a limiting factor for their development as drugs.  
Compounds in which the protonable nitrogen is substituted or is replaced by another atom have also 
been evaluated. Of these, emiglitate, a synthetic analogue of deoxynojirimycin,11 and salacinol, a naturally 
occurring thiasugar,9 display remarkable potency both in vitro and in vivo. Interestingly in these 
compounds, the protonable nitrogen carries a substituent harboring an electron dense region, a structural 
feature that is uncommon in natural and synthetic iminosugars or in α-glucosidase inhibitors in general. 
Likewise there is little information on the effect of replacing the hydroxyl residues decorating the 
iminosugar pyranose ring with different substituents. Conceivably this may drastically affect the inhibitory 
activity since key features of the natural substrate are removed. However the recent report12 that 4,5 
dihydroxy-1,2 cyclohexane dicarboxylic acids are endowed with α-glucosidase inhibitory activity, 
challenges this view. Given these premises, and provided the aim of this thesis on the design and synthesis 
of new nitrogen containing heterocyclic compounds with a potentially useful bio-activity, we embarked, in 
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collaboration with Glyconova (Colleretto Giacosa, Italy) and Innovative Chemistry (Milano, Italy), in a 
chemical programaimed at synthesizing and evaluating, as glycosidases inhibitors, a novel series of 
azasugars embedding in their structure some of the non-canonical features discussed above. In the course of 
our studies we found that a series of new compounds, characterized by a piperidine scaffold bearing in 
position 3 of the heterocycle carboxy functionality, and by the presence of a heteromethylaryl appendance, 
directly linked on the nitrogen atom, act as potent α-glucosidase inhibitors. Unlike acarbose and the other 
main α-glucosidase inhibitors, the compounds sound to act through a reversible uncompetitive mechanism 
of inhibition which makes them attractive as candidate for drug development. 
 
1.2 Present work 
1.2.1 Chemistry 
The scaffold 1-heteroarylmethyl-4-hydroxy-piperidine-3-carboxylic acids 7a-7d (Chart 1)13 was 
prepared with slight modifications of the literature procedures. In detail the commercially available ethyl 1-
benzyl-4-oxo-3-piperidine carboxlate hydrochloride 1 (from Aldrich), after neutralization by TEA 
(triethylamine) was reduced by sodium borohydride to give an inseparable mixture of the corresponding 
alcohol 2 (SL34/14/1) (mixture of cis- and trans- isomers).14 This mixture was treated with tert-
butyldimethylsilyl chloride (TBSCl) in the presence of imidazole in DMF to give the TBS-ether 5 and the 
cis-isomer of alcohol 2b.15 Column chromatography on silica gel furnished pure alcohol 2b. Removal of N-
benzyl protecting group by means of palladium on carbon (10%) in ethanol, followed by alkylation of the 
chlorohydrate by means of Hüning base in acetonitrile16 in the presence of alkylating halides, furnished the 
targets7a-7d. Sample (SL34/81/1) was prepared by simple NaOH/MeOH mediated hydrolysis of sample 2 
(SL34/14/1).  
 
Chart 1. Reagents and Conditions. i: NEt3, NaBH4/CH3OH. ii: NaOHaq2M/MeOH (1/10). iii: TBDMSCl/Imidazole/DMF. iv: 
Pd/C (10%), EtOH; v: CH3CN, base, ArCH2X; and then ii. 
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Chart 2. Reagents and Conditions. i: ACE-Cl, Toluene then MeOH; ii: (for 10a-10d) NaHCO3, EtOH, ArCH2X  then iii 
NaOHaq  2M/MeOH (1/10); (for 10e-10f) CH3CN, base, ArCH2X then iii NaOHaq 2M/MeOH (1/10); iv: ClCOOEt, Toluene, 
Reflux; v: NaOHaq 5M/ Toluene, 50°C; vi: LDA, THF, HMPA (mixture of 2-3, 3-4, 4-5 ene-isomers 13); vii: HClaq (1N); viii: 
SOCl2/MeOH; ix: Flash chromatography; x: NaOHaq 2M/ Toluene,refulx. HCl/ether; xi: NaOHaq, (ButOCOO)O2, ButOH; xii: 
LDA, THF. xiii: MCPA/DCM; xiv : KOH/MeOH; xv: (a) TFA, DCM, (b) ACN, base, ArCH2X; xvi: HCl (1N). 
Preparations of samples 10a-10f were realized as outlined into Chart 217 starting from commercially 
available arecoline hydrobromide 8. Accordingly, demethylation of arecoline was performed by known 
procedure.18 Product 15 (SL34/76/1) was obtained from 9 by its hydrolysis and tested as such. The 
demethylated product 9, in turn, was alkylated by the suitable alkyl halide in the presence of bicarbonate,19 
followed by hydrolysis with sodium hydroxide, to give the targets 10a (SL34/56/1), 10b (SL34/58/1), 10c 
(SL34/59/1) and 10d (SL34/57/1).Targets 10e (SL42/06/1) and 10f (42/05/1) were synthetized by adopting, 
as alkylating procedure, that above described followed by hydrolysis by NaOHaq/MeOH.16 In order to test the 
potential activity of other double bond isomer, product 14 (SL42/27/1) was prepared via an alternative 
demethylation procedure of arecoline with chloroformiate followed by isomerization of the resulting 
carbamate 12 (see Chart 2) with LDA, in the presence of hexametapol (HMPA), and SO2Cl2 mediated 
esterification with MeOH. The N-Boc protected 5-hydroxy guvacine scaffold 20 was obtained by means of 
oxidation of product 17 (see Chart 2) by meta-chloroperbenzoic acid followed by elimination to give 
intermediate 20. After removal of N-Boc protecting group, the corresponding alkylation16 furnished targets 
21a (SL42/77/1), 21b (SL42/81/1), 21c (SL42/80/1), 21d (SL42/79/1) and 21e (SL42/82/1). Hydrolysis of 
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the said products with hydrogen chloride furnished the end products 22a (SL42/87/1), 22b (SL42/86/1), 
22c (SL42/85/1), 22d (SL42/84/1) and 22e (SL42/88/1) (see Chart 2). 
1.2.2 Screening of the glycosidase activity 
All the compounds underwent initial testing at 100 µM level. Given the presence of a carboxyl residue 
in sp2 configuration on the azasugar mimicking the transition state of uronic acid, in addition to α-
glucosidase the compounds were also tested on α-glucuronidase and hyluronidase (Table 1).  
Table 1*: Effect of a series of compounds tested at 100 µM on a set of glycolytic enzymes. 
 
β-glucosidase 
(Almonds) 
β-glucuronidase 
(Helixpomatia) 
α-glucosidase 
S.cereviasie 
Hyaluronidase 
(Bovinetestes) 
β-mannosidase 
(Jackbean) 
β-mannosidase 
(Helixpomatia) 
SL34/14/1 - 95 100 103 - - 
SL34/56/1 - 89 97 100 - - 
SL34/57/1 - 95 99 99 - - 
SL34/58/1 - 96 95 101 - - 
SL34/59/1 - 102 102 99 - - 
SL34/68/1 - 108 85 100 - - 
SL34/70/1 - 103 95 100 - - 
SL34/71/1 - 104 97 100 - - 
SL34/72/1 - 102 82 100 - - 
SL34/81/1 - 102 82 100 - - 
SL42/05/1 - 100 93 100 - - 
 SL42/06/1 - 100 97 102 - - SL42/27/1 88.7 96.3 109 100 104 97 
SL42/77/1 71.7 93 92 99 84 100 
SL42/79/1 83.3 105 94 99 98 107 
SL42/80/1 86.8 102 105 99 104 111 
SL42/81/1 82.3 103 97 100 93 78 
SL42/82/1 87.4 97 95 100 101 71 
SL42/84/1 99.2 103 3 104 78 89 
SL42/85/1 96.5 100 2 102 94 117 
SL42/86/1 90.4 103 2 101 79 96 
SL42/87/1 99.6 97 95 101 104 97 
SL42/88/1 111.3 102 3 100 85 96 
*: The compounds were dissolved in DMSO not to exceed 1% of the total volume. The results were computed as percent of 
the enzymatic activity measured in the presence of DMSO alone. Details on the individual assays are given in the text. 
None displayed activity toward these two enzymes. On the other hand, SL42/84/1, SL42/85/1, 
SL42/86/1 and SL42/88/1 were identified as potent α-glucosidase inhibitors. The IC50 of these compounds, 
evaluated over a concentration ranging between 0.1 to 100 µM, fell between 2 and 12 µM. Compound 
SL42/85/1 displayed the highest inhibitory activity with IC50 of 2.2 µM.  An inspection of the structure of 
the active compounds points to key features that are required for activity. Beside the critical presence of the 
5-hydroxy residue not replaceable by the same substituent in 4 position as in SL34/70/1, SL34/71/1, 
SL34/68/1, a 3-carboxylate residue on the piperidine ring appears crucial since its esterification, as in 
compounds SL42/79/1, SL42/80/1, SL42/81/1 and SL42/82/1, lead to loss of activity. By the same token, 
the presence of an N-substituent carrying an electron-dense region, appears critical given the absence of 
activity of SL42/87/1 in which the pyridine or the 1,3-diazacyclohexan-2,6-dione rings are replaced by a 
benzene ring. The remarkable inhibitory activity of these compounds in spite of the reduced protonability 
of the tertiary amine and the other major structural changes introduced in comparison to the known α-
glucosidase inhibitors, such as the reduced hydroxylation of the piperidine ring, lead us to consider the 
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possibility they could act through a different mechanism than that of the canonical transition state analogue 
of the D-glucosyl cabocation. Studies are currently on the way to confirm this hypothesis.  
1.2.3 Conclusions  
In the present investigation, a series of N-heteroarylmethyl 3-carboxy-5-hydroxy piperidine 
compounds was found endowed with potent α-glucosidase inhibitory activity. Distinctly from acarbose and 
the other clinically available inhibitors, the compounds displayed uncompetitive modality of enzyme 
inhibition which makes them good candidates for in vivo testing. The results from the biological evaluation 
of compounds whose structure is comprised within a rather limited chemical space have allowed the 
identification of structural features that are critical for the activity of this novel class of α-glucosidase 
inhibitors. A carboxylate and single hydroxyl residues properly positioned on the azasugar ring along with 
a suitable aglicone attached to the protonable nitrogen, were found to be necessary as well as sufficient for 
activity. The simple scaffold and the significant inhibitory activity observed are good starting points for 
further structural investigations on these molecules. The data gathered fill, at least in part, the inadequacy 
of information on the structure-activity relationship of uncompetitive α-glucosidase inhibitors and should 
serve as basis for the design and development of novel therapeutics for the treatment of diabetes mellitus 
and other diseases in which α-glucosidase is involved. 
1.3 Experimental section 
1.3.1 Chemistry: Material and Methods 
All starting materials, unless otherwise stated, were purchased and used without any further 
purification. The starting material for the 4-hydroxy-piperidine-3-carboxylic acid scaffold was the 
commercially available ethyl 1-benzyl-4-oxopiperidine-3-carboxylate from Sigma Aldrich. For the 
compounds reported into Chart 2 the starting material was the commercially available Arecoline 
hydrobromide from Qingdao Sicemo, LTD, Qingdao, China. Solvents were distilled and dried according to 
standard procedures. Column chromatography was performed using Merck KGaA Silicagel 60 (230-400 
Mesh-ASTM). Melting points were obtained using a Stuart Scientific SMP3 Melting Point apparatus. IR 
spectra were recorded on a Nicolet 380 FT-IR infrared spectrometer.  NMR spectroscopy was performed 
on a Varian-Mercury 400 spectrometer using the residual signal of the solvent as the internal standard. The 
chemical shifts are reported in ppm and coupling constants (J) in Hz. GC–MS spectra were recorded using 
Agilent Technologies 6850 and 5975 GC-Mass instrumentation. LC–MS spectra were obtained using an 
Agilent Technologies MSD1100 single-quadrupole mass spectrometer. Elemental analyses were obtained 
at Laboratorio Scienze Ambientali (Ravenna, Italy) using a Flash 2000, series CHNS/O Analyzer (Thermo 
Scientific).  
Preparation of ethyl 1-benzyl-4-hydroxypiperidine-3-carboxylate 2 (SL34/14/1) 
Ethyl 1-benzyl-4-oxo-3-piperidine carboxlate hydrochloride 1 (5 g, 16.8 mmol) was dissolved into 
130 mL methanol. NEt3 (2.3 mL, 16.8 mmol) was dropped into this solution at 0℃ and kept stirring for 10 
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min at this temperature. NaBH4 (2.1 g, 3.0 eq) was added into the reaction mixture in portions. The reaction 
mixture was kept at 0℃ for 2hrs. HClaq (5M) was added to adjust the pH =2~3. The solvent was partially 
removed to small volume under vacuum and the residue was neutralized by saturated NaHCO3 solution. 
This mixture was extracted by CH2Cl2 (30mL×3). The organic phase was dried (Na2SO4) and the solvent 
removed under vacuum to get 3.64 g of yellow liquid as a mixture of two diastereomers which was purified 
by flash chromatography (AcOEt: cyclohexane =3:2) to give product 2 (SL34/14/1) (3.64 g, ratio: 
trans/cis=4/7, yield: 82.7%). 
Spectra for (3S*, 4S*)-ethyl 1-benzyl-4-hydroxypiperidine-3-carboxylate 2a 
IR (film): 1731 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.18 (t, J=7.2 Hz, 3H), 1.57 (m, 1H), 1.87 (m, 
1H), 2.03 (m, 2H), 2.53 (m, 1H), 2.78 (m, 1H), 3.04 (m, 1H), 3.45 (qAB, J=13.6 Hz, 2H), 3.71 (m, 1H), 4.08 
(m, 2H), 7.15-7.27 (m, 5H); 13C NMR (100 MHz, CDCl3) δ= 14.12, 32.57, 49.64, 51.33, 53.41, 60.88, 
62.24, 69.67, 127.8, 128.28, 128.96, 173.38; MS (EI) m/z =263 [M]; Elemental Analysis: Calcd. for 
C15H21NO3: C, 68.42; H, 8.04; N, 5.32; O, 18.23; Found: C, 68.64; H, 8.07; N, 5.34 
Spectra for (3S*, 4R*)-ethyl 1-benzyl-4-hydroxypiperidine-3-carboxylate 2b 
IR (film): 1731 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.16 (t, J=7.2 Hz, 3H), 1.71 (m, 1H), 1.80 (m, 
1H), 2.41 (m, 2H), 2.58 (m,1H), 2.68 (m, 2H), 3.41 (qAB, J=13.2 Hz, 2H), 4.01 (m, 1H), 4.08 (m, 2H), 
7.15-7.26 (m, 5H); 13C NMR (100 MHz, CDCl3) δ= 14.08, 31.51, 46.17, 50.62, 60.76, 62.70, 77.50, 127.19, 
128.24, 129.08, 173.70; MS (EI) m/z = 263 [M]. 
Preparation of sodium 1-benzyl-4-hydroxypiperidine-3-carboxylates 3 and 4 (SL34/81/1) 
Compound 2 (150 mg, 0.57 mmol) was mixed with NaOHaq (0.32 mL, 2 M) and MeOH (3 mL) for 3 
hrs at r.t. After the reaction completed, the solvent was removed under vacuum. The residue was treated 
with anhydrous MeOH and filtered. The filtrate was concentrated under vacuum to get the mixture of two 
diastereomers (SL34/81/1) (140 mg, ratio: trans/cis= 2:3, yield: 95%) 
Spectral data of mixture SL34/81/1 
Sodium (3S*, 4S*)-1-benzyl-4-hydroxypiperidine-3-carboxylate 3 
IR (film): 1644 cm−1; 1H NMR (400 MHz, CD3OD) δ=1.57 (dq, J1=4.0 Hz, J2=10.8 Hz, 1H), 1.88 (m, 
1H), 2.05 (m, 2H), 2.31 (ddd, J1=4.0 Hz, J2=1.2 Hz, J2=10.0 Hz,1H), 2.88 (m, 1H), 3.15 (m, 1H), 3.54 (qAB, 
J=12.8 Hz, 2H), 3.61 (dt, J1=4.8 Hz, J2=10.8 Hz, 1H), 7.30 (m, 5H); 13C NMR (100 MHz, CDCl3) δ= 33.94, 
49.43, 53.01, 55.88, 63.68, 71.89, 128.32, 129.25, 130.75, 138.61, 181.01; MS (ESI) m/z =234 [M-Na]-; 
Elemental Analysis: Calcd. for C13H16NNaO3: C, 60.69; H, 6.27; N, 5.44; Na, 8.94; O, 18.66;  Found: C, 
60.85; H, 6.29; N,5.45.  
Sodium (3S*, 4R*)-1-benzyl-4-hydroxypiperidine-3-carboxylate 4 (for the spectra of 
corresponding acid derivative see product 7d) 
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IR (film): 1644 cm−1; 1H NMR (400 MHz, CD3OD) δ=1.75 (m, 2H), 2.44(m, 1H), 2.52 (m, 3H), 2.86 
(m, 1H), 3.54 (qAB, J=12.8 Hz, 2H), 4.11 (m, 1H), 7.30 (m, 5H); 13C NMR (100 MHz, CDCl3) δ= 32.16, 
49.63, 52.57, 55.87, 64.22, 66.87, 128.26, 129.21, 130.65, 138.55, 181.56; MS (ESI) m/z =234 [M-Na]-. 
Preparation of (3S*, 4R*)-ethyl 1-benzyl-4-hydroxypiperidine-3-carboxylate 2b and (3S*, 4S*)-
ethyl 1-benzyl-4-(ter-butyldimethylsilyloxy)piperidine-3-carboxylate 5. 
The inseparable mixture of two diastereomers 2 (2.5 g, 9.5 mmol), was treated with imidazole (0.36 g, 
5.2 mmol) and TBDMSCl (0.72 g, 4.75 mmol) in anhydrous DMF (16 mL) at r.t. After stirring for 5hrs the 
reaction mixture was decomposed with ice/water and extracted with CH2Cl2 (3×30 mL). The organic phase 
was washed by brine, dried by sodium sulphate and the solvent removed under vacuum to get yellow oil 
(3.3 g). Purification by flash chromatography (Ether : Cyclohexane=1:1) gave 2b (1.17 g) and 5 (1.31 g) in 
85% overall yields. Spectral data as follow: 
(3S*, 4R*)-ethyl 1-benzyl-4-hydroxypiperidine-3-carboxylate 2b （ for spectral data see 
compound 2） 
(3S*, 4S*)-ethyl-1-benzyl-4-(ter-butyldimethylsilyloxy)piperidine-3-carboxylate 5 
IR (film): 1732 cm−1; 1H NMR (400 MHz, CDCl3) δ= 0.01 (s, 3H), 0.04 (s, 3H), 0.85 (s, 9H), 1.23 (t, 
J= 7.2 Hz, 3H), 1.65 (m, 1H), 1.84 (m, 1H), 2.16 (t, J=12.0 Hz, 1H), 2.28 (t, J=12.0 Hz, 1H), 2.62 (dt, 
J1=2.8 Hz, J2=12.0 Hz, 1H), 2.80 (m, 1H), 2.89 (d, J=10.8 Hz, 1H), 3.52 (s, 2H), 3.90 (ddd, J1=4.0 Hz, 
J2=4.4 Hz, J3=5.6 Hz, 1H), 4.09 (m, 2H), 7.20-7.31(m, 5H); 13C NMR (100 MHz, CDCl3) δ= 14.13, 20.26, 
32.57, 44.42, 46.92, 60.80, 66.08, 173.82; MS (EI) m/z =377 [M]; Elemental Analysis: Calcd. for 
C21H35NO3Si: C, 66.80; H, 9.34; N, 3.71; O, 12.71; Si, 7.44; Found: C,66.98; H, 9.37; N, 3,72. 
Preparation of (3S*, 4R*)-ethyl 4-hydroxypiperidine-3-carboxylate hydrochloride 6 
Product 2b (1.03 g, 3.9 mmol), Pd/C 10% (1.0 g) and EtOH (100 mL) were mixed together and left to 
react in Parr apparatus for 1.5 hrs under hydrogen pressure (15 psi). The reaction mixture was filtered 
through celite. The filtrate was concentrated under vacuum to obtain, as yellow oil, compound 6 (0.65 g, 
Yield: 96%). Spectral data were superimposable with literature data.20 
Synthesis of (3S*, 4R*)-4-hydroxy-1-(heteroarylmethyl)piperidine-3-carboxylic acids: 
Preparation of (3S*, 4R*)-4-hydroxy-1-(pyridin-2-yl-methyl)piperidine-3-carboxylic acid 7a 
(SL34/70/1) as general procedure. 
Compound 6 (87 mg, 0.5 mmol), 2-(bromomethyl)-pyridine hydrobromide (126 mg, 0.5 mmol), N,N-
diisopropyl ethyl amine (0.35 mL, 2.0 mmol) and CH3CN (10 mL) were mixed together at 0℃. The 
reaction was kept at r.t. for 5 hrs. After the reaction completed (t.l.c. test) the solvent was concentrated 
under vacuum and the residue was dissolved in 20 mL CH2Cl2. The organic phase was washed by saturated 
NaHCO3. The aqueous phase was extracted by CH2Cl2 (15 mL×2). The organic phase was collected, dried 
with sodium sulphate and the solvent removed under vacuum to afford a residue which was purified by 
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flash chromatograph (AcOEt: MeOH=1:1) to get pure compound 7a (SL34/70/1) (100 mg, yield: 75.8%) 
identified as ethyl ester. Spectral data as follow 
Ethylester of (3S*, 4R*)-4-hydroxy-1-(pyridin-2-yl-methyl)piperidine-3-carboxylic acid 7a 
IR (film): 1728 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.17 (t, J=6.4 Hz, 3H), 1.81 (m, 2H), 2.51 (m, 
2H), 2.71(m, 2H), 3.38 (bs, 1H, OH), 3.64 (qAB, J=14.4 Hz, 2H), 4.11(m, 3H), 7.11(m, 1H), 7.34 (d, J=8.0 
Hz, 1H), 7.59 (dt, J1=2.0 Hz, J2=7.6 Hz, 1H), 8.50 (m, 1H); 13C NMR (100 MHz, CDCl3) δ= 14.05, 31.71, 
46.30, 47.13, 50.32, 60.61, 64.26, 65.74, 121.98, 122.98, 136.35, 149.10, 158.49, 173.56; MS (EI) m/z 
=264 [M]; Elemental Analysis: C14H20N2O3 C, 63.62; H, 7.63; N, 10.60; O, 18.16; Found: C, 63.81; H, 
7.65; N, 10.63. 
Product 7a (L34/70/1) was obtained by treatment of the corresponding ester (100 mg, 0.43 mmol) 
with NaOHaq (0.32 mL, 2 M) and MeOH (2.5 mL) at r.t. for 5 hrs. The solvent was removed under vacuum 
to get a crude mixture which was purified by flash chromatography (AcOEt: acetone: H2O: CH3COOH= 
5:3:2:2) to get pure 7a (87 mg, yield: 92%) 
IR (film): 1658 cm−1; 1H NMR (400 MHz, CD3OD) δ= 1.79 (m, 2H), 2.48 (m, 1H), 2.55 (m, 2H), 
2.70 (bs, 2H), 3.61 (qAB, J=13.6 Hz, 2H), 4.05 (bs, 1H), 7.33 (m, 1H), 7.30 (m, 1H), 7.54 (d, J=7.6 Hz, 1H), 
7.81 (dt, J1=1.2 Hz, J2=7.6 Hz, 1H), 8.48 (m, 1H); 13C NMR (100 MHz, CD3OD) δ= 32.57, 49.63, 49.85, 
53.10, 65.09, 66.74, 123.78, 125.20, 138.60, 149.70, 159.44, 181.52; MS (EI) m/z =235 [M-H]-; Elemental 
Analysis: Calcd. for C12H16N2O3: C, 61.00; H, 6.83; N, 11.86; O, 20.32;  Found: C, 61.15; H, 6.85; N, 
11.89. 
Preparation of (3S*, 4R*)-4-hydroxy-1-(pyridin-3-ylmethyl)piperidine-3-carboxylic acid 7b 
(SL34/71/1). 
This product was prepared following the above reported procedure for SL34/70/1. Starting from 
compound 6 (87 mg, 0.5 mmol), 3-(bromomethyl)-pyridine hydrobromide (126 mg, 0.5 mmol), the ethyl 
ester of 7b was obtained after the flash chromatography (AcOEt: MeOH=1:1) (95 mg, yield: 72%). 
IR (film): 1728 m−1; 1H NMR (400 MHz, CDCl3) δ= 1.17 (t, J=7.2 Hz, 3H), 1.76 (m, 1H), 1.82 (m, 
1H), 2.46 (m, 2H), 2.67 (m, 2H), 3.50 (bs, 1H), 3.50 (qAB, J=13.6 Hz, 2H), 4.10 (m, 3H), 7.21 (dd, J1=4.8 
Hz, J2=7.6 Hz,1H), 7.62 (d, J=7.6 Hz, 1H), 8.46 (d, J=14.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ= 
14.05, 31.76, 46.33, 48.12, 50.93, 59.95, 60.66, 65.94, 123.28, 133.77, 136.59, 148.42, 150.19, 173.41; MS 
(EI) m/z =264 [M]; Elemental Analysis: Calcd. for C14H20N2O3: C, 63.62; H, 7.63; N, 10.60; O, 18.16;  
Found: C, 63.80; H, 7.65; N, 10.63. 
 
Following the same procedure for the preparation of compound SL34/70/1, the ethyl ester of 
compound 7b (95 mg, 0.41 mmol) was treated with NaOHaq (0.31 mL, 2 M) and MeOH (2.5 mL). After 
chromatography (AcOEt: acetone: H2O: CH3COOH= 5:3:2:2) 7b was obtained (85 mg, yield: 94.4%) 
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IR (film): 1654 cm−1; 1H NMR (400 MHz, CD3OD) δ= 1.75 (m, 2H), 2.49 (m, 3H), 2.73 (m, 1H), 
3.58 (qAB, J=13.6 Hz, 2H), 4.10 (m, 1H), 7.40 (dd, J1=5.6 Hz, J2=8.0 Hz, 1H), 7.84 (dt, J1=1.6 Hz, J2=8.0 
Hz, 1H), 8.43 (dd, J1=1.2 Hz,J2=4.8 Hz, 1H), 8.51 (d, J=1.6 Hz, 1H); 13C NMR (100 MHz, CD3OD) δ= 
32.49, 49.43, 49.63, 51.32, 51.32, 61.05, 66.78, 125.03, 125.07, 135.60, 139.35, 148.92, 151.00, 181.46; 
MS (EI) m/z =235 [M-H]-; Elemental Analysis: Calcd. for C12H16N2O3: C, 61.00; H, 6.83; N, 11.86; O, 
20.32; Found: C, 61.16; H, 6.85; N, 11.89. 
Preparation of (3S*, 4R*)-4-hydroxy-1-(pyridin-4-ylmethyl)piperidine-3-carboxylic acid 7c 
(SL34/68/1). 
This product was prepared following the above reported procedure for SL34/70/1. Starting from 
compound 6 (87 mg, 0.5 mmol), 4-(bromomethyl)-pyridine hydrobromide (126 mg, 0.5 mmol), ethyl ester 
of 7c was obtained after the flash chromatography (AcOEt: MeOH=1:1) (100 mg, yield: 75.8%) 
IR (film): 1728 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.17 (t, J=7.2 Hz, 3H), 1.79 (m, 2H), 2.45 (m, 
2H), 2.66 (m, 2H), 3.48 (qAB, J=14.8 Hz, 2H), 3.66 (bs, 1H, OH), 4.08 (q, J=7.2 Hz, 2H), 4.13(m, 1H), 7.21 
(d, J=6.0 Hz, 2H), 8.45 (dd, J1=1.2 Hz, J2=4.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ= 14.06, 31.86, 
46.41, 48.02, 51.03, 60.63, 61.47, 65.11, 123.67, 147.87, 149.50, 149.54, 173.29; MS (EI) m/z =264 [M]; 
Elemental Analysis: Calcd. for C14H20N2O3: C, 63.62; H, 7.63; N, 10.60; O, 18.16;  Found: C, 63.79; H, 
7.65; N, 10.63. 
 
Following the same procedure for the preparation of compound SL34/70/1, starting from the 
corresponding ethyl ester of 7c (100 mg, 0.43 mmol), NaOHaq (0.33 mL, 2 M) and MeOH (2.5 mL), 
compound 7c was obtained after chromatography (AcOEt: acetone: H2O: CH3COOH= 5:3:2:2) (80 mg, 
yield: 84.6%) 
IR (film): 1658 cm−1; 1H NMR (200 MHz, CD3OD) δ= 1.77 (m, 2H), 2.58 (m, 4H), 3.57 (s, 2H), 4.06 
(s, 1H), 7.40 (m, 2H), 8.40 (m, 2H); 13C NMR (100 MHz, CD3OD) δ= 32.59, 49.45, 49.66, 52.83, 62.58, 
66.81, 125.80, 125.84, 149.94, 150.02, 150.42, 181.49; MS (EI) m/z =235 [M-H]-; Elemental Analysis: 
Calcd. for C12H16N2O3: C, 61.00; H, 6.83; N, 11.86; O, 20.32 ;  Found: C, 61.14; H, 6.85; N, 11.89. 
 
Preparation of (3S*, 4R*)-1-benzyl-4-hydroxypiperidine-3-carboxylic acid 7d (SL34/72/1) 
Compound 7d (SL34/72/1) was obtained by hydrolysis of compound 2b (100 mg, 0.43 mmol), 
NaOHaq (0.33 mL, 2 M) and MeOH (2.5 mL), removal of the solvent and flash chromatography of the 
residue (AcOEt: acetone: H2O: CH3COOH= 5:3:1:1) (88 mg, yield: 93.6%). 
IR (film): 1644 cm−1; 1H NMR (400 MHz, CD3OD) δ= 1.76 (m, 2H), 2.44 (m, 1H), 2.53 (m, 3H), 2.83 
(m, 1H), 3.54 (qAB, J=13.2, 2H), 4.10 (m, 1H), 7.22-7.35 (m, 5H); 13C NMR (100 MHz, CD3OD) δ= 34.77, 
51.86, 52.08, 52.29, 66.90. 69.82, 130.94, 131.89, 133.46, 141.24, 184.22; MS (EI) m/z = 234 [M-H]-; 
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Elemental Analysis: Calcd. for C13H17NO3:C, 66.36; H, 7.28; N, 5.95; O, 20.40; Found: C, 66.58; H, 7.30; 
N, 5.97. 
Preparation of methyl 1,2,5,6-tetrahydropyridine-3-carboxylate hydrochloride 9 
The pH of a solution of arecoline hydrobromide 8 (Qingdao Sicemo, LTD, Qingdao, China) (15.0 g) 
in water (30 mL) was adjusted to pH=13~14 by saturated Na2CO3 solution. This solution was extracted by 
ether (50 mL×3). The yellow oil (Arecoline, 9.8 g) was obtained after drying and removing the solvent.  
Arecoline (1.55 g, 10 mmol) was dissolved into 35mL CH2Cl2. A mixture of ACE-Cl (1.2 mL, 
11mmol) and ClCH2CH2Cl (2 mL) was dropped into the reaction mixture at 0 °C and kept stirring for 15 
min. The temperature was risen to 100 °C and the mixture refluxed for 6 hrs (monitor by TLC). The solvent 
was removed under vacuum. The residue was dissolved into 25 mL methanol. This reaction mixture was 
kept refluxing at 110 °C for 6 hrs until the reaction completed (monitor by TLC: AcOEt : 
Cyclohexane=3:2). Then the solvent was removed to get compound 9 (0.83 g, two steps overall yield: 
58.5%). This product is directly used in the next step without any further purification. 
IR (film): 1710 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.72 (s, 1H, NH), 2.19 (m, 2H), 2.87 (t, J=5.7 
Hz, 2H), 3.49 (m, 2H), 3.68 (s, 3H), 6.99 (m, 1H); 13C NMR (100 MHz, CDCl3) δ= 26.15, 41.83, 44.02, 
51.40, 130.26, 138.22, 166.41; MS (EI) m/z =141 [M-HCl];  Elemental Analysis: Calcd. for C7H12ClNO2: 
C, 47.33; H, 6.81; Cl, 19.96; N, 7.89; O, 18.01; Found: C, 47.48; H, 6.83; N, 7.92. 
 
Synthesis of sodium-1-(heteroarylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylates: 
Preparation of sodium-1-benzyl-1,2,5,6-tetrahydropyridine-3-carboxylate 10a (SL34/56/1) as 
general procedure. 
NaHCO3 (179 mg, 2.24 mmol) and EtOH (20 mL) were mixed together and keeping stirring at 0 °C 
for 5mins. Then product 9 (100 mg, 0.56 mmol) and (bromomethyl)-benzene (96.6 mg, 0.56 mmol) were 
added into the mixture at 0° C. The reaction mixture was refluxed at 110 °C for 5 hrs until the reaction was 
completed (t.l.c. test). The solvent was removed under vacuum and the residue was dissolved with 20 mL 
CH2Cl2. The organic phase was washed by saturated NaHCO3. The aqueous phase was extracted by 
CH2Cl2 (15mL×3). The organic phase was collected, dried with sodium sulphate and concentrated under 
vacuum to get crude product. This crude product was purified by flash chromatography (AcOEt: 
cyclohexane = 1:4) to get 10a-methyl ester (50 mg, yield: 55.7%) which was identified by its spectral data. 
IR (KBr): 1722 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.33 (m, 2H), 2.54 (t, J=5.6 Hz, 2H), 3.24 (m, 
2H), 3.66 (s, 2H), 3.73 (s, 3H), 7.02 (m, 1H), 7.25-7.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ=  26.55, 
48.30, 51.47, 51.62, 62.44, 127.12, 128.28, 129.05, 138.00, 166.35; MS (EI) m/z =231 [M]; Elemental 
Analysis: Calcd. for C14H17NO2: C, 72.70; H, 7.41; N, 6.06; O, 13.83; Found: C, 72.90; H, 7.43; N, 6.08. 
Methyl ester derivative of 10a (45 mg) was dissolved in 1 mL of MeOH. Then 0.145 mL of NaOHaq 
(2 M) was added. This reaction mixture was kept at 50 °C for 2.5 hrs. After the reaction completed, the 
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solvent was removed under vacuum to get the crude product. This crude product was dissolved into the 
anhydrous MeOH and filtered. The filtrate was concentrated under vacuum to get the pure 10a (SL34/56/1) 
(40 mg, yield: 85%) 
IR (film): 1700 cm−1; 1H NMR (400 MHz, CD3OD) δ= 2.63 (m, 2H), 3.31 (m, 4H), 4.44 (s, 2H), 7.21 
(m, 1H), 7.44-7.59 (m, 5H); 13C NMR (100 MHz, CD3OD) δ= 23.91, 60.79, 125.41, 130.26, 130.39, 
131.29, 132.41, 138.05, 138.08, 166.65; MS (ESI) m/z = 216 [M-Na]- ; Elemental Analysis: 
Calcd.forC13H14NNaO2: C, 65.26; H, 5.90; N, 5.85; Na, 9.61; O, 13.37; Found: C, 65.48; H, 5.92; N, 5.87. 
 
Preparation of sodium 1-(pyridin-2-ylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylate 10b 
(SL34/58/1) 
Following the same procedure for the preparation of compound (SL34/56/1), starting from NaHCO3 
(239 mg, 2.84 mmol), EtOH (20 mL), product 9 (126 mg, 0.71 mmol) and 2-(bromomethyl)pyridine 
hydrobromide (179 mg, 0.71 mmol), compound 10b-methyl ester was obtained after flash chromatography 
(AcOEt : MeOH =9 :1) (127 mg, yield: 77.0%) 
IR (film): 1722 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.36 (m, 2H), 2.61 (t, J=5.6 Hz, 2H), 3.28 (qAB, 
J= 2.8 Hz, 2H), 3.71 (s, 3H), 3.80 (s, 1H), 7.02 (m, 1H), 7.17 (m, 1H), 7.42 (d, J=8.0 Hz, 1H), 8.44 (dt, 
J1=1.2 Hz, J2=7.6 Hz, 1H), 8.57 (d, J=4.8 Hz , 1H); 13C NMR (100 MHz, CDCl3) δ= 26.46, 48.73, 51.62, 
63.96, 122.07, 122.99, 128.93, 136.45, 137.94, 149.25, 158.48, 166.79; MS (EI) m/z =232[M]; Elemental 
Analysis: Calcd. for C13H16N2O2: C, 67.22; H, 6.94; N, 12.06; O, 13.78; Found: C, 67.46; H, 6.96; N, 12.10. 
Following the same procedure for the preparation of compound (SL34/56/1), starting from the 
corresponding ester of 10b (87 mg, 0.38 mmol), and 0.28 ml of NaOHaq (2 M), compound 10b (SL34/58/1) 
was obtained (72 mg, yield: 80%) 
IR (film): 1662 cm−1; 1H NMR (400 MHz, CD3OD) δ= 2.29 (m, 2H), 2.57 (t, J=5.6 Hz, 2H), 3.27 (dd, 
J1=2.8 Hz, J2=4.8 Hz, 2H), 3.79 (s, 2H), 6.69 (m, 1H), 7.32 (dddd, J1=1.2 Hz, J2=4.8 Hz, J3=7.6 Hz, 1H), 
7.56 (dt, J1=7.6 Hz, J2=1.2 Hz, 1H), 7.83 (dt, J1=2.0 Hz, J2=7.6 Hz, 1H), 8.50 (m, 1H); 13C NMR 
(100 MHz, CD3OD) δ= 26.85, 50.30, 54.39, 64.61, 123.92, 125.24, 132.14, 135.78, 138.70, 149.65, 159.21, 
174.70; MS (ESI) m/z = 217 [M-Na]-; Elemental Analysis: Calcd. for C12H13N2NaO2: C, 60.00; H, 5.45; N, 
11.66; Na, 9.57; O, 13.32; Found: C, 60.17; H, 5.47; N, 11.69. 
 
Preparation of sodium 1-(pyridin-3-ylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylate 10c 
(SL34/59/1) 
Following the same procedure for the preparation of compound SL34/56/1, starting from NaHCO3 
(239 mg, 2.84 mmol), EtOH (20 mL), product 9 (126 mg, 0.71 mmol) and 3-(bromomethyl)pyridine 
hydrobromide (179 mg, 0.71 mmol), compound (SL34/59/1-methyl ester) was obtained after flash 
chromatography (AcOEt : MeOH =98:2) (70 mg, yield: 42.4%) 
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IR (film): 1712 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.31 (m, 2H), 2.53 (t, J=5.6 Hz, 2H), 3.20 (m, 
2H), 3.63 (s, 2H), 3.70 (s, 3H), 7.00 (m, 1H), 7.24 (m, 1H), 7.67 (d, J= 8.0 Hz, 1H), 8.50 (d, J= 4.4 Hz, 1H), 
8.55 (s, 1H); 13C NMR (100 MHz, CDCl3) δ= 26.44, 48.35, 51.53, 51.56, 59.58, 123.36, 128.79, 133.52, 
136.56, 137.90, 148.68, 150.30, 166.17; MS (EI) m/z =232 [M]; Elemental Analysis: Calcd. for 
C13H16N2O2: C, 67.22; H, 6.94; N, 12.06; O, 13.78; Found: C,67.38; H, 6.96; N,12.09. 
Following the same procedure for the preparation of compound (SL34/56/1), starting from the 
SL34/59/1-methyl ester (70 mg, 0.30 mmol), and 0.23 ml of NaOHaq (2 M), compound 10c (SL34/59/1) 
was obtained (60 mg, yield: 83%) 
IR (film): 1663 cm−1; 1H NMR (400 MHz, CD3OD) δ= 2.30 (m, 2H), 2.60 (t, J=5.6 Hz, 2H), 3.21 (dd, 
J1=2.4 Hz, J2=4.4 Hz, 2H), 3.70 (s, 2H), 6.69 (m, 1H), 7.41 (dddd, J1=0.8 Hz, J2=5.2 Hz, J3=7.6 Hz, 1H), 
7.89 (dt, J1=1.6 Hz, J2=8.0 Hz, 1H), 8.45 (dd, J1=1.6 Hz, J2=4.8 Hz, 1H), 8.53 (m, 1H); 13C NMR 
(100 MHz, CD3OD) δ= 26.80, 50.11, 54.11, 60.57, 125.12, 125.14, 132.04, 132.16, 135.36, 135.61, 139.51, 
148.99, 151.12, 174.59; MS (ESI) m/z =217 [M-Na]-; Elemental Analysis: Calcd. for C12H13N2NaO2: C, 
60.00; H, 5.45; N, 11.66; Na, 9.57; O, 13.32; Found: C, 60.19; H, 5.47; N, 11.70. 
 
Preparation of sodium 1-(pyridin-4-ylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylate 10d 
(SL34/57/1) 
Following the same procedure for the preparation of compound SL34/56/1, starting from NaHCO3 
(239 mg, 2.84 mmol), EtOH (20 mL), product 9 (126 mg, 0.71 mmol) and 4-(bromomethyl)pyridine 
hydrobromide (179 mg, 0.71 mmol), compound (SL34/57/1-methyl ester) was obtained after flash 
chromatography (AcOEt : MeOH =8:1) (80 mg, yield: 48.5%) 
IR (film): 1710 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.35 (m, 2H), 2.52 (m, 2H), 3.22 (m, 2H), 3.64 
(s, 2H), 3.72 (s, 3H), 7.02 (m, 1H), 7.28 (d, J= 6.0 Hz, 2H), 8.54 (m, 2H); 13C NMR (100 MHz, CDCl3) δ= 
26.44, 48.59, 51.51, 51.65, 61.12, 123.67, 128.81, 137.88, 147.50, 149.83, 165.15; MS (EI) m/z =232 [M]; 
Elemental Analysis: Calcd. for C13H16N2O2: C, 67.22; H, 6.94; N, 12.06; O, 13.78; Found: C, 67.41; H, 
6.96; N, 12.09. 
Following the same procedure for the preparation of compound (SL34/56/1), starting from SL34/57/1-
methyl ester (150 mg, 0.56 mmol), and 0.70 ml of NaOHaq (2 M), compound 10d (SL34/57/1) was 
obtained (114 mg, yield: 85%) 
IR (film): 1666 cm−1; 1H NMR (400 MHz, CD3OD) δ= 2.31 (m, 2H), 2.55 (t, J=6.0 Hz, 2H), 3.22 (dd, 
J1=2.4 Hz, J2=4.8 Hz, 2H), 3.70 (s, 2H), 6.69 (m, 1H), 7.46 (d, J=7.2 Hz, 2H), 8.46 (d, J=7.2 Hz, 2H); 13C 
NMR (100 MHz, CD3OD) δ= 26.84, 50.31, 54.30, 62.24, 125.93, 125.96, 132.03, 132.14, 135.68, 149.99, 
150.07, 174.61; MS (EI) m/z =217 [M-Na]- ; Elemental Analysis: Calcd. for C12H13N2NaO2: C, 60.00; H, 
5.45; N, 11.66; Na, 9.57; O, 13.32; Found: C, 60.18; H, 5.47; N,11.69. 
Preparation of sodium 1-((2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)-1,2,5,6-
tetrahydropyridine-3-carboxylate 10e (SL42/06/1) 
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Product 9 (150 mg, 0.85 mmol), 6-(chloromethyl)uracil (137 mg, 0.85 mmol) and diisopropyl ethyl 
amine (0.739 mL, 4.25 mmol) were mixed in 15 mL of CH3CN. This reaction mixture was kept at r.t. for 3 
hrs. After the reaction completed (t.l.c testing), the solvent was removed under vacuum to get the crude 
product. This crude product was purified after flash chromatography (AcOEt : MeOH =3:1) to get 
SL42/06/1-methyl ester (150 mg, yield: 66.7%) 
IR (film): 1733, 1716, 1700, 1653 cm−1; 1H NMR (400 MHz, CD3OD) δ= 2.40 (m, 2H), 2.58 (t, J=6.0 
Hz, 2H), 3.23 (qAB, J=2.8 Hz, 2H), 3.42 (d, J= 1.2 Hz, 2H), 3.73 (s, 3H), 4.35 (s, 1H), 7.03 (m, 1H); 13C 
NMR (100 MHz, CD3OD) δ= 27.19, 41.27, 48.37, 52.21, 58.66, 100.40, 129.61, 139.33, 155.35, 167.64; 
MS (EI) m/z = 266 [M+1]; Elemental Analysis: Calcd. for C12H15N3O4: C, 54.33; H, 5.70; N, 15.84; O, 
24.13; Found: C, 54.43; H, 5.71; N, 15.87. 
The SL42/06/1-methyl ester (50 mg, 0.18 mmol) was treated with NaOHaq (2 M, 0.43 mL) at 50°C 
for 3 hrs. After the hydrolysis was completed, the solvent was removed under vacuum. The residue was 
dissolved in anhydrous MeOH (5 mL). The mixture was filtered. The solution was concentrated under 
vacuum to give 10e (SL42/06/1) (25 mg, 48 %) 
IR (film): 1715, 1670 cm−1; 1H NMR (400 MHz, D2O) δ= 2.50 (m, 2H), 3.03 (m, 2H), 3.59 (m, 2H), 
3.85 (m, 2H), 5.92 (m, 1H), 6.77 (m, 1H); 13C NMR (100 MHz, D2O) δ= 23.61, 48.36, 51.35, 56.09, 
102.44, 130.12, 133.00, 149.98, 152.81, 166.53, 172.85; MS (ESI) m/z =274 [M+H]; Elemental Analysis: 
Calcd. for C11H12N3NaO4: C, 48.36; H, 4.43; N, 15.38; Na, 8.41; O, 23.42; Found: C, 48.46; H, 4.44; N, 
15.41. 
 
Preparation of sodium 1-((1H-benzo[d]imidazol-2-yl)methyl)-1,2,5,6-tetrahydropyridine-3-
carboxylate 10f (SL42/05/1) 
Following the same procedure for the preparation of SL42/06/1, starting from 9 (150 mg, 0.85 mmol), 
2-(chloromethyl)-benzimidazole (142 mg, 0.85 mmol) and diisopropyl ethyl amine (0.443 mL, 2.55 mmol), 
compound SL42/05/1-methyl ester (50 mg, yield: 21.7%) was obtained after flash chromatography 
(AcOEt : cyclohexane = 3:1)  
IR (film): 1709 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.33 (m, 2H), 2.64 (t, J=5.2 Hz, 2H), 3.31 (qAB, 
J=2.8 Hz, 2H), 3.70 (s, 3H), 3.96 (s, 2H), 7.01 (m, 1H), 7.22 (m, 2H), 7.57(m, 2H), 10.42 (bs, 1H, NH); 13C 
NMR (100 MHz, CDCl3) δ= 26.30, 48.90, 51.63, 51.72, 55.85, 12.38, 137.82, 152.09, 166.05; MS (EI) m/z 
= 240 [M-OCH3]; Elemental Analysis: Calcd. for C15H17N3O2: C, 66.40; H, 6.32; N, 15.49; O, 11.79; 
Found: C, 66.57; H, 6.34; N, 15.53. 
Following the same procedure for the preparation of compound SL42/06/1, starting from SL42/05/1-
methyl ester (50 mg, 0.18 mmol), and 0.14 ml of NaOHaq (2 M), compound 10f (SL42/05/1) was obtained 
(30 mg, yield: 60%) 
IR (film): 1663 cm−1; 1H NMR (400 MHz, D2O) δ= 2.42 (m, 2H), 2.96 (m, 2H), 3.55 (m, 2H), 4.22 (m, 
2H), 6.70 (m, 1H), 7.32 (m, 2H), 7.61 (m, 2H); 13C NMR (100 MHz, D2O) δ=  23.73, 47.94, 51.06, 52.63, 
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115.02, 123.30, 130.54, 132.58, 147.06, 173.10; MS (ESI) m/z =280 [M+H]; Elemental Analysis: Calcd. 
for C14H14N3NaO2: C, 60.21; H, 5.05; N, 15.05; Na, 8.23; O, 11.46; Found: C, 60.43; H, 5.07; N,15.10. 
 
Preparation of 1-ethyl 3-methyl 5,6-dihydropyridine-1,3(2H)-dicarboxylate 11 
The pH of a solution of arecoline hydrobromide 8 (Qingdao Sicemo, LTD, Qingdao, China) (15.0 g) 
in water (30 mL) was adjusted to 13~14 by saturated Na2CO3 solution. This solution was extracted by ether 
(50 mL×3). The yellow oil (Arecoline, 9.8 g) was obtained after drying and removing the solvent. 
Arecoline (6.59 g, 42.5 mmol) was dissolved into 80ml toluene at 0℃. A mixture of ClCOOEt (12.24 
mL, 11 mmol) and toluene (20 mL) was dropped into the reaction mixture at 0 ℃ in 1 hour and kept 
stirring for 15 min at this temperature. Then the temperature was increased to 100 ℃ and refluxed for 2.5 
hrs. This reaction was decomposed with ice water and the pH adjusted to 2-3 with HClaq (1 M). The 
mixture was extracted by AcOEt (20 mL×3). The organic phase was washed by NaHCO3 and brine, dried 
and the solvent removed under vacuum to get 11 as yellow oil (5.8 g, yield: 64%)  
IR (film): 1704 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.26 (t, J=7.1 Hz, 3H), 2.31(m, 2H), 3.52 (t, 
J=5.6 Hz, 2H), 3.75(s, 3H), 4.16 (m, 4H), 7.07 (m, 1H); 13C NMR (100 MHz, CDCl3) δ= 14.65, 25.37, 
39.19, 42.49, 51.69, 61.44, 128.96, 137.78, 155.54, 165.64; MS (EI) m/z =213 [M]; Elemental Analysis: 
Calcd. for C10H15NO4: C, 56.33; H, 7.09; N, 6.57; O, 30.01;  Found: C, 56.54; H, 7.12; N,6.59. 
 
Preparation of 1-(ethoxycarbonyl)-1,2,5,6-tetrahydropyridine-3-carboxylic acid 12 
Product 11 (462 mg, 2.0 mmol) was dissolved into 10 ml toluene at 0 °C. A solution of NaOHaq (0.6 
mL, 5 M) was dropped into the reaction mixture at 0 °C. Then the temperature was rose to 50 °C for 5.5 hrs. 
The reaction mixture was decomposed with ice water, adjusted the pH to 2-3 with HClaq (1 M) and 
extracted with AcOEt (25 mL × 3). The organic phase was collected, dried with Na2SO4 and the solvent 
removed under vacuum to get compound 12 (390 mg, 98%). This product was directly used for the next 
step without any further purification. 
IR (film): 1705, 1687 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.28 (t, J=8.8 Hz, 3H), 2.32 (m, 2H), 
3.53 (t, J=5.6 Hz, 2H), 3.76 (m, 4H), 7.08(s, 1H); 13C NMR (100 MHz, CDCl3) δ= 14.60, 25.51, 42.24, 
48.11, 61.74, 127.87, 140.23, 157.89, 169.91; MS (EI) m/z =199 [M]; Elemental Analysis: Calcd. for 
C9H13NO4: C, 54.26; H, 6.58; N, 7.03; O, 32.13;  Found: C, 54.44; H, 6.60; N,7.05. 
 
Preparation of 1-ethyl 3-methyl 5,6-dihydropyridine-1,3(4H)-dicarboxylate 14 (SL42/27/1) 
BuLi (2.2 mL, 2.5M in THF, 5.5 mmol) was added into a solution of diisopropyl ethyl amine (0.70 
mL, 5.0 mmol) in THF (20 mL) at -78 °C. The temperature was rose to -10 °C and 4 ml of HMPA were 
added at this temperature. This reaction mixture was kept at this temperature for 30mins and then cooled 
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down to -78 °C again. A solution of compound 12 (500 mg, 2.5 mmol) in THF (5 mL) was dropped into 
the base solution at -78 °C. This reaction mixture was kept at -78 °C for 3 hrs, then poured into a cold 
saturated NH4Claq (20 mL). The pH was adjusted to pH=2-3 and the mixture was extracted with AcOEt (30 
mL × 3). The organic phase was washed with HCl (1 M) and brine, dried with Na2SO4 and evaporated to 
get crude product which was purified by flash chromatography (AcOEt : Cyclohexane =3:1) to get a 
mixture of ene-isomers 13. This mixture was processed in the next step without any purification. 
The mixture of isomers 13 (360 mg, 1.81 mmol) was directly dissolved into 1 mL of MeOH. This 
solution was added into a solution of SO2Cl2 (2.88 mL) in MeOH (20 mL) at 0oC. This reaction mixture 
was kept at 0 oC for 1hr. After the reaction completed, the solvent was removed to get the crude product 
which was purified by column chromatography (AcOEt : cyclohexane= 1:4) to give pure compound 14 
(SL42/27/1). 
IR (film): 1724, 1700 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.34 (t, J=6.8 Hz, 3H), 1.85 (m, 2H), 
2.32 (dt, J=1.2 Hz, J=6.0 Hz, 2H), 3.61 (m, 2H), 3.74(s, 3H), 4.27 (q, J=6.8 Hz, 1H), 8.03 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ= 14.45, 20.63, 20.89, 42.16, 51.32, 62.76, 102.12, 135.47, 153.36, 167.96; MS 
(EI) m/z =213 [M]; Elemental Analysis: Calcd. for C10H15NO4: C, 56.33; H, 7.09; N, 6.57; O, 30.01;  
Found: C, 56.50; H, 7.11; N, 6.59. 
 
Preparation of 1,4,5,6-tetrahydropyridine-3-carboxylic acid hydrochloride 15 (SL34/76/1) 
Product 9 (500 mg, 2.82 mmol) was dissolved into 10ml toluene at 0 °C. A solution of NaOHaq (8.6 
mL, 2 M) was dropped into the reaction mixture at 0 °C. Then the temperature was rose to 110 °C and kept 
for 6 hrs (monitoring by tlc: AcOEt/ acetone/ water/ acetic acid=5:3:2:2). The reaction mixture was 
decomposed with ice water and the pH adjusted to 2-3 with HClaq (3 M). The solvent was removed under 
vacuum. The residue was treated with ethereal hydrogen chloride and filtered to get pure 1521,22(330 mg, 
92%).  
mp: 305 °C (Decomp).IR (film): 1665 cm−1; 1H NMR (400 MHz, CD3OD) δ= 2.27 (m, 2H), 2.92 (t, 
J=6.0 Hz, 2H), 3.56 (m, 2H), 6.75 (m, 1H); 13C NMR (100 MHz, CD3OD) δ= 24.32, 41.00, 44.13, 130.86, 
134.50, 173.12. 
 
Preparation of 1-tert-butyl 3-methyl 5,6-dihydropyridine-1,3(2H)-dicarboxylate 16 
Compound 9 (5.49 g, 31.0 mmol) was mixed with triethylamine (5.65 mL, 40.3 mmol) and di-tert-
butyl dicabonate (10.14 g, 46.5 mmol) in 60 mL of anhydrous methanol at r.t. The reaction mixture was 
kept overnight. After removing the solvent under vacuum, 60 mL of water were added to the residue. The 
pH of the mixture was adjusted to 4-5 and extracted with ethyl acetate (80 mL×3). The collected organic 
phase were dried and evaporated to get the compound 16 (11.08 g, Yield: 79%). Spectral data were 
superimposable with literature data.23 
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Preparation of 1-tert-butyl 3-methyl 2,3-dihydropyridine-1,3(6H)-dicarboxylate 17 
BuLi (8.96 mL, 2.5 M in THF) was added into a solution of diisopropyl ethyl amine (3.15 mL, 22.41 
mmol) in THF (35 mL) at -78°C. Then the temperature was rose to -10 °C for 30 min and then cooled 
down to -78°C. A solution of compound 16 (3 g, 12.45 mmol) in THF (10 mL) was dropped into the base 
solution and kept for 3 min. The reaction mixture was poured into a cold NH4Cl solution (1M, 80 mL) and 
extracted with ether (60 mL × 3). The organic phase was collected, dried and evaporated to get crude 
product which was purified by flash chromatography (AcOEt : Cyclohexane =1:4) to give pure compound 
17 (1.48 g,  yield: 49.3%). Spectral data were superimposable with literature data.23 
 
Preparation of (1S*,5S*,6R*)-3-tert-butyl 5-methyl 7-oxa-3-azabicyclo[4.1.0]heptane-3,5-
dicarboxylate 18 and (1R*,5S*,6S*)-3-tert-butyl 5-methyl 7-oxa-3-azabicyclo[4.1.0]heptane-3,5-
dicarboxylate 19 
Product 17 (250 mg, 1.03 mmol) was dissolved into anhydrous CH2Cl2 (20 mL). 3-Chloroperbenzoic 
acid (MCPA, 357 mg, 2.06 mmol) was added. The reaction mixture was kept at r.t for 3 hrs, then an extra 1 
eq. of MCPA (179 mg, 1.03 mmol) was added and the mixture left overnight. The reaction was 
decomposed with Na2S2O5 and extracted with AcOEt (15 mL × 3). The organic phase was collected, 
washed with Na2S2O5, brine, dried with Na2SO4 and evaporated to get a crude mixture of 18 and 19 which 
was purified by flash chromatography (AcOEt : cyclohexane =1:4) (175 mg, overall yield: 66%). 
An aliquot of the mixture was further purified to get pure isolated 18 and 19. Spectral data as follow 
18: White solid. Mp: 70-74oC; IR (film): 1738, 1698 cm−1; 1H NMR (400 MHz, CDCl3) δ= 1.45 (s, 
9H), 3.00 (m, 2H), 3.34 (m, 1H), 3.42 (d, J=15.2 Hz, 1H), 3.61 (d, J=4.0 Hz, 1H), 3.76 (s, 3H), 3.84-4.20 
(m, 2H); 13C NMR (100 MHz,CDCl3) δ= 28.33, 38.10, 38.92, 41.28, 50.89, 51.22, 52.17, 80.30, 154.32, 
170.88. MS (EI) m/z =242 [M-CH3]; Elemental Analysis: Calcd. for C12H19NO5: C, 56.02; H, 7.44; N, 5.44; 
O, 31.09; Found: C, 56.15; H, 7.46; N, 5.45. 
19: Oil. IR (film): 1738, 1698 cm−1; 1H NMR (400 MHz, CD3OD) δ=1.41 (s, 9H), 3.03 (d, J=19.2 Hz 
1H), 3.23 (d, J=20.8 Hz 1H), 3.44 (m, 1H), 3.48 (dd, J1=4.0 Hz, J2=1.2 Hz, 1H), 3.57 (m, 1H), 3.71(s, 3H), 
3.78 (m, 1H); 13C NMR (100 MHz,CDCl3) δ= 28.26, 39.80, 40.35, 42.03, 50.00, 50.90, 52.14, 
80.13,154.75, 171.48. MS (EI) m/z =242 [M-CH3]; Elemental Analysis: Calcd. for C12H19NO5: C, 56.02; H, 
7.44; N, 5.44; O, 31.09; Found: C, 56.17; H, 7.46; N, 5.46. 
Preparation of 1-tert-butyl 3-methyl 5-hydroxy-5,6-dihydropyridine-1,3(2H)-dicarboxylate 20. 
A mixture of compounds 18 and 19 (500 mg, 2.02 mmol) and KOH solid (226 mg, 4.04 mmol) were 
dissolved in 20 mL of MeOH. The reaction mixture was kept at r.t for 30 min. The pH of the reaction was 
adjusted to 6-7 by HClaq (2 M). The solvent was removed under vacuum. The residue was mixed with 20 
mL of water and extracted with AcOEt (15 mL × 3). The organic phase was collected, dried with Na2SO4 
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and evaporated. The crude product was purified by flash chromatography (AcOEt : cyclohexane =2:3) to 
get pure compound 20 (350 mg, yield: 67%). 
White solid. Mp: 78-85 oC; IR (film): 1699 cm−1; 1H NMR (400 MHz, CD3OD) δ=1.47 (s, 9H), 3.49-
3.51(m, 1H), 3.65-3.73 (m, 1H), 3.78 (s, 3H), 3.97 (dt, J1=18.4 Hz, J2=2.4 Hz, 1H), 4.18 (dt, J1=18.4 Hz, 
J2=2.0 Hz, 1H), 4.26 (m, 1H), 6.92 (m, 1H); 13C NMR (100 MHz,CDCl3) δ= 28.43, 42.78, 46.16, 52.05, 
63.46, 80.72, 129.34, 139.79, 154.95, 165.66. MS (EI) m/z =257 [M]; Elemental Analysis: Calcd. for 
C12H19NO5: C, 56.02; H, 7.44; N, 5.44; O, 31.09; Found: C, 56.17; H, 7.46; N, 5.46. 
 
Synthesis of methyl 1-(heteroarylmethyl)-5-hydroxy-1,2,5,6-tetrahydropyridine-3-carboxylates: 
Preparation of methyl 1-benzyl-5-hydroxy-1,2,5,6-tetrahydropyridine-3-carboxylate 21a 
(SL42/77/1) and 1-benzyl-5-hydroxy-1,2,5,6-tetrahydropyridine-3-carboxylic acid hydrochloride 22a 
(SL42/87/1) (as general procedure). 
Compound 20 (100 mg, 0.39 mmol) was dissolved in 3 mL of CH2Cl2. TFA (3 mL) was added into 
this solution at 0 oC. The reaction mixture was kept at 0 oC for 20mins. The solvent was removed under 
vacuum. The crude residue was dissolved in 10 ml of CH3CN. (Bromomethyl)benzene (67 mg, 0.389 
mmol) and diisopropyl ethyl amine (0.27 mL, 1.56 mmol) were added into the solution at 0 oC. This 
reaction mixture was kept at r.t. for 3hrs. After the reaction completed, the solvent was removed under 
vacuum. The residue was dissolved with CH2Cl2 and washed with brine. The organic phase was separated, 
dried and the solvent was removed. This crude product was purified by flash chromatography (AcOEt : 
cyclohexane = 2:3) to get pure compound 21a (SL42/77/1) (20 mg, 21%) 
IR (film): 1718 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.36 (bs, 1H, OH), 2.53 (dd, J1=11.6 Hz, J2=3.2 
Hz, 1H), 2.75 (dd, J1=11.6 Hz, J2=3.6 Hz, 1H), 2.99 (d, J=17.2 Hz, 1H), 3.43 (d, J=16.8 Hz, 1H), 3.68 (qAB, 
J=12.8 Hz, 2H), 3.75 (s, 3H), 4.21 (m, 1H), 7.31 (m, 5H); 13C NMR (100 MHz, CDCl3) δ= 51.69, 51.85, 
56.39, 62.00, 63.97, 127.51, 128.45, 129.09, 131.29, 137.50, 166.03. MS (EI) m/z =247 [M]; Elemental 
Analysis: Calcd. for C14H17NO3: C, 68.00; H, 6.93; N, 5.66; O, 19.41; Found: C, 68.18; H, 6.95; N, 5.67. 
Preparation of 22a (SL42/87/1). 
Compound 21a (20 mg) was dissolved into 2ml of HClaq (1 M). After refluxing for 4.5 hrs at 110 oC, 
the solvent was removed under vacuum to get compound 22a (SL42/87/1) (20 mg, yield: 91%).  
IR (film): 1708 cm−1; 1H NMR (400 MHz, D2O) δ= 3.31-3.62 (m, 2H), 3.76-4.25 (m, 2H), 4.50 (m, 
2H), 4.67 (m, 1H), 7.11(m, 1H), 7.55 (m, 5H) ; 13C NMR (100 MHz, D2O) δ= 48.91, 54.14, 59.63, 60.08, 
126.53, 127.88, 129.33, 129.49, 130.36, 131,13, 135.87, 166.76. MS (ESI) m/z = 269 [M]; Elemental 
Analysis: Calcd. for C13H16ClNO3: C, 57.89; H, 5.98; Cl, 13.14; N, 5.19; O, 17.80; Found: C, 58.07; H, 
6.00; N, 5.21. 
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Synthesis of methyl 5-hydroxy-1-(pyridin-2-ylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylate 
21b (SL42/81/1) and the corresponding acid 5-hydroxy-1-(pyridin-2-ylmethyl)-1,2,5,6-
tetrahydropyridine-3-carboxylic acid hydrochloride 22b (SL42/86/1) 
Following the procedure of SL/42/77/1 and starting from 20 (90 mg, 0.35 mmol), 2-(bromomethyl)-
pyridine hydrobromide (87 mg, 0.35 mmol) and diisopropyl ethyl amine (0.24 mL, 1.4 mmol) compound 
21a (SL42/81/1) was obtained (36 mg, yield: 41%) after flash chromatography (AcOEt :MeOH=5:1). 
IR (film): 1710 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.56 (d, J=11.6 Hz, 1H), 2.71 (dd, J1=11.6 Hz, 
J2=3.6 Hz, 1H), 2.99 (d, J=16.8 Hz, 1H), 3.38 (d, J=16.8 Hz, 1H), 3.66 (s, 3H), 3.74 (m, 2H), 4.20 (m, 2H), 
4.70 (s, 1H, OH), 6.90 (m, 1H), 7.12 (m, 1H), 7.30 (d, J=4.8 Hz, 1H), 7.60 (m, 1H), 8.45 (d, J=4.4 Hz, 1H); 
13C NMR (100 MHz, (CD3)2CO) δ= 51.00, 51.53, 56.57, 62.87, 63.93, 122.19, 122.86, 131.15, 136.71, 
139.82, 149.11, 158.41, 165.51; MS (ESI) m/z =249 [M+1]+; Elemental Analysis: Calcd. for C13H16N2O3: 
C, 62.89; H, 6.50; N, 11.28; O, 19.33; Found: C, 63.09; H, 6.52; N, 11.32. 
Preparation of 22b (SL42/86/1) 
Compound SL42/81/1 (15.0 mg) was dissolved into 2 ml of HClaq (1 M). The reaction was refluxed 
for 3 hrs at 110 oC. The solvent was removed under vacuum to get compound 22b (SL42/86/1) (15 mg, 
yield: 81%). 
IR (film): 1708 cm−1; 1H NMR (400 MHz, D2O) δ= 3.52 (m, 2H), 4.00 (m, 2H), 4.74 (m, 2H), 7.13 (m, 
1H), 8.00 (m, 2H), 8.45 (m, 1H), 8.83 (d, J=5.6 Hz, 1H); 13C NMR (100 MHz, D2O) δ= 49.50, 54.54, 
57.75, 60.47, 126.37, 126.72, 127.74, 136.92, 143.61, 146.11, 146.14, 166.92; MS (EI) m/z = 269 [M-HCl-
H]-; Elemental Analysis: Calcd. for C12H16Cl2N2O3: C, 46.92; H, 5.25; Cl, 23.08; N, 9.12; O, 15.63; Found: 
C, 47.04; H, 5.26; N, 9.14. 
 
Synthesis of methyl 5-hydroxy-1-(pyridin-3-ylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylate 
21c(SL42/80/1) and the corresponding acid 5-hydroxy-1-(pyridin-3-ylmethyl)-1,2,5,6-
tetrahydropyridine-3-carboxylic acid hydrochloride 22c (SL42/85/1) 
Following the procedure of SL/42/77/1 and starting from 20 (90 mg, 0.35 mmol), 3-(bromomethyl)-
pyridine hydrobromide (87 mg, 0.35 mmol) and diisopropyl ethyl amine (0.24 mL, 1.4 mmol), compound 
21c (SL42/80/1) was obtained after flash chromatography (AcOEt :MeOH=5:1)(75 mg, yield: 87%). 
IR (film): 1685 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.56 (dd, J1=11.2 Hz, J2=2.4 Hz, 1H), 2.76(dd, 
J1=3.6 Hz, J2=11.2 Hz, 1H), 2.99 (d, J=16.4 Hz, 1H), 3.42 (d, J=16.8 Hz, 1H), 3.70 (qAB, J=13.6 Hz, 2H), 
3.76 (s, 3H), 4.24 (m, 1H), 4.76(s, 1H, OH), 6.98 (m, 1H), 7.72 (dd, J1=11.2 Hz, J2=3.6 Hz, 1H), 8.57 (m, 
2H), 8.60 (s, 1H); 13C NMR (100 MHz, (CD3)2CO) δ= 51.93, 52.07, 57.36, 59.62, 65.13, 124.19, 130.58, 
134.65, 137.32, 140.87, 149.40, 151.10, 166.49; MS (ESI) m/z =249 [M+1]; Elemental Analysis: Calcd. 
for C13H16N2O3: C, 62.89; H, 6.50; N, 11.28; O, 19.33; Found: C, 63.02; H, 6.51; N, 11.30. 
Preparation of 22c (SL42/85/1) 
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Compound SL42/80/1 (20 mg) was dissolved into 2ml of HClaq (1 M). This reaction was refluxed for 
5 hrs at 110 oC. The solvent was removed under vacuum to get compound 22c (SL42/85/1) (23 mg, yield: 
92%).  
IR (film): 1707 cm−1; 1H NMR (400 MHz, D2O) δ= 3.55 (dd, J1=4.0Hz, J2=12.4 Hz, 1H), 3.62 (dd, 
J1=4.4 Hz, J2=12.8 Hz, 1H), 4.02 (dt, J1=2.4 Hz, J2=16.8 Hz, 1H), 4.17 (d, J=15.6 Hz, 1H), 4.86 (m, 2H), 
7.14 (m, 1H), 8.25 (dd, J1=5.6 Hz, J2=8.0 Hz, 1H), 8.88 (dt, J1=1.2 Hz, J2=8.4 Hz, 1H), 8.99 (d, J=5.6 Hz, 
1H), 9.12 (s, 1H); 13C NMR (100 MHz, D2O) δ= 49.21, 54.19, 55.67, 60.07, 126.02, 128.04, 128.78, 
136.55, 143.22, 143.79, 149.33, 166.91; MS (EI) m/z =269 [M-HCl-H]-; Elemental Analysis: Calcd. for 
C12H16Cl2N2O3: C, 46.92; H, 5.25; Cl, 23.08; N, 9.12; O, 15.63; Found: C, 47.03; H, 5.26; N, 9.14. 
 
Synthesis of methyl 5-hydroxy-1-(pyridin-4-ylmethyl)-1,2,5,6-tetrahydropyridine-3-carboxylate 
21d (SL42/79/1) and the corresponding acid 5-hydroxy-1-(pyridin-4-ylmethyl)-1,2,5,6-
tetrahydropyridine-3-carboxylic acid hydrochloride 22d (SL42/84/1) 
Following the procedure of SL/42/77/1 and starting from 20 (100 mg, 0.37 mmol), 4-(bromomethyl)-
pyridine hydrobromide (94 mg, 0.37 mmol) and diisopropyl ethyl amine (0.27 mL, 1.56 mmol), compound 
21d (SL42/79/1) was obtained after flash chromatography (AcOEt :MeOH=5:1) (70 mg, yield: 78%).  
IR (film): 1685 cm−1; 1H NMR (400 MHz, CDCl3) δ= 2.57 (dd, J1=12.0 Hz, J2= 2.8 Hz, 1H), 2.74 (dd, 
J1=4.0 Hz, J2=12.0 Hz, 1H), 3.01 (d, J=16.4 Hz, 1H), 3.42 (d, J=16.8 Hz, 1H), 3.68 (qAB, J=14.0 Hz, 2H), 
3.76 (s, 3H), 4.25 (m, 1H), 4.76 (bs, 1H, OH), 6.98 (m, 1H), 7.32 (m, 2H), 8.59 (m, 2H); 13C NMR 
(100 MHz, (CD3)2CO) δ= 51.93, 52.19, 57.50, 61.06, 65.18, 124.48, 130.64, 140.77, 148.59, 150.56, 
166.47; MS (ESI) m/z =249 [M+1]; Elemental Analysis: Calcd. for C13H16N2O3: C, 62.89; H, 6.50; N, 
11.28; O, 19.33; Found: C, 63.10; H, 6.52; N, 11.32. 
Preparation of 22d (SL42/84/1) 
Compound SL42/79/1 (20 mg) was dissolved into 2 ml of HClaq (1 M). This reaction was refluxed for 
5 hrs at 110 oC. The solvent was removed under vacuum to get compound 22d (SL42/84/1) (17 mg, yield: 
68%).  
IR (film): 1707 cm−1; 1H NMR (400 MHz, D2O) δ= 3.51 (dd, J1=4.0 Hz, J2=12.8 Hz, 1H), 3.63 (dd, 
J1=4.0 Hz, J2=12.8 Hz, 1H), 4.05 (dt, J1=1.2 Hz, J2=16.4 Hz, 1H), 4.02 (d, J=16.4 Hz, 1H), 4.91 (m, 2H), 
7.17 (m, 1H), 8.33 (d, J=6.4 Hz,1H), 8.98 (d, J=6.4Hz, 1H); 13C NMR (100 MHz, D2O) δ= 49.80, 54.62, 
57.52, 60.04, 125.92, 129.14, 136.64, 142.35, 148.66, 166.77; MS (EI) m/z =269 [M-HCl-H]-; Elemental 
Analysis: Calcd. for C12H16Cl2N2O3: C, 46.92; H, 5.25; Cl, 23.08; N, 9.12; O, 15.63; Found: C, 47.05; H, 
5.26; N, 9.15. 
 
Synthesis of methyl 1-((2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)-5-hydroxy-1,2,5,6-
tetrahydropyridine-3-carboxylate 21e (SL42/82/1) and the corresponding acid1-((2,6-dioxo-1,2,3,6-
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tetrahydropyrimidin-4-yl)methyl)-5-hydroxy-1,2,5,6-tetrahydropyridine-3-carboxylic acid 
hydrochloride 22e (SL42/88/1) 
Following the procedure of SL/42/77/1 and starting from 20 (105 mg, 0.39 mmol), 6-(chloromethyl) 
uracil (63 mg, 0.39 mmol) and diisopropyl ethyl amine (0.20 mL, 1.17 mmol), compound 21e (SL42/82/1) 
was obtained after flash chromatography (AcOEt : MeOH=9:1) (50 mg, yield: 46%). 
IR (film): 1716 cm−1; 1H NMR (400 MHz, (CD3)2CO) δ= 2.64 (dd, J1=4.4 Hz, J2=11.6 Hz, 1H), 2.78 
(dd, J1=4.4 Hz, J2=11.6 Hz, 1H), 3.11 (d, J=16.4 Hz, 1H), 3.30 (d, J=16.4 Hz, 1H), 3.56 (qAB, J=15.2 Hz, 
2H), 3.71 (s, 3H), 4.32 (m, 1H), 4.42 (d, J=1.2 Hz, 1H, OH), 5.63 (m, 1H), 6.89 (m, 1H), 10.02 (m, 2H, 
NH); 13C NMR (100 MHz, (CD3)2CO) δ= 51.75, 52.03, 57.56, 58.15, 64.67, 97.38, 100.23, 130.68, 139.65, 
152.66, 165.11, 166.42. MS (ESI) m/z =282 [M+H]; Elemental Analysis: Calcd. for C12H15N3O5: C, 51.24; 
H, 5.38; N, 14.94; O, 28.44; Found: C, 51.42; H, 5.40; N,15.00. 
Preparation of 22e (SL42/88/1) 
Compound SL42/82/1 (22 mg) was dissolved into 2ml of HClaq (1 M). The reaction was refluxing for 
4 hrs at 110 oC. The solvent was removed under vacuum to get compound 22e (SL42/88/1) (20 mg, yield: 
69%).  
IR (film): 1712 cm−1; 1H NMR (400 MHz, D2O) δ= 3.45 (m, 2H), 3.89 (dt, J1=2.0 Hz, J2=16.4 Hz, 
1H), 4.06 (d, J=16.8 Hz, 1H), 4.23 (m, 3H), 6.22 (s, 1H), 7.19 (m, 1H); 13C NMR (100 MHz, D2O) δ= 
49.58, 54.80, 55.19, 59.98, 105.22, 125.62, 136.76, 144.15, 152.34, 165.85, 166.56; MS (EI) m/z = 398 
[M+Na]+; Elemental Analysis: Calcd. for C11H16Cl3N3O5: C, 35.08; H, 4.28; Cl, 28.24; N, 11.16; O, 21.24; 
Found: C, 35.17; H, 4.29; N,11.19. 
 
1.3.2 Biology: Material and Methods 
1.3.2.1 Chemicals and Reagents 
The newly synthesized compounds were weighted and dissolved in DMSO as 100 mM stock solution 
and aliquots stored at -80°C till the time of use. The chemical reagents and the enzymes α-glucosidase (EC 
3.2.1.20) from Saccharomyces cerevisiae, β-glucuronidase (E.C. 3.2.1.31) from bovine liver and 
hyaluronidase (E.C. 3.2.1.35) from bovine testes were purchased from Sigma (St. Louis, MO). From the 
same supplier were purchased the chromogenic substrates 4-Nitrophenyl derivative of α-glucopyranoside, 
phenolphthalein β-glucuronide, and hyaluronic acid from bovine vitreous humor. The cell vitality Alamar 
Blue dye were obtained through Invitrogen (Carlsbad, CA).  
1.3.2.2 In vitro enzymatic assays 
α-glucosidase activity was measured by a kinetic end-point assay.24 A mix consisting of 50 µL 
deionizated water, 0.35 µL of α-glucosidase (0.175 U/mL) and 1 µL of the compound stock solution in 
DMSO, was pre-incubated 20 minutes at 37°C followed by the addition of 50 µL phosphate buffered saline 
(140 mM) pH 7.2, 1.35 µL reduced glutathione (9 mM) and 12 µL 4-nitrophenyl-α-glucopyranoside (0.9 
Chapter 1 
24 
 
mM) as substrate. The cocktail was further incubated 45 minutes at 37°C and the color development 
monitored at 400 nm on a Benchmark Plus spectrophotometer plate reader (BioRad). The percent effect of 
the compound on the α-glucosidase enzymatic activity was calculated by the following formula: % 
Inhibition/Activation = [(AC - AS)/AC] ×100, where AC is the absorbance of the control (samples with 
DLSO alone) and AS is the absorbance of the tested sample. Each experiment was performed in triplicates, 
along with appropriate blanks. 
β-glucuronidase activity was assayed by monitoring the quantity of phenolphthalein liberated by 
alkalinization of the reaction mix at the end of the incubation. Hyaluronidase was assayed by the 
nephelometric procedure. 
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Chapter 2.  
Synthesis of enantiomerically pure 1, 4-dihydropyridine 
using “solid” ammonia (magnesium nitride) 
2.1 Introduction 
1,4-dihydropyridine derivatives has attracted significant attention due to their wide spectrum of 
biological activity. These compounds containing the 1,4-dihydropyridine moiety have been found to act as 
calcium modulators,1-3 BACE-1 inhibitors,4 drugs in the treatment of vasodilatation,5 mineral corticoid 
receptor antagonist,6 hepatoprotection, neuromodulatory, anti-atherosclerosis, anti-diabetes, antioxidant, 
antimutagenic and antitumoragents.7-9 1,4-Dihydropyridines such as nifedipine, (Adalat®, Procardia®), 
amlodipine and nimodipine (Figure 1) are widely prescribed as antihypertensive drugs.10 In addition, the 
dihydropyridine moiety has found application as an NADH analogue.11-14 
N
H
MeOOC COOEt
O NH2
Cl
2
amlodipine
N
H
MeOH2CH2COOC COOi-Pr
NO2
nimodipine
N
H
MeOOC COOMe
NO2
nifedipine  
Figure 1. Some typical antihypertensive drugs based on 1,4-dihydropyridine scaffold 
The most classic method to prepare dihydropyridines was discovered by Hantzsch in 188215 and 
consists of a multicomponent reaction (MCR) between an aldehyde, a β-keto ester and a 30% aqueous 
ammonia solution as the nitrogen source.6-10,16 
There are many pathways to generate Hantzsch esters. For simplicity, usually they are described as 
four discrete steps. The first step can be visualized as proceeding through a Knoenenagel condensation 
product as key intermediate (Scheme 1): 
 
Scheme1 
A second key intermediate is an ester enamine, which is produced by condensation of the second 
equivalent of the β-ketoester with ammonia (scheme 2): 
 
Scheme 2
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Further condensation between these two intermediate gives the final derivatives (scheme 3): 
 
Scheme 3 
 But due to the modest yield reported, a lot of improvements on this method have been developed, 
including the use of catalysts such as boronic acids,17,18 metal triflates,19 molecular iodine,20 TMS iodide,21 
Bu4NHSO4,22 bakers’ yeast,23 ceric ammonium nitrate,24 in situ generated HCl,25 and silica-supported 
acids.26,27 Solvent free28 and microwave irradiation conditions29,30 have also been reported. Some authors 
have described the use of ultrasounds, microwaves and solvent free conditions has recently been published 
reporting shorter reaction time and higher yield31-34 Several authors have prepared polycyclic systems 
containing the 1,4-dihydropyridine ring using dimedone and different acid catalysis.35-37 An 
environmentally friendly synthesis of 1,4-dihydropyridine derivatives was developed by the one-pot 
reaction of aldehydes, ethyl acetoacetate and ammonia in water under refluxing conditions in moderate 
yield.38 Silica supported 12-tungstophosphoric acid catalysts has afforded 1,4-dihydropyridines under 
solvent-free conditions in high yields.39 An interesting synthesis of 1,4-DHP in variable yields using 
aldimines and propiolate ester in the presence of a catalytic amount of Scandium(III) triflate has been 
reported (Scheme 4).40  
  
Scheme 4 
As far is concerned the synthesis of enantiomerically pure 1,4-DHP, several methods for synthesis of 
chiral DHPs have been reported, including asymmetric induction, resolution of racemic mixture, or 
chemoenzymatic method. Asymmetric Michael addition using α-methyl benzylamine as chiral inducer has 
been reported as well. By this synthetic startegy better results have been recently obtained by Yamamoto41 
on an asymmetric synthesis of  (+)- and (-)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid 
derivatives using t-butylester of L-valine as a chiral auxiliary. The asymmetric synthesis of 4-N-substituted 
4-aryl-3-carbethoxy 1,4-DHP has been achieved in good yield and moderate enantio-selectivity using 
bifunctional thiourea-ammonium salts as catalyst (scheme 5).42 
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Scheme 5 
A Lewis acid (Zn[(L)proline]2) catalyzed one pot synthesis of Hantzsch 1,4-dihydropyridine (DHP) 
derivatives under solvent-free condition by conventional heating and microwave irradiation has been 
reported.43 The Lewis acid catalyst Zn[(L)proline]2 used in this reaction afford 1,4-DHP in moderate to 
good yield. The catalyst is reusable up to five cycles without appreciable loss of its catalytic activity. 
Ammonia is the reagent of choice as a source of nitrogen in organic chemistry, as well as in the 
Hantzsch reaction, yet its use can be hampered by handling issues, especially on a small scale. Among the 
modifications recently been reported, special emphasis warrants the use of substitutes of aqueous ammonia 
with reagents able to produce ammonia in situ (e.g. urotropine, metallo-nitrides, etc, etc). Nano aluminum 
nitride in the presence of water acts as solid source of ammonia, which is used for the preparation of 1,4-
dihydropyridines and bis-(1,4-dihydropyridines). An efficient and simple procedure for the one-pot 
synthesis of 1,4-dihydropyridine and bis-(1,4-dihydropyridine) derivatives was achieved by combination of 
methyl acetoacetate or ethyl acetoacetate with aldehydes or dialdehydes and aluminum nitride at 80 ºC in 
water in high purity and good yields (scheme 6).44 
 
Scheme 6 synthesis of 1,4-dihydropyridines using nano aluminum nitride as solid source 
Magnesium nitride (Figure 2), a commercially available, bench-stable solid, has been largely ignored 
by the synthetic community to date. It has been known to release ammonia in the presence of protic solvent, 
such as water and alcohol.45-48 Taking this information into account, considering the property of 
magnesium nitride and the easier operation as a solid material in handling, magnesium nitride could be 
considered as an alternative of ammonia in the organic synthesis. Recently, it has been utilized by Steven V. 
Ley’s group as a source to release ammonia in presence of protic solvents for the preparation of different 
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N-containing compounds.48-50 In this chapter we will report our own results in using magnesium nitride as 
ammonia source and optically active ester of acetoacetate as counterpart in the condensation reaction. 
Actually, the need of enantiomerically pure 1,4-dihydropyridines for biotest6,51-55 is a well known problem 
and we feel that a contribution to this problem is welcomed among the research groups involved in the field 
of synthesis and bio-activity of dihydropyridines. 
 
Figure 2. Mg2N3 cubic cell: green: Mg, blue: N 
 
2.2 Present work 
2.2.1 Preparation of enantiomerically pure acetoacetate ester 
The suitable starting acetoacetate, to be used in the Hantzsch reaction as the source of chirality in the 
final DHPs were been easily prepared from a commercially available ethyl acetonacetate. It was ri-
functionalized by introducing a chiral alchoxy functionality, e.g. natural menthol or (S)-2-hydroxy-
propanol (lactic ester), via a MAOS (Microwave Assisted Organic Synthesis) mediated trans-esterification 
in absence of any catalyst. (Scheme 7) 
 
Scheme 7. Preparation of enatiomerically pure acetoacetate ester 
2.2.2 Preparation of target DHPs 
A series of enantiomerically 1,4-dihydropyridines were synthesized via the one-pot condensation of 
an aldehyde, a β-keto ester, which was prepared as above described, and magnesium nitride in 1,4-dioxane. 
(Scheme 8 and Table 1) 
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Scheme 8. Preparation of 1,4-diydropyridines 4a-4p 
It must be stressed out that, from synthetic point of view, a reasonable difference with the already 
published results, is based on the use of the aprotic dioxane, instead of protic ethanol as reported by Ley, as 
solvent. By this way a slow decomposition of magnesium nitride, by the enolic form of the acetoacetate, 
takes place allowing the use of a stoichiometric amount of magnesium nitride, acetoacetate and aldehyde. 
A series of the title compounds have been synthesized via one-pot condensation of aldehyde, β-ketoester 
and magnesium nitride in dioxane (Scheme 8 and Table 1). The starting optically active acetoacetate esters  
(2a) and (2b) were prepared in good yield by a MAOS (Microwave Assisted Organic Synthesis) mediated 
trans-esterification in absence of any catalyst.56 Any attempt to obtain the dihydropyridines (4a-q) under 
MAOS conditions partially failed. In fact, even in the best cases, the yields obtained were lower than those 
obtained by convective heating whereas the time needed to complete the reaction was of the same order of 
running the reaction under convective heating. In summary, in this chapter we propose an easy protocol for 
the preparation of optically active Hantzch esters in satisfactory yields. 
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Table 1. Synthesis of optically active Hantzch esters from aldehydes 3 and acetoacetate 1 
 
Entry R1 Product 
Yield 
(%) Entry R1 Product 
Yield 
(%) 
1 
  
4a 
95 9 
S
 
 
4i 
28 
2 
NO2
  
4b 
66 10 
S  
 
4j 
73 
3 
NO2
  
4c 
66 11 N
  
4k 
58 
4 
NO2
  
4d 
46 12 
 
 
4l 
52 
5 
MeO OMe
  
4e 
41 13 
MeO
 
 
4m 
26 
6 
OMe
  
4f 
43 14 
N
Boc
  
4n 
22 
7 
 
 
4g 
65 15 
NO2
  
4o 
50 
8 CH3(CH)6  
 
4h 
58 16 NO2
  
4p 
25 
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2.3 Experimental section 
All starting materials, unless otherwise stated, were purchased and used without any further 
purification. Solvents were distilled and dried according to standard procedures. All the reactions were run 
in a sealed tube under a nitrogen atmosphere. Column chromatography was performed using Merck KGaA 
Silicagel 60 (230-400 Mesh-ASTM). Melting points were obtained using a Stuart Scientific SMP3 Melting 
Point apparatus and are not corrected. Optical rotations were obtained using a Perkin Elmer 343 
polarimeter. IR spectra were recorded on a Nicolet 380 FT-IR infrared spectrometer. NMR spectroscopy 
was performed on a Varian-Mercury 400 spectrometer using the residual signal of the solvent as the 
internal standard. The chemical shifts are reported in ppm and coupling constants (J) are reported in Hz. 
GC–MS spectra were recorded using Agilent Technologies 6850 and 5975 GC-Mass instrumentation. LC–
MS spectra were obtained using an Agilent Technologies MSD1100 single-quadrupole mass spectrometer. 
Elemental analyses were performed at CNR-ISMAR, Bologna, Italy. 
 
(2S)-1-Ethoxy-1-oxopropan-2-yl 3-Oxobutanoate (1a) 
(S)-(–)-Ethyl lactate (0.3 mol, 35 mL) and ethyl acetoacetate (0.15 mol, 19.5 mL), in a 50 mL flask, 
were heated at reflux temperature in a microwaves oven (Milestone/MicroSynth) at 500 W for 3 h. During 
this time the EtOH produced during the transesterification was removed by side-arm distillation. The 
excess (S)-(–)-ethyl lactate was removed by rotary evaporation. The residue was found to consist of 24.2 g 
(80% conversion) of the target compound. The analytical data (including the optical rotation) were 
analogous with the literature.56 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 3-Oxobutanoate (1b) 
The title product was prepared using the previously reported microwave-assisted organic synthesis 
technique. The analytical data (including the optical rotation) were analogous with the literature.56 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-phenyl-1,4-dihydropyridine-3,5-
dicarboxylate (4a); Typical Procedure 
A mixture of benzaldehyde (3a) (0.203 mL, 2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 
(2) (0.100 g, 1 mmol) in anhydrous 1,4-dioxane (3 mL) in a 5 mL sealed tube was stirred for 24 h at 80 °C. 
The mixture was cooled, dissolved in ice-cold H2O (10 mL), and extracted with CH2Cl2 (3 x 15 mL). The 
combined organic layer was dried over MgSO4, the solvent removed in vacuo and the product purified by 
flash chromatography on silica gel (EtOAc–cyclohexane, 35:65).  
Yellow oil; yield: 0.896 g (95%); : +133.43 (c 0.7, CHCl3). IR (film): 1740, 1695 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.14 (t, J = 7.1 Hz, 3 H), 1.25 (t, J = 7.1 Hz, 3 H), 1.42 (d, J = 6.9 Hz, 3 H), 1.46 (d, 
J = 6.9 Hz, 3 H), 2.34 (s, 3 H), 2.35 (s, 3 H), 4.07 (m, 2 H), 4.18 (m, 2 H), 4.96 (q, J = 7.1 Hz, 1 H), 5.03 (q, 
J = 6.9 Hz, 1 H), 5.07 (s, 1 H), 5.97 (s, 1H, NH), 7.13–7.31 (m, 5 H, Ar). 13C NMR (100 MHz, CDCl3): δ = 
13.96, 14.06, 16.87, 17.04, 19.51, 19.85, 39.45, 60.94, 61.13, 68.24, 68.44, 103.15, 103.88, 126.11, 127.73, 
[ ]20Dα
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128.14, 145.27, 147.45, 166.65, 166.70, 171.20, 171.47. MS (ESI): m/z = 474 [M + H+]+. Elemental 
Analysis: Calcd. for C25H31NO8: C, 63.41; H, 6.60; N, 2.96. Found: C, 63.60; H, 6.62. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-
dicarboxylate (4b) 
The product was prepared according to the typical procedure from 4-nitrobenzaldehyde (3b) (0.302 g, 
2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture was 
extracted with EtOAc (3 × 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65).  
Yellow solid; yield: 0.681 g (66%); mp: 55 °C; : +63.64 (c 1.1, CHCl3). IR (film): 1735, 1701 cm-1. 
1H NMR (400 MHz, CDCl3): δ = 1.13 (t, J = 7.2 Hz, 3 H), 1.25 (t, J = 7.2 Hz, 3 H), 1.42 (d, J = 6.8 Hz, 3 
H), 1.48 (d, J = 6.8 Hz, 3 H), 2.26 (s, 3 H), 2.38 (s, 3 H), 4.05 (m, 2 H), 4.20 (m, 2 H), 4.96 (q, J = 6.8 Hz, 
1 H), 5.00 (q, J = 6.8 Hz, 1 H), 5.15 (s, 1 H), 6.43 (s, 1 H), 7.47 (d, J = 9.6 Hz, 2 H), 8.07 (d, J = 9.6 Hz, 2 
H). 13C NMR (100 MHz, CDCl3): δ = 13.94, 14.03, 16.90, 17.01, 19.34, 19.56, 39.83, 61.02, 61.37, 68.33, 
68.55, 101.83, 102.61, 123.17, 129.08, 145.64, 146.55, 154.79, 166.10, 166.15, 170.95, 171.46. MS (ESI): 
m/z = 519 [M + H+]+. Elemental Analysis: Calcd. for C25H30N2O10: C, 57.91; H, 5.83; N, 5.40. Found: C, 
58.03; H, 5.84. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-
dicarboxylate (4c) 
The product was prepared according to the typical procedure from 3-nitrobenzaldehyde (3c) (0.302 g, 
2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture was 
extracted with EtOAc (3 × 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
Yellow oil; yield: 0.684 g (66%); : +60.9 (c 1.1, CHCl3). IR (film): 1738, 1701 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.12 (t, J = 6.8 Hz, 3 H), 1.24 (t, J = 6.8 Hz, 3 H), 1.44 (d, J = 6.8 Hz, 3 H), 1.49 (d, 
J = 6.8 Hz, 3 H), 2.37 (s, 3 H), 2.41 (s, 3 H), 4.04 (m, 2 H), 4.20 (m, 2 H), 4.97 (q, J = 6.8 Hz, 1 H), 5.00 (q, 
J = 7.2 Hz, 1 H), 5.16 (s, 1 H), 6.17 (s, 1 H, NH), 7.39 (t, J = 7.8 Hz, 1 H), 7.68 (dt, J = 1.4 Hz, J = 7.7 Hz, 
1 H), 8.01 (ddd, J = 1.0 Hz, J = 1.4 Hz, J = 8.2 Hz, 1 H), 8.14 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 
13.88, 14.02, 16.82, 16.95, 19.13, 19.37, 39.85, 60.90, 61.45, 68.23, 68.53, 101.83, 102.73, 121.25, 123.44, 
128.58, 134.80, 145.71, 146.78, 147.83, 149.81, 166.09, 166.22, 170.91, 171.74. MS (ESI): m/z = 541 [M + 
Na+]+. Elemental Analysis: Calcd. for C25H30N2O10: C, 57.91; H, 5.83; N, 5.40. Found: C, 59.59; H, 5.99. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-
dicarboxylate (4d) 
The product was prepared according to the typical procedure from 2-nitrobenzaldehyde (3d) (0.151 g, 
1 mmol), β-keto ester 1a (0.404 g, 2 mmol) and Mg3N2 (2) (0.50 g, 0.5 mmol). The crude mixture was 
[ ]20Dα
[ ]20Dα
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extracted with EtOAc (3 × 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
Yellow oil; yield: 0.236 g (46%); : +55.0 (c 1.0, CHCl3). IR (film): 1735, 1701 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.03 (t, J = 6.8 Hz, 3 H), 1.26 (t, J = 6.8 Hz, 3 H), 1.41 (d, J = 7.2 Hz, 3 H), 1.45 (d, 
J = 7.6 Hz, 3 H), 2.26 (s, 3 H), 2.41 (s, 3 H), 3.96 (m, 2 H), 4.19 (m, 2 H), 4.92 (q, J = 6.8 Hz, 1 H), 5.01 (q, 
J = 7.2 Hz, 1 H), 6.09 (s, 1 H), 6.77 (bs, 1 H, NH), 7.25 (t, J = 8.4 Hz, 1 H), 7.48 (t, J = 8.0 Hz, 1 H), 7.56 
(d, J = 7.6 Hz, 1 H), 7.82 (d, J = 8.0 Hz, 1 H). 13C NMR (100 MHz, CDCl3): d = 13.00, 13.05, 14.96, 15.26, 
15.46, 33.34, 59.73, 60.37, 67.47, 67.55, 101.48, 102.00, 123.19, 125.98, 131.05, 132.02, 142.16, 145.20, 
145.63, 146.10, 165.37, 165.89, 170.09, 171.16. MS (ESI): m/z = 519 [M + H+]+. Elemental Analysis: 
Calcd. for C25H30N2O10: C, 57.91; H, 5.83; N, 5.40. Found: C, 59.71; H, 6.01. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]4-(3,5-Dimethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-
3,5-dicarboxylate (4e) 
The product was prepared according to the typical procedure from 3,5-dimethoxybenzaldehyde (3e) 
(0.332 g, 2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture 
was extracted with EtOAc (3 ×  10 mL), dried over Na2SO4 and purified by flash chromatography 
(EtOAc–cyclohexane, 35:65). 
Yellow oil; yield: 0.441 g (41%); : +40.0 (c 1.1, CHCl3). IR (film): 1740, 1698 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.17 (t, J = 7.0 Hz, 3 H), 1.25 (t, J = 7.2 Hz, 3 H), 1.44 (d, J = 6.8 Hz, 3 H), 1.49 (d, 
J = 7.6 Hz, 3 H), 2.34 (s, 3 H), 2.35 (s, 3 H), 3.75 (s, 6 H), 4.14 (m, 4 H), 5.00 (q, J = 7.2 Hz, 1 H), 5.06 (q, 
J = 7.2 Hz, 1 H), 5.07 (s, 1 H), 5.84 (s, 1 H, NH), 6.27 (s, 1 H), 6.50 (s, 1 H), 6.51 (s, 1 H). 13C NMR (100 
MHz, CDCl3): d = 13.74, 13.89, 16.82, 16.93, 18.88, 19.20, 39.31, 54.94, 60.82, 61.08, 68.02, 68.29, 97.51, 
102.13, 102.98, 106.47, 145.04, 146.08, 149.92, 160.05, 166.66, 170.01, 171.59. MS (ESI): m/z = 534 [M + 
H+]+. Elemental Analysis: Calcd. for C27H35NO10: C, 60.78; H, 6.61; N, 2.63. Found: C, 60.96; H, 6.63. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]4-(2-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate (4f) 
The product was prepared according to the typical procedure from 2-methoxybenzaldehyde (3f) 
(0.272 g, 2 mmol), β-keto ester 1a (0.808 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture 
was extracted with EtOAc (3 x 10 mL), dried over MgSO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
Yellow oil; yield: 0.431 g (43%); : +55.56 (c 0.9, CHCl3). IR (film): 1740, 1691 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.03 (t, J = 7.1 Hz, 3 H), 1.25 (t, J = 7.1 Hz, 3 H), 1.40 (d, J = 6.9 Hz, 3 H), 1.45 (d, 
J = 6.9 Hz, 3 H), 2.21 (s, 3 H), 2.32 (s, 3 H), 3.72 (s, 3 H), 3.95 (m, 2 H), 4.19 (m, 2 H), 4.87 (q, J = 7.1 Hz, 
1 H), 4.98 (q, J = 7.1 Hz, 1 H), 5.28 (s, 1 H), 6.65 (bs, 1 H, NH), 6.78 (m, 2 H), 7.08 (dt, J = 1.8 Hz, J = 7.4 
Hz, 1 H), 7.21 (dd, J = 1.8 Hz , J = 7.5 Hz , 1 H). 13C NMR (100 MHz, CDCl3): δ = 13.79, 13.99, 16.76, 
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16.80, 18.86, 19.23, 35.36, 55.08, 60.64, 61.10, 67.80, 67.99, 101.31, 102.13, 110.51, 119.67, 127.16, 
131.26, 135.37, 145.04, 146.08, 157.24, 167.05, 167.27, 171.36, 172.11. MS (ESI): m/z = 504 [M + H+]+. 
Elemental Analysis: Calcd. for C26H33NO9: C, 62.02; H, 6.61; N, 2.78. Found: C, 62.20; H, 6.63. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-styryl-1,4-dihydropyridine-3,5-
dicarboxylate (4g) 
The product was prepared according to the typical procedure from trans-cinnamaldehyde (3g) (0.264 
g, 2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture was 
extracted with EtOAc (3 x 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
Yellow oil; yield: 0.645 g (65%); : +44.55 (c 0.9, CHCl3). IR (film): 1741, 1698 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.19 (t, J = 6.8 Hz, 3 H), 1.26 (t, J = 6.8 Hz, 3 H), 1.51 (d, J = 6.4 Hz, 3 H), 1.53 (d, 
J = 6.4 Hz, 3 H), 2.32 (s, 3 H), 2.33 (s, 3 H), 4.16 (m, 4 H), 4.69 (d, J = 6.0 Hz, 1 H), 5.08 (q, J = 6.8 Hz, 1 
H), 5.12 (q, J = 7.2 Hz, 1 H), 5.99 (s, 1 H, NH), 6.36 (m, 2 H), 7.14–7.31 (m, 5 H, Ar). 13C NMR (100 
MHz, CDCl3): δ = 14.02, 14.08, 17.05, 17.11, 19.46, 19.60, 36.33, 61.05, 61.15, 68.25, 68.36, 100.54, 
101.23, 126.25, 126.78, 128.28, 128.37, 128.73, 131.76, 137.83, 145.49, 146.18, 166.63, 166.74, 171.33, 
171.49. MS (ESI): m/z = 500 [M + H+]+. Elemental Analysis: Calcd. for C27H33NO8: C, 64.92; H, 6.66; N, 
2.80. Found: C, 65.18; H, 6.69. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]4-Heptyl-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate (4h) 
The product was prepared according to the typical procedure from octanal (3h) (0.256 g, 2 mmol), β-
keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture was extracted with 
EtOAc (3 x 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–cyclohexane, 35:65). 
Yellow oil; yield: 0.572 g (58%); : +52.00 (c 0.9, CHCl3). IR (film): 1741, 1696 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 0.83 (t, J = 7.0 Hz, 3 H), 1.19–1.41 (complex pattern, 18 H), 1.48 (d, J = 7.2 Hz, 3 
H), 1.49 (d, J = 6.8 Hz, 3 H), 2.23 (s, 3 H), 2.26 (s, 3 H), 3.95 (t, J = 5.6 Hz, 1 H), 4.18 (m, 4 H), 5.05 (q, J 
= 7.2 Hz, 1 H), 5.06 (q, J = 6.8 Hz, 1 H), 6.32 (s, 1 H, NH). 13C NMR (100 MHz, CDCl3): δ = 14.03, 14.06, 
16.95, 16.98, 19.12, 19.16, 22.62, 24.70, 29.39, 29.92, 31.92, 32.70, 36.95, 60.94, 61.12, 68.05, 68.09, 
101.93, 102.47, 146.00, 146.39, 167.11, 167.41, 171.58, 171.71. MS (ESI): m/z = 496 [M + H+]+. 
Elemental Analysis: Calcd. for C26H41NO8: C, 63.01; H, 8.34; N, 2.83. Found: C, 63.17; H, 8.36. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(thien-2-yl)-1,4-dihydropyridine-3,5-
dicarboxylate (4i) 
The product was prepared according to the typical procedure from thiophene-2-carbaldehyde (3i) 
(0.332 g, 2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture 
was extracted with EtOAc (3 x 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
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Yellow oil; yield: 0.268 g (28%); : +33.08 (c 1.3, CHCl3). IR (Nujol): 1737, 1697 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.21 (t, J = 7.6 Hz, 3 H), 1.26 (t, J = 7.1 Hz, 3 H), 1.48 (d, J = 7.1 Hz, 3 H), 1.50 (d, 
J = 7.1 Hz, 3 H), 2.36 (s, 3 H), 4.19 (m, 4 H), 5.06 (q, J = 7.1 Hz, 1 H), 5.10 (q, J = 7.1 Hz, 1 H), 5.42 (s, 1 
H), 6.01 (s, 1 H, NH), 6.86 (m, 2 H), 7.05 (dd, J = 1.4 Hz, J = 5.0 Hz, 1 H). 13C NMR (100 MHz, CDCl3): 
δ = 14.04, 14.08, 16.96, 17.07, 19.52, 19.79, 34.25, 61.06, 61.17, 68.45, 68.59, 102.89, 103.31, 123.13, 
123.46, 126.41, 144.96, 145.64, 151.34, 166.38, 166.44, 171.23, 171.37. MS (ESI): m/z = 480 [M + H+]+. 
Elemental Analysis: Calcd. for C23H29NO8S: C, 57.61; H, 6.10; N, 2.92. Found: C, 57.80; H, 6.30. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(thien-3-yl)-1,4-dihydropyridine-3,5-
dicarboxylate (4j) 
The product was prepared according to the typical procedure from thiophen-3-carbaldehyde (3j) 
(0.332 g, 2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture 
was extracted with EtOAc (3 x 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
Yellow oil; yield: 0.704 g (73%); : +52.35 (c 1.7, CHCl3). IR (film): 1740, 1698 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 1.21 (t, J = 7.0 Hz, 3 H), 1.26 (t, J = 6.6 Hz, 3 H), 1.45 (d, J = 7.2 Hz, 3 H), 1.50 (d, 
J = 7.2 Hz, 3 H), 2.32 (s, 3 H), 2.33 (s, 3 H), 4.17 (m, 4 H), 5.03 (q, J = 6.8 Hz, 1 H), 5.06 (q, J = 7.2 Hz, 1 
H), 5.20 (s, 1 H), 6.15 (bs, 1 H, NH), 6.98 (m, 1 H), 7.06 (dd, J = 1.2 Hz, J = 5.0 Hz,1 H), 7.12 (dd, J = 3.0 
Hz, J = 4.9 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.05, 14.07, 16.96, 17.08, 19.43, 19.63, 34.33, 
61.07, 61.20, 68.30, 68.46, 102.43, 103.00, 120.55, 124.49, 127.69, 145.22, 145.81, 147.50, 166.66, 166.72, 
171.35, 171.49. MS (ESI): m/z = 480 [M + H+]+. Elemental Analysis: Calcd. for C23H29NO8S: C, 57.61; H, 
6.10; N, 2.92. Found: C, 57.80; H, 6.30. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(pyridin-3-yl)-1,4-dihydropyridine-3,5-
dicarboxylate (4k) 
The product was prepared according to the typical procedure from pyridine-3-carbaldehyde (3k) 
(0.332 g, 2 mmol), β-keto ester 1a (0.836 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture 
was extracted with EtOAc (3 x 10 mL), dried over Na2SO4 and purified by flash chromatography (EtOAc–
cyclohexane, 9:1). 
White solid; yield: 0.549 g (58%); mp 127 °C; : +74.00 (c 1.0, CHCl3). IR (film): 1741, 1699 cm–1. 
1H NMR (400 MHz, CDCl3): d = 1.11 (t, J = 7.0 Hz, 3 H), 1.24 (t, J = 6.8 Hz, 3 H), 1.43 (d, J = 7.1 Hz, 3 
H), 1.48 (d, J = 7.1 Hz, 3 H), 2.33 (s, 3 H), 2.36 (s, 3 H), 4.04 (m, 2 H), 4.18 (m, 2 H), 4.95 (q, J = 7.1 Hz, 
1 H), 5.00 (q, J = 7.1 Hz, 1 H), 5.04 (s, 1 H), 6.90 (s, 1 H, NH), 7.16 (dd, J = 4.7 Hz, J = 7.7 Hz, 1 H), 7.64 
(m, 1 H), 8.36 (m, 1 H), 8.52 (d, J = 2.0 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 13.95, 14.05, 16.89, 
17.02, 19.19, 19.41, 37.55, 60.97, 61.29, 68.26, 68.48, 101.99, 102.74, 123.04, 135.92, 143.19, 145.69, 
146.59, 147.14, 149.65, 166.28, 166.29, 171.02, 171.51. MS (ESI): m/z = 475 [M + H+]+. Elemental 
Analysis: Calcd. for C24H30N2O8: C, 60.75; H, 6.37; N, 5.90. Found: C, 60.91; H, 6.39. 
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Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(naphthalen-2-yl)-1,4-dihydropyridine-3,5-
dicarboxylate (4l) 
The product was prepared according to the typical procedure from naphthalene-2-carbaldehyde (3l) 
(0.312 g, 2 mmol), β-keto ester 1a (0.808 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The crude mixture 
was extracted with EtOAc (3 x 10 mL), dried over MgSO4 and purified by flash chromatography (EtOAc–
cyclohexane, 35:65). 
Yellow oil; yield: 0.543 g (52%); : +49.60 (c 1.0, CHCl3). IR (film): 1744, 1699 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 0.95 (t, J = 7.1 Hz, 3 H), 1.20 (t, J = 7.1 Hz, 3 H), 1.39 (d, J = 7.1 Hz, 3 H), 1.44 (d, 
J = 7.1 Hz, 3 H), 2.36 (s, 6 H), 3.95 (m, 2 H), 4.16 (m, 2 H), 4.90 (q, J = 7.1 Hz, 1 H), 5.02 (q, J = 7.1 Hz, 1 
H), 5.23 (s, 1 H), 5.87 (s, 1 H, NH), 7.36 (m, 2 H), 7.49 (dd, J = 1.8 Hz, J = 8.7 Hz, 1 H), 7.68–7.77 
(complex pattern, 4 H). 13C NMR (100 MHz, CDCl3): δ = 13.53, 13.93, 16.82, 16.93, 18.98, 19.30, 39.70, 
60.72, 61.18, 68.01, 68.35, 102.34, 103.26, 124.94, 125.37, 126.52, 127.12, 127.21, 127.28, 127.67, 132.19, 
133.16, 144.98, 145.09, 146.07, 166.71, 171.19, 171.79. MS (ESI): m/z = 524 [M + H+]+. Elemental 
Analysis: Calcd. for C29H33NO8: C, 66.53; H, 6.35; N, 2.68. Found: C, 66.71; H, 6.37. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]2,6-Dimethyl-4-(6-methoxynaphthalen-2-yl)-1,4-
dihydropyridine-3,5-dicarboxylate (4m) 
The product was prepared according to the typical procedure from 6-methoxynaphthalene-2-
carbaldehyde (3m) (0.300 g, 1.6 mmol), β-keto ester 1a (0.649 g, 3.2 mmol) and Mg3N2 (2) (0.083 g, 0.8 
mmol). The reaction mixture was stirred for 29 h at 90–100 °C, and then at r.t. for an additional 48 h. The 
crude mixture was extracted with CH2Cl2 (3 x 15 mL), dried over MgSO4 and purified by flash 
chromatography (EtOAc–cyclohexane, 35:65). 
Yellow oil; yield: 0.224 g (26%); : +54.27 (c 1.0, CHCl3). IR (film): 1740, 1691 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 0.97 (t, J = 7.1 Hz, 3 H), 1.23 (t, J = 7.1 Hz, 3 H), 1.42 (d, J = 7.1 Hz, 3 H), 1.47 (d, 
J = 7.1 Hz, 3 H), 2.35 (s, 3 H), 2.38 (s, 3 H), 3.89 (s, 3 H), 3.94 (m, 2 H), 4.18 (m, 2H), 4.91 (q, J = 7.1 Hz, 
1 H), 5.01 (q, J = 7.1 Hz, 1 H), 5.19 (s, 1 H), 6.16 (s, 1 H, NH), 7.01–7.13 (m, 2 H), 7.46 (dd, J = 1.8 Hz, J 
= 8.5 Hz, 1 H), 7.61 (m, 3 H). 13C NMR (100 MHz, CDCl3): δ = 13.72, 14.03, 16.90, 17.03, 18.40, 19.74, 
39.52, 55.23, 60.85, 61.16, 68.15, 68.42, 102.96, 103.81, 105.51, 118.17, 126.12, 126.41, 127.73, 128.74, 
129.27, 133.18, 142.91, 144.38, 145.44, 157.11, 166.72, 166.78, 171.20, 171.61. MS (ESI): m/z = 554 [M + 
H+]+. Elemental Analysis: Calcd. for C30H35NO9: C, 65.09; H, 6.37; N, 2.53. Found: C, 65.30; H, 6.39. 
Bis[(2S)-1-ethoxy-1-oxopropan-2-yl]4-[1-(tert-Butoxycarbonyl)-1H-indol-3-yl]-2,6-dimethyl-1,4-
dihydropyridine-3,5-dicarboxylate (4n) 
The product was prepared according to the typical procedure from tert-butyl-3-formyl-1H-indole-1-
carboxylate (3n) (0.492 g, 2.0 mmol), β-keto ester 1a (0.808 g, 2.0 mmol) and Mg3N2 (2) (0.100 g, 1.0 
mmol). The reaction mixture was stirred for 29 h at 90–100 °C, and then at r.t. for an additional 48 h. The 
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crude mixture was extracted with CH2Cl2 (3 x 15 mL), dried over MgSO4 and purified by flash 
chromatography (EtOAc–cyclohexane, 35:65). 
Yellow oil; yield: 0.272 g (22%); : +38.34 (c 0.8, CHCl3). IR (film): 1732, 1699 cm–1. 1H NMR 
(400 MHz, CDCl3): δ = 0.96 (t, J = 7.1 Hz, 3 H), 1.24 (t, J = 7.1 Hz, 3 H), 1.36 (d, J = 7.1 Hz, 3 H), 1.43 (d, 
J = 7.1 Hz, 3 H), 1.64 (s, 9 H), 2.28 (s, 3 H), 2.35 (s, 3 H), 3.80–3.99 (complex pattern, 2 H), 4.19 (m, 2 H), 
4.91 (q, J = 7.1 Hz, 1 H), 5.00 (q, J = 7.1 Hz, 1 H), 5.34 (s, 1 H), 6.59 (bs, 1 H, NH), 7.02 (d, J = 2.4 Hz, 1 
H), 7.15–7.24 (complex pattern, 2 H), 7.38 (s, 1 H), 7.67 (d, J = 7.9 Hz, 1 H). 13C NMR (100 MHz, 
CDCl3): δ = 13.60, 13.98, 16.82, 16.89, 19.07, 19.47, 28.13, 30.70, 60.76, 61.20, 68.11, 68.38, 83.24, 
102.72, 110.87, 114.80, 120.44, 121.98, 123.55, 124.40, 129.66, 144.48, 145.69, 166.78, 171.14, 171.80. 
MS (ESI): m/z = 613 [M + H+]+. Elemental Analysis: Calcd. for C32H40N2O10: C, 62.73; H, 6.58; N, 4.57. 
Found: C, 62.91; H, 6.60. 
Bis[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]2,6-Dimethyl-4-(3-nitrophenyl)-1,4-
dihydropyridine-3,5-dicarboxylate (4o) 
The product was prepared according to the typical procedure from 3-nitrobenzaldehyde (3c) (0.302 g, 
2 mmol), β-keto ester 1b (0.960 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The mixture was stirred for 
28 h at 90–100 °C. The crude mixture was extracted with CH2Cl2 (3 × 10 mL), dried over MgSO4 and 
purified by flash chromatography (Et2O–cyclohexane, 30:70). 
Yellow solid; yield: 0.589 g (50%); mp 151 °C; : 20 –26.25 (c 0.8, CHCl3). IR (NuJol): 1700 cm–1. 
1H NMR (400 MHz, CDCl3): δ = 0.49 (d, J = 7.1 Hz, 3 H), 0.58 (d, J = 7.1 Hz, 3 H), 0.76 (d, J = 6.9 Hz, 3 
H), 0.84 (d, J = 6.5 Hz, 3 H), 0.90 (d, J = 6.5 Hz, 3 H), 0.94 (d, J = 7.1 Hz, 3 H), 0.72–2.08 (complex 
pattern, 18 H), 2.33 (s, 3 H), 2.43 (s, 3 H), 4.67 (dt, J = 4.3 Hz, J = 11.2 Hz, 2 H), 5.10 (s, 1 H), 5.64 (bs, 1 
H, NH), 7.38 (t, J = 8.1 Hz, 1 H), 7.62 (dt, J = 1.4 Hz, J = 8.1 Hz, 1 H), 8.01 (ddd, J = 1.0 Hz, J = 2.4 Hz, J 
= 5.9 Hz, 1 H), 8.14 (t, J = 2.2 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 15.64, 16.87, 19.61, 20.91, 
22.06, 22.85, 23.91, 25.52, 31.46, 34.35, 39.96, 41.05, 41.58, 47.27, 47.54, 3.33, 74.10, 103.19, 104.10, 
121.23, 123.39, 128.68, 134.60, 144.25, 145.37, 148.05, 150.13, 166.69. MS (ESI): m/z = 595 [M + H+]+. 
Elemental Analysis: Calcd. for C35H50N2O6: C, 70.68; H, 8.47; N, 4.71. Found: C, 70.93; H, 8.50. 
Bis[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]2,6-Dimethyl-4-(2-nitrophenyl)-1,4-
dihydropyridine-3,5-dicarboxylate (4p) 
The product was prepared according to the typical procedure from 2-nitrobenzaldehyde (3d) (0.302 g, 
2 mmol), β-keto ester 1b (0.960 g, 4 mmol) and Mg3N2 (2) (0.100 g, 1 mmol). The mixture was stirred for 
24 h at 90–100 °C, then at 120 °C for 8 h, and then at r.t. for an additional 48 h. The crude mixture was 
extracted with CH2Cl2 (3 x 10 mL), dried over MgSO4 and purified by flash chromatography (Et2O–
cyclohexane, 30:70). 
Yellow solid; yield: 287 mg (25%); mp 93 °C; : 20 +20.87 (c 1.0, CHCl3). IR (film): 1687 cm–1. 
1H NMR (400 MHz, CDCl3): δ = 0.46 (d, J = 7.1 Hz, 3 H), 0.51 (d, J = 7.1 Hz, 3 H), 0.65 (d, J = 6.7 Hz, 3 
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H), 0.82 (d, J = 6.7 Hz, 6 H), 0.88 (d, J = 7.1 Hz, 9 H), 0.90–1.94 (complex pattern, 12 H), 2.27 (s, 3 H), 
2.34 (s, 3 H), 4.64 (dq, J = 4.3 Hz, J = 9.8 Hz, 2 H), 5.78 (bs, 1 H, NH), 5.96 (s, 1 H), 7.23 (m, 1 H), 7.46 
(dt, J = 1.2 Hz, J = 7.1 Hz, 1 H), 7.56 (dd, J = 1.2 Hz, J = 7.9 Hz, 1 H), 7.81 (dd, J = 1.2 Hz, J = 8.3 Hz, 1 
H). 13C NMR (100 MHz, CDCl3): δ = 15.58, 16.34, 19.71, 19.99, 20.62, 20.99, 20.98, 22.84, 23.54, 25.24, 
26.33, 31.42, 31.50, 34.08, 34.18, 39.68, 40.22, 40.72, 46.14, 46.40, 73.37–73.42, 74.16–74.21, 103.92, 
104.45, 124.21, 126.61, 131.60, 132.76, 143.45, 143.76, 145.00, 147.42, 166.80, 166.97. MS (ESI): m/z = 
595 [M + H+]+. Elemental Analysis: Calcd. for C35H50N2O6: C, 70.68; H, 8.47; N, 4.71. Found: C, 70.96; H, 
8.80. 
 
References and notes 
1. Yamamoto, T.; Niwa, S.; Ohno, S.; Onishi, T.; Matsueda, H.; Koganei, H.; Uneyama, H.; Fujita, S.; Takeda, T.; Kito, 
M.; Ono, Y.; Saitou, Y.; Takahara, A.; Iwata, S.; Shoji, M. Bioorg. Med. Chem. Lett. 2006, 16, 798-802. 
2. Dagnino, L.; Likwongken, M. C.; Wolowyk, M. W.; Wynn, H.; Triggle, C. R.; Knaus, E. E. J. Med. Chem. 1986, 29, 
2524-2529. 
3. Dagnino, L.; Likwongken, M. C.; Wynn, H.; Wolowyk, M. W.; Triggle, C. R.; Knaus, E. E. J. Med. Chem. 1987, 30, 
640-646. 
4. Choi, S.-J.; Cho, J.-H.; Im, I.; Lee, S.-D.; Jang, J.-Y.; Oh, Y.-M.; Jung, Y.-K.; Jeon, E.-S.; Kim, Y.-C. Eur. J. Med. 
Chem. 2010, 2578-2590. 
5. Iwanam, M.; Shibanuma, T.; Fujimoto, M.; Kaway, R.; Tamazawa, K.; Takenaka, T.; Takahashi, K.; Murakami, M. 
Chem. Pharm. Bull. 1979, 27, 1426. 
6. Arhancet, G. B.; Woodard, S. S.; Dietz, J. D.; Garland, D. J.; Wagner, G. M.; Iyanar, K.; Collins, J. T.; Blinn, J. R.; 
Numann, R. E.; Hu, X.; Huang, H.-C. J. Med. Chem. 2010, 53, 4300-4304. 
7. Zhang, B.-l.; He, W.; Shi, X.; Huan, M.-l.; Huang, Q.-j.; Zhou, S.-y. Bioorg. Med. Chem. Lett. 2010, 20, 805-808. 
8. Briede, J.; Daija, D.; Stivrina, M.; Duburs, G. Cell Biochem. Funct. 1999, 17, 89-96. 
9. Klusa, V. Drugs Future. 1995, 20, 135. 
10. Chang, C.-C.; Cao, S.; Kang, S.; Kai, L.; Tian, X.; Pandey, P.; Dunne, S. F.; Luan, C.-H.; Surmeier, D. J.; Silverman, R. 
B. Bioorg. Med. Chem. 2010, 18, 3147-3158. 
11. Che, J.; Lam, Y. L. Synlett 2010, 2415-2420. 
12. Hoffmann, S.; Seayad, A. M.; List, B. Angew. Chem. Int. Ed. 2005, 44, 7424-7427. 
13. Rueping, M.; Sugiono, E.; Azap, C.; Theissmann, T.; Bolte, M. Org. Lett. 2005, 7, 3781-3783. 
14. Storer, R. I.; Carrera, D. E.; Ni, Y.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 84-86. 
15. Hantzsch, A. Justus Liebigs Ann. Chem. 1882, 215, 1. 
16. Evans, C. G.; Jinwal, U. K.; Makley, L. N.; Dickey, C. A.; Gestwicki, J. E. Chem. Commun. 2011, 47, 529. 
17. Sridhar, R.; Perumal, P. T. Tetrahedron. 2005, 61, 2465-2470. 
18. Debache, A.; Boulcina, R.; Belfaitah, A.; Rhouati, S.; Carboni, B. Synlett. 2008, 509-512. 
19. Wang, L. M.; Sheng, J.; Zhang, L.; Han, J. W.; Fan, Z. Y.; Tian, H.; Qian, C. T. Tetrahedron. 2005, 61, 1539-1543. 
20. Ko, S.; Sastry, M. N. V.; Lin, C. C.; Yao, C. F. Tetrahedron Lett. 2005, 46, 5771-5774. 
21. Sabitha, G.; Reddy, G.; Reddy, C. S.; Yadav, J. S. Tetrahedron Lett. 2003, 44, 4129-4131. 
22. Tewari, N.; Dwivedi, N.; Tripathi, R. P. Tetrahedron Lett. 2004, 45, 9011-9014. 
23. Lee, J. H. Tetrahedron Lett. 2005, 46, 7329-7330. 
24. Ko, S. K.; Yao, C. F. Tetrahedron. 2006, 62, 7293-7299. 
25. Sharma, G. V. M.; Reddy, K. L.; Lakshmi, P. S.; Krishna, P. R. Synthesis-Stuttgart. 2006, 55-58. 
26. Maheswara, M.; Siddaiah, V.; Damu, G. L. V.; Rao, Y. K.; Rao, C. V. J. Mol. Catal. A. Chem. 2006, 255, 49-52. 
27. Gupta, R.; Paul, S.; Loupy, A. Synthesis-Stuttgart. 2007, 2835-2838. 
28. Zolfigol, M. A.; Safaiee, M. Synlett. 2004, 827-828. 
29. Ohberg, L.; Westman, J. Synlett. 2001, 1296-1298. 
30. Salehi, H.; Guo, Q. X. Synth. Commun. 2004 ,34, 4349-4357. 
31. Wang, S.-X.; Li, Z.-Y.; Zhang, J.-C.; Li, J.-T. Ultrason. Sonochem. 2008, 15, 677-680. 
32. Kumar, A.; Maurya, R. A. Synlett. 2008, 883-885. 
33. Mirza-Aghayan, M.; Langrodi, M. K.; Rahimifard, M.; Boukherroub, R. Appl. Organomet. Chem. 2009, 23, 267-271. 
34. Torchy, S.; Cordonnier, G.; Barbry, D.; Vanden Eynde, J. J. Molecules. 2002, 7, 528-533. 
35. M., M. V.; S.A., S.; S., S. M. Bulletin of the Catalysis Society of India. 2007, 6. 
36. Arslan, M.; Faydali, C.; Zengin, M.; Kucukislamoglu, M.; Demirhan, H. Turkish Journal of Chemistry. 2009, 33, 769-
774. 
37. Nikpassand, M.; Mamaghani, M.; Tabatabaeian, K. Molecules. 2009, 14, 1468-1474. 
38. Zonouz, A. M.; Sahranavard, N. J. Chem. 2010, 7, S372-S376. 
39. Rafiee, E.; Eavani, S.; Rashidzadeh, S.; Joshaghani, M. Inorg. Chim. Acta. 2009, 362, 3555-3562. 
Chapter 2 
39 
 
40. Kikuchi, S.; Iwai, M.; Murayama, H.; Fukuzawa, S. I. Tetrahedron Lett. 2008, 49, 114-116. 
41. Yamamoto, T.; Ohno, S.; Niwa, S.; Tokumasu, M.; Hagihara, M.; Koganei, H.; Fujita, S.; Takeda, T.; Saitou, Y.; 
Iwayama, S.; Takahara, A.; Iwata, S.; Shoji, M. Bioorgan. Med. Chem.Lett. 2011, 21, 3317-3319. 
42. Yoshida, K.; Inokuma, T.; Takasu, K.; Takemoto, Y. Molecules. 2010, 15, 8305-8326. 
43. Sivamurugan, V.; Sureshkumar, R.; Palanichamy, M.; Murugesan, V. J. Heterocyclic Chem. 2005, 42, 969. 
44. Ghorbani-Choghamarani, A.; Zolfigol, M. A.; Hajjami, M.; Goudarziafshar, H.; Nikoorazm, M.; Yousefi, S.; Tahmasbi, 
B. J. Braz. Chem. Soc. 2011, 22, 525-531. 
45. Moser, L.; Herzner, R. Monatsh. Chem. 1923, 115. 
46. Moser, L.; Herzner, R. Chem. Abstr. 1924, 18, 3625. 
47. Ley, S. V.; Paquette, L. A. J. Am. Chem. Soc. 1974, 96, 6670. 
48. Bridgwood, K. L.; Veitch, G. E.; Ley, S. V. Org. Lett. 2008, 10, 3627-3629. 
49. Veitch, G. E.; Bridgwood, K. L.; Ley, S. V. Org. Lett. 2008, 10, 3623-3625. 
50. Veitch, G. E.; Bridgwood, K. L.; Rands-Trevor, K.; Ley, S. V. Synlett. 2008, 2597-2600. 
51. Sobolev, A.; Franssen, M. C. R.; Vigante, B.; Cekavicus, B.; Makarova, N.; Duburs, G.; de Groot, A. Tetrahedron: 
Asymmetry. 2001, 12, 3251-3256. 
52. Sobolev, A.; Franssen, M. C. R.; Vigante, B.; Cekavicus, B.; Zhalubovskis, R.; Kooijman, H.; Spek, A. L.; Duburs, G.; 
de Groot, A. J. Org. Chem. 2002, 67, 401-410. 
53. Sobolev, A.; Franssen, M. C. R.; Makarova, N.; Duburs, G.; de Groot, A. Tetrahedron: Asymmetry. 2000, 11, 4559-
4569. 
54. Boatto, G.; Nieddu, M.; Faedda, M. V.; De Caprariis, P. Chirality. 2003, 15, 494-497. 
55. de Castro, M.; Salazar, L.; Sinisterra, J. Tetrahedron: Asymmetry 1997, 8, 857-858. 
56. Gianotti, M.; Martelli, G.; Spunta, G.; Campana, E.; Panunzio, M.; Mendozza, M. Synth. Commun. 2000, 30, 1725-1730. 
 
 
 
 40 
 
 
Chapter 3. 
 Use of N-trialkylsilylimines in the synthesis of N-containing 
heterocycles via a Hetero Diels-Alder strategy 
3.1 Introduction:  
Imines chemistry has achieved a dramatic development in the past decades. Due to their importance in 
organic synthesis, many N-substituted imines have been developed and applied for the syntheses of amino 
acids, β-lactams, heterocycles, alkaloids, aziridines, and amines.1,2 Among the reported imines, variously 
substituted N-trialkylsilylimines in general and N-trimethylsilylimines, in particular, play a prominent role 
as a result of their easy preparation and use in a plethora of synthetic applications.3 Some of these 
researches’ studies have been developed in the laboratories where this thesis’ study has been realized.4-12 
3.1.1 Preparation of N-trimethylsilyl imines 
N-trimethylsilyl imines are useful intermediate in the organic synthesis. They can be prepared in 
several ways. One of the simplest and high efficient method for the preparation is based on the addition-
elimination reaction of an alkaline metallo hexamethyldisilylamines to aldehydes and ketones (Scheme 1). 
 
Scheme 1: Preparation of N-(trialkylsilyl)imines 
Recently an interesting alternative to this procedure appeared in literature: Nikonov and coworkers13 
reported an elegant preparation of silyl-aldimines via a chemoselective hydrosilylation of nitriles catalyzed 
by Ruthenium complex (Scheme 2). For other methods for the preparation of silylimines the reader may 
refers to reported reviews.3,4 
 
Scheme 2 
As above anticipated, N-trialkylsilylimines have found useful application in the synthesis of a large 
variety of organic compounds presenting a nitrogen atom in their scaffold, including heterocycles. 
Accordingly, in this chapter will be reported the studies on the synthesis of piperidine scaffold starting 
from suitable decorated N-trimethyl silyl imines. As a matter of fact six-member nitrogen containing 
Chapter 3 
41 
 
heterocyclic rings constitute a framework very frequently encountered in natural products. Among them 
piperidine ring is one of the most common and continues to be highly used moiety in pharmaceutical 
research.14-18 There is special emphasis towards the preparation of piperidines bearing an hydroxyalkyl side 
chain at β-position of the nitrogen atom, since such scaffold may be identified as such or suitably 
elaborated in alkaloids with important bioactivity,19,20 for examples Conhydrine, (-)-Castanospermine, (-)-
slaframine, and (-)-swainsonine (Fig. 1). 
 
Figure 1. 
Numbers of very valuable synthetic methods for the preparation of this backbone, particularly those 
associated with conhydrines,21 have been already appeared in literature. However, to our knowledge, very 
few of them are based on a hetero Diels–Alder strategy.15-18,22-25 In order to apply this strategy, using as 
suitable starting material a silyl imine, the latter must be converted into a diene. For the sake of easy 
reading and understanding, in the following section are reported the protocol to convert silyl imine into the 
corresponding azadiene and the basic properties of these interesting intermediates. 
3.1.2 Preparation of electrophilic azadienes from N-Silylimines  
Acylimines are good synthons for the hetero Diels–Alder (HDA) strategy to prepare heterocycles and 
natural products.26-32 An important part of this strategy involves the use of imino Diels Alder reaction 
which provides an efficient route to the construction of functionalized six-member nitrogen-containing 
heterocyclic structures,33 with control of regio-, diastereo- and enantioselectivity.34 The HDA adducts have 
been used as such for the synthesis of complex cyclic structures as new heterocycles or open-chain 
compounds. The synthetic scope of azadienes (Scheme 3) in the preparation of important intermediates in 
organic synthesis is well documented.4,7,10,35,36 
 
Scheme 3 
Reaction of N-trimethylsilylimine with an acylating agent such as acyl chlorides in the presence of a 
base gives rise to the formation of a 3-trialkylsilyloxy-2-aza-1,3-diene 3 (Scheme 3). After the pioneering 
work by the Ghosez group37,38 such intermediates have been proved, inter alia, to be useful starting 
materials in hetero Diels-Alder reaction, with carbonyl compounds as dienophiles.39 The formation of the 
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azadiene has been supposed to happen via a nucleophilic attack of the imine’s nitrogen lone pair to the 
ketene as represented in Scheme 3. The ketene 2 is formed in situ in the reaction pot, adding triethylamine 
to the corresponding acyl chloride. The 3-trialkylsilyloxy-2-aza-1,3-dienes 3 with various substitution 
patterns are obtained in variable yields. Their stability largely depends on the said substitution pattern. The 
X group on ketene may be an hydrogen,38,40, alkyl/aryl groups,38 or a heterogroups as an amidic one: it is 
possible to isolate and spectroscopically characterise the azadienes deriving from ketenes carrying in the α-
position amido groups, halogens or sulphidic substituents. The stability is mostly conferred by the nature of 
the silylimines 1 utilized. The most stable 3-trialkylsilyoxy-2-aza-1,3-dienes are the triisopropyl- and tert-
butyl-dimethyl silyloxy ones because the triisopropyl- and tert-butyl-dimethylsilyl groups are not easily 
labile. It is even possible to purify by flash chromatography on a short silica gel-column the azadienes 
carrying an amidic substituent in position 4 and a tert-butyl-dimethylsilyl group on the oxygen.36,41 The 
configuration of the isolated and purified azadienes has been determined by a serie of NOE experiments. In 
the Figure 2, the results obtained for two stable azadienes A and B are reported as examples. Observing the 
increment values obtained, it can be deducted that the configuration of these azadienes is s-cis-ZE.10,36,42  
 
Figure 2 
In order to give a paramount sight on the preparation it must be underlined that an alternative route for 
the preparation of 3-trialkylsilyloxy-2-azadienes, is the Pinner-Ghosez procedure.38 Azadienes of type 1 
have been used as dienophile counterparts in hetero Diels-Alder reaction. 
3.1.3 Reactivity of trialkylsilyloxy-2-aza-1,3-dienes: six-member ring formation via Hetero-
Diels Alder reactions between azadienes and an appropriate dienophile.  
The hetero Diels-Alder (HDA) reaction using heterodienes and/or heterodienophiles is a very useful 
method for constructing heterocyclic rings and is widely used as a key step in the synthesis of natural 
products.28,43-46  
3-Trialkylsilyloxy-2-aza-1,3-dienes have been used in HDA reactions with a variety of dienophiles 
furnishing pyridones, isoquinolones, tetrahydropyridones, piperidones, pyrimidones, tetrahydrooxazinones 
with various substitution patterns.3 This chemistry has been mainly developed by Ghosez's and our groups. 
Ghosez has demonstrated the importance of the trialkylsilyloxy group at C-3 in doing this diene a good 
enophile, because it increases the nucleophilicity of the diene at C-4 by raising the energy of the HOMO 
and increasing its coefficient at C-4. In fact, according to the FMO theory,47 the cycloaddition of the 
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carbonyl dienophile to 1,3-dienes is a HOMOdiene LUMOdienophile controlled process. The presence of the 
trialkylsilyloxy group at C-3 also decreases the energy barrier between the cisoid and transoid 
conformation of the diene, thus favouring the cycloaddition over reactions on the nitrogen atom.48,49 
Among the several applications of hetero Diels-Alder reaction using azadienes generated from 
aldimines that concerning the synthesis of Conhydrine, a biologically active piperidine derivative5 found 
with Conine in the poison hemlock (Conium maculatum, popularly known as Cicuta, the Socrates poison) 
is worth of mention since constitutes the prodrome of the work performed during this thesis and which will 
be the object of the following section. The synthetic strategy involved the reaction of a chiral azadiene 350 
with vinylsulfone 4 or 7 that afforded the Diels Alder adducts 5 and 6 or 8 and 9 respectively (see Scheme 
4). The use of the more dienophile 7 resulted in better yields.51 In particular, when the reaction was carried 
out using microwaves afforded the expected HAD-adduct in 82% chemical yields and 1/1 diastereomeric 
ratio. The synthetic utility of this methodology has been demonstrated by converting the cyclic adducts 8 
and 9 to corresponding conhydrines 12 and 13 in two steps (Scheme 4).52  
 
Scheme 4 
3.2 Present work  
3.2.1 Preparation of 6-Aromatic- and Heteroaromatic-Substituted Piperidin-2-one Scaffold 
by Hetero Diels-Alder (HDA) Strategy.53 
As above anticipated, functionalized 2-azadienes have been shown to be versatile intermediates for the 
preparation of five- and six-member heterocycles.33,35,54,55 Moreover the azadiene system has been used for 
an electrocyclization reaction to give4,48,56-59 different heterocyclic compounds such as β-lactam rings via a 
two step Staudinger’s reaction,7,6 tetramic acid scaffold,40 perhydrooxazin-2-ones, cyclic intermediates in 
the synthesis of α-amino-β-hydroxy-acids,59,60 β-hydroxy-carboxylic acids40 and 1,3-aminols.8,9,28,61  
Recently, as above reported, the HDA-approach has been used for the synthesis of Conhydrine, a poisonous 
alkaloid present in conium maculatum and characterized by a piperidine scaffold.5 By the present work we 
report the natural prosecution of our studies in this stream by extending the preparative utility of this novel 
approach to piperidine-2-one heterocyclic rings substituted in position 6 by an aromatic or heteroaromatic 
group.15,17,18,22-24 The synthetic protocol for the preparation of the starting azadiene 1 (scheme 5) was that 
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already published: synthesis of a N-trimethylsilylimine62 and coupling of this intermediate with a suitable 
acyl chloride in the presence of a base such as triethylamine (TEA).38 In order to obtain the target 
piperidine-2-one scaffold the azadiene thus prepared was reacted with a dienophilic moiety bearing two 
carbon atoms to allow the formation of a six-member heterocyclic ring (Scheme 5). The intrinsic 
characteristic flexibility of a sulfonyl group, which may be easily removed, according well established 
literature protocol, or elaborated to more complex decorations of the heterocyclic ring, drove our choice 
towards the vinylsulfone 2a (Scheme 5) which presents, additionally, the necessary electron-poor nature for 
a normal electron demand hetero Diels-Alder reaction. 
 
Scheme 5. Reaction of azadiene 1(a-e) with dienophiles 2a 
 
Fig. 3 X-ray crystal structure of 3a with partial atomic numbering scheme. The atomic displacement 
parameters are drawn at the 30% probability level. 
Reaction of the azadiene 1a with the vinylsulphone 2a in anhydrous toluene at reflux for seven hrs 
(Scheme 5 and Table 1 entry 1) or at 110°C under microwave irradiation for 20 min. (Table 1 entry 2) gave 
rise to the formation of the piperidin-2-one 3a in 38% and 50% yields, respectively, and occurs with full 
exo selectivity in analogy to the already reported results by Ghosez’s group, some of them supported by X-
Ray structures determination.63-65 Since better yields were obtained using MAOS technique, this procedure 
was adopted for all the examples reported in Table 1.  As previously pointed out the trans relationship 
between the positions 5 and 6 is observed.63-65 The structural relationship between the substituents in 5 and 
6 positions of the piperidin-2-one ring has been confirmed by an X-ray diffraction study, carried out in 
order to unequivocally determine the correct structure of 3a. This analysis shows that the piperidinone ring 
adopts a distorted half-chair conformation with the hydrogens bound to C5 and C6 in trans position 
[H5C5C6H6 torsion angle of 176(1)°, see Figure 3]. In addition π-π interactions are present between the 
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two phenyl rings. Moreover the sole cyclic product obtained is that arising from a [4+2] HDA reaction, 
although in moderate-low yields (Table 1). 
Table 1. Synthesis of piperidin-2ones 3a-e 
Entry Diene 1 X Ar 3(Y%) 
1[a] 1a H Ph 3a(38)  
2[b] 1a H Ph 3a(50) 
3[b] 1b H p-MeO-Ph 3b(26) 
4[b] 1c H p-NO2-Ph 3c(13) 
5[b] 1d H Thienyl 3d(25) 
6[b] 1e H 3-Pyridyl 3e(18) 
[a]: Convective heating. [b]: Dielectric heating 
On the contrary, using azadienes 1(f-h), characterized by the presence of a substituent X on the 4-
position, a β-lactam ring 4 is also detected in the crude reaction mixture, (Scheme 6 and Table 2) 
independently from the reaction conditions adopted (convective or dielectric heating, Table 2 entries 1 and 
2), thus showing a competitive electrocyclization reaction of the diene itself with the formation of the 
corresponding β-lactam ring 4. 
 
Scheme 6. Reaction of azadiene 1(f-h) with dienophiles 2a 
From a stereochemical point of view the stereo relationship between the substituents in 3 and 5 and in 
5 and 6 positions of the piperidine-2-one ring 3 are trans as well as invariably trans is the stereo-
relationship of the substituents in 3 and 4 positions of the β-lactam 4. 
Table 2. Reaction of azadiene 1(f-h) with dienophiles 2a 
Entry Diene 1 X Ar 3 (Y%) 4 (Y%) 
1[a] 1f Cl Ph 3f (11) 4f (30)6 
2[b] 1f Cl Ph 3f (17) 4f (38) 
3[b] 1g Br Ph 3g (16) 4g (42)6 
4[b] 1h Ph-S- Ph 3h (3) 4h (16)7 
[a]Convective heating. [b] Dielectric heating 
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This competition between a [2+2EC] electrocyclic reaction and a [4+2] cycloaddition has been already 
observed by our group using the same diene-scaffold and a carbonyl compound as dienophile. Theoretical 
studies by Density Functional computations66 showed that the competition between the formation of a 
perhydrooxazinone (arising from a 4+2 HDA reaction ) and/or a β-lactam (arising from a [2+2EC] 
Staudinger reaction) is governed by a delicate interplay between temperature and the very nature of the 
substituents of the diene and dienophile, respectively. Similar computational studies have also been 
performed in the present case where the competition is between the piperidin-2-one 3f and the β-lactam 4f 
formation. The example of entry 1 of Table 2, yielding the compounds 3f and 4f (X=Cl, Ar=Ph) has been 
used as study case. In order to have the most complete overview of the reaction profile, we took in exam, 
from theoretical point of view, both the 5-6 cis (arising from an endo attack) and 5-6 trans (arising from an 
exo attack) possible stereo relationships of the substituents. Figure 4 shows the energy profiles, Figure 5 the 
geometries of the corresponding transition states and Figure 6 the variation of the G# energy barriers against 
temperature. From Figure 4 it may anticipated that HDA reaction is favoured in comparison with the 
formation of the [2+2EC] electrocyclic ring closure. In particular, the HDA exo1 approach has the lowest 
energy barrier (Fig. 4). However, careful analysis from Figure 6, shows that, on the basis of the variation of 
the G# barriers, the formation of the β-lactam is possible only at high temperature conditions. As the matter 
of fact, from experimental point of view, the formation of the β-lactam ring takes place at toluene reflux 
temperature (110 °C) whereas at low temperature (25 °C) only traces of the six-member ring are detected 
by NMR analysis after 5 hrs. The slope of the data in Figure 6, obtained through linear regression, indicates 
that exo1 reaction is higher than the electrocyclic closure (0.048 against 0.0035), and that the two lines 
intersect at 488 T[K]. This intersection temperature indicates qualitatively when the mechanism changes 
thus suggesting that only at high temperatures it is possible to obtain the β-lactam product. Figure 4 shows 
the energy profiles of the two possible endo pathways, which have been called respectively endo1 (C), and 
endo2stack (B) (Fig. 5). Endo2stack (B) is due to the stacking interaction between the phenyl group of the 
diene with the phenyl group of the –SO2Ph substituent of the dienophile (see the corresponding transition 
states geometries in Fig. 5) 
 
Figure 4. E0 energy profiles for the 2+2EC (black line), exo1 (green line), endo1(red line) and 
endo2stack (blue line) pathways.  
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Against the three different electrostatic minima with almost identical energy, the exo1 (A) (Fig. 5) 
approach is favoured compared with both the endo pathways. Among them the endo2stack (B) approach 
has a slightly higher barrier than endo1(C). The stabilizing stacking interaction probably does not 
compensate the strain at which the molecule is forced to maximize the non-bonded interaction. In fact, 
linear regression of the G# data in Figure 6, shows that endo2stack (B) has a higher slope (0.06) than exo1 
(A) and endo1(C) (~0.048) due to a destabilizing entropy effect. 67 
 
Figure 5. Optimized transition states geometries: (A) exo1, (B) endo2stack and (C) endo1 mechanisms. 
 
Figure 6. Variation of the G # energy barriers of the 2+2EC (black line) and HDA ( endo1, red line, 
endo2stack, blu line and exo1, green line) reactions against temperature. 
Taking advantage of the results reported by De Lucchi51 on the reactivity of the sulfones in Diels-
Alder reaction, the next step of our studies was to consider a new reaction pathway in which the electron 
demanding nature of the dienophile was increased by adding an extra sulfone group in its scaffold. To 
support this choice and before studying the mechanism from a theoretical point of view, we have analyzed 
the global electrophilic indices of 1f, 2a and 2b through the conceptual DFT descriptors.67-70 The results of 
this theoretical investigation have been reported in Table 3. Both the dienophiles 2a and 2b have a high 
index but 2b is higher than 2a and consequently a better reactivity in the HDA reaction which should 
further disfavour the formation of the β-lactam side product. This result has been tested from a theoretical 
point of view investigating the reaction of the diene 1f with the dienophile 2b (Scheme 7). For this reaction 
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we have detected two different HDA transition states: no-stack1 and stack1 (see Figure 7 for the geometries 
of the corresponding transition states). Because stack1, which has the corresponding stacking interaction 
described in the 1f + 2a reaction, due to a destabilizing entropy effect, is not favoured, we have limited our 
discussion to the no-stack1 pathway.  
Table 3. Electrophilic indice of 1f, 2a and 2b 
             N
H
HCl
ArO
Si
 
                    1f 
H
SO2Ph  
2a 
SO2Ph
SO2Ph  
2b 
μ                 0.15 0.17 0.18 
𝑥𝑥                3.99 4.65 4.89 
η                 0.22 0.31 0.28 
S                4.47 3.25 3.55 
△Nmax    0.66 0.55 0.64 
ω               1.31 1.29 1.56 
△ω -0.02 0.25 
 
 
Figure 7. Optimized transition states geometries: (A) stack1 and (B) no-stack1 mechanisms. 
 
Figure 8. E0 energy profiles for the 2+2EC (black line) and no-stack1 (red line) pathways. 
Chapter 3 
49 
 
In Figure 8, together with the 2+2EC pathway, is reported the energy profile of the no-stack1 
mechanism and in Figure 8 the variation of the G# energy barrier of the no-stack1 reaction against 
temperature. Figure 8 shows that the HDA pathway is even more stabilized in comparison with the 2+2EC 
mechanism. This disulfone system forms an electrostatic minimum stabilized of 11.7 kcal/mol. The energy 
barrier to form the HDA product is now reduced by half compared to the mono-sulfone case (8.7 against 
16.3 kcal/mol.), being lower than the stabilization due to the electrostatic interaction. Diagram in Figure 9 
shows that, despite a higher slope (~0.06), the intersection temperature becomes 524 T[K]. In other words, 
this qualitative diagram indicates that is necessary a higher temperature to form the β-lactam. 
 
Figure 9. Variation of the G# energy barriers of the 2+2EC (black line) and HDA no-stack1(red line) 
reactions against temperature. 
Having in mind the theoretical simulations, we increased the reactivity of the dienophile introducing a 
second sulfone moiety into the vinylsulfone scaffold (Scheme 7). As predicted a higher yielding HDA 
reaction took place and no traces of a β-lactam compound was present in the crude reaction mixture 
(Scheme 7 and Table 4). 
 
Scheme 7. Reaction of azadiene 1 with dienophiles 2b. 
Once again the stereo relationship between the substituents on the C-3 (if present) and C-6 positions 
(piperidine numbering) was in a mutual cis relationship as dictated by an HDA mechanism. To test the 
practicability and synthetic utility of the protocol herein reported, the elaboration of compound 5a to the 
racemic (±)-2-phenyl-piperidine was explored and proved to be relatively straightforward (Scheme 8). The 
protocol to elaborate 5a to the corresponding 671 was identified in the use of a popular desulphonation by 
means of sodium amalgam in methanol. Elaboration of 6 to the 2-phenyl-piperidine 7 by means of LiAlH4 
has been already reported.71 
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Table 4. Synthesis of Piperydin-2-ones 5 from azadiene 1 and dienophile 2b 
Entry Diene 1 R Ar 5 (Y%) 4 (Y%) 
1 1a H Ph 5a (61) 4a (0) 
2 1c H p-NO2-Ph 5c (30) 4c (0) 
3 1d H Thienyl 5d (38) 4d (0) 
4 1e H 3-Pyridyl 5e (75) 4e (0) 
5 1f Cl Ph 5f (64) 4f (0) 
6 1h Ph-S- Ph 5h (25) 4h (0) 
7 1i Cl p-F-Ph 5i (96) 4i (0) 
 
 
Scheme 8. Synthesis of 2-phenylpiperidine. 
3.2.2 Conclusions 
From the results reported we have demonstrated that the reactivity of azadiene of type 1 may be 
extended to the preparation of an important scaffold as is that of piperidine. Application of this strategy to 
the preparation of other bio-important compounds, presenting different decorations on the ring, is currently 
under studies. Theoretical studies addressed to disclose the main parameters which favours the [4+2] 
reaction versus the competitive [2+2] have been carried out and the relative results reported. 
 
3.3 Experimental Section 
General: All the reactions were conducted under N2 atmosphere. NMR spectra were recorded with a 
Varian instrument at 400 MHz (1H) and 100 MHz (13C). Chemical shifts (δ) for 1H and 13C NMR spectra 
and J value are reported in ppm. All chemical shifts are quoted relative to deuterated solvent signals. 
Optical rotations were measured at 25 °C with a Perkin–Elmer Polarimeter 141. Mass spectra were 
recorded with a Finnigan MAT GCQ spectrometer in the electron impact mode at 70 eV and are reported as 
m/z. The infrared spectra were recorded with a Perkin Elmer Spectrum BX spectrometer; wave numbers are 
reported in cm-1.  Elemental analyses were performed at CNR-ISMAR, Bologna, Italy. Solvents were 
distilled and dried according to the standard  procedure. 
Reaction of the azadiene 1a with the sulphone 2a, under convective heating (Entry 1 Table 1). 
Azadiene 1a (1 mmol) was dissolved in 10 mL of anhydrous toluene and phenyl vinylsulfone 2a (0.17 
g, 1 mmol) was added in one portion under magnetic stirrer. The solution was warmed at reflux 
temperature for 7 hrs then was cooled at room temperature. The solvent was removed in vacuo and the 
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crude reaction mixture was purified by crystallization with ethanol Product 3a (0.12 g) was obtained in 38% 
yield. 
Reaction of the azadiene 1a with the sulphone 2a, under MAOS conditions (Entry 2 Table 1) 
Azadiene 1a (1 mmol) was dissolved in 10 mL of anhydrous toluene and was put in a flask for 
microwave oven synthesis (Milestone). Phenyl vinylsulfone (0.17 g, 1 mmol) was added and the mixture 
was submitted to microwave irradiation for 20’ at 500 Watt power. The solvent was evaporated and the 
pure product 3a (0.16 g) was obtained by crystallization of the crude reaction mixture with ethanol in 50% 
yield. 
 (5S*, 6R*)-6-phenyl-5-(phenylsulfonyl)piperidin-2-one 3a: white solid; m.p.= 229°C. IR (CHCl3): 
1668 cm-1. 1H-NMR (400 MHz, CDCl3): δ = 7.81 (m, 2H, Ar), 7.62 (m, 1H, Ar), 7.16 (m, 2H, Ar), 7.27 (m, 
3H, Ar), 7.12 (m, 2H, Ar), 5.73 (bs, 1H, NH), 5.15(dd, J1 = 3.2 Hz, J2 = 4.4 Hz, 1H, 6-H), 3.42 (q, J = 5.6 
HZ, 1H, 5-H), 2.79 (dt, J1 =8.0 Hz, J2= 18.0 Hz, 1H, 3-HA), 2.48 (dt, J1 =6.4Hz, J2= 18.0 Hz, 1H, 3-HB), 
2.22 (m, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, CDCl3): δ = 170.54, 139.77, 137.62, 134.09, 129.41, 
129.11, 126.87, 128.53, 126.44, 63.76, 55.20, 28.05, 18.47 ppm. Ms (m/z): 316, 174, 173, 158, 144. 
C17H17NO3S (315.09) calculated: C 64.74, H 5.43, N 4.44; found: C 64.80, H 5.44, N 4.44. 
 
X-ray Crystallography for 3a 
The X-ray intensity data for 3a were measured on a Bruker SMART Apex II diffractometer equipped 
with a CCD area detector using a graphite monochromated Mo-Kα radiation source (λ = 0.71073 Å). Cell 
dimensions and the orientation matrix were initially determined from a least-squares refinement on 
reflections measured in three sets of 20 exposures, collected in three different ω regions, and eventually 
refined against all data. For all crystals, a full sphere of reciprocal space was scanned by 0.3°ω steps. The 
software SMART.72 was used for collecting frames of data, indexing reflections and determination of 
lattice parameters. The collected frames were then processed for integration by software72 and an empirical 
absorption correction was applied with SADABS.73 The structure was solved by direct methods (SIR 97)74 
and subsequent Fourier syntheses and refined by full-matrix least-squares calculations on F2 (SHELXTL)75 
attributing anisotropic thermal parameters to the non-hydrogen atoms. All hydrogen atoms were located in 
the Fourier map. The methylene and aromatic hydrogens were placed in calculated positions and refined 
with isotropic thermal parameters U(H) = 1.2 Ueq(C), and allowed to ride on their carrier carbons whereas 
the methine and aminic H atoms were located in the Fourier map and refined isotropically. 
C17H17NO3S, 3a, M = 315.38, monoclinic, space group P21/c (No. 14), a = 15.9096(11), b = 5.7746(4), 
c = 17.2601(12) Å, β = 17.2601(12)°, V = 1516.49(18) Å3, Z = 4, T = 293(2) K, Dc = 1.381gcm–1, μ(Mo-
Kα) = 0.226 mm–1, F(000) = 664 crystal size = 0.20 x 0.2510 x 0.05 mm, 16370 reflections collected [R(int) 
= 0.0353], 3707 unique. Final R [I > 2σ(I)] = 0.0402, wR2[I σ 2σ(I)] =0.0937, and for all data R (all data) = 
0.0643, wR2 (all data) = 0.1055. 
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CCDC-829176 contains the supplementary crystallographic data for compound 3a. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Reaction of the azadiene 1b-h with the sulphone 2a, under MAOS conditions:  General procedure.  
Azadiene 1b-h (1 mmol) was dissolved in 10 mL of anhydrous toluene and was put in a flask for 
microwave oven synthesis (Milestone). Phenyl vinylsulphone (0.17 g, 1 mmol) was added and the mixture 
was submitted to microwave irradiation for 20’ at 500 Watt power. The solvent was evaporated and the 
residue was purified by flash chromatography (eluent CH2Cl2/ethylacetate, 75/25) to afford the products 
3b-h and the β-lactams 4f-h in the yields and ratios reported in Table 1 and in Table 2.  
 (5S*, 6R*)-6-(4-methoxyphenyl)-5-(phenylsulfonyl)piperidin-2-one 3b: white solid; m.p =160-
165°C. IR (CHCl3): 1667 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 7.75 (m, 2H, Ar), 7.59 (m, 1H, Ar), 7.46 
(m, 2H, Ar), 6.97 (d, J = 8.8 Hz, 2H, Ar), 6.72 (d, J = 8.8 Hz, 2H, Ar), 6.48 (bs, 1H, NH), 5.01 (dd, J1 = 1.6 
Hz, J2 = 4.4 Hz, 1H, 6-H), 3.72 (s, 3H, OMe), 3.36 (dt, J1= 4.8 Hz, J2 = 6.0 Hz, 1H, 5-H), 2.70 (m, 1H, 3-
HA), 2.40 (m, 1H, 3-HB), 2.16 (m, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, CDCl3): δ = 170.63, 159.49, 
137.68, 133.81, 131.51, 129.21, 128.35, 127.64, 114.21, 63.78, 55.20, 54.60, 28.06, 18.41 ppm. Ms (m/z): 
345, 329, 203, 188, 172, 134, 92, 77. C18H19NO4S (345.10) calculated: C 62.59, H 5.54, N 4.06; found: C 
62.55, H 5.55, N 4.05. 
 (5S*, 6R*)-6-(4-nitrophenyl)-5-(phenylsulfonyl)piperidin-2-one 3c: yellow solid. m.p.= 225-
230°C. IR (CHCl3): 1675 cm-1. 1H-NMR (400 MHz, CDCl3): δ =8.17 (d, J = 8.8 Hz, 2H, Ar), 7.84 (d, J = 
8.8 Hz, 2H, Ar), 7.69 (m, 1H, Ar), 7.56 (m, 2H, Ar), 7.39 (m, 2H, Ar), 6.41 (bs, 1H, NH), 5.31 (dd, J1 = 2.4 
Hz, J2 = 4.4 Hz, 1H, 6-H), 3.38 (dt, J1= 4.8 Hz, J2 = 6.8 Hz, 1H, 5-H), 2.77 (m, 1H, 3-HA), 2.47 (m, 1H, 3-
HB), 2.24-2.08 (m, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, CDCl3): δ =170.52, 147.97, 147.02, 137.05, 
134.51, 129.63, 128.59, 127.70, 124.30, 63.58, 54.58, 28.06, 19.07 ppm. Ms (m/z): 360, 359, 299, 227, 218, 
201, 171, 115, 91, 78. C17H16N2O5S (360.08) calculated: C 56.60, H 4.47, N 7.77; found: C 56.85, H 4.48, 
N 7.79.  
(5S*, 6R*)-5-(phenylsulfonyl)-6-(thiophen-3-yl)piperidin-2-one 3d: yellow solid. m.p = 190°C. IR 
(CHCl3): 1672 cm-1. 1H-NMR (400 MHz, CDCl3): δ = 7.83 (m, 2H, Ar), 7.64 (m, 1H, Ar), 7.53 (m, 2H, 
Ar), 7.18 (m, 1H, Th), 6.86 (m, 2H, Th), 6.29 (bs, 1H, NH), 5.38 (dd, J1 = 2.8 Hz, J2 = 4.8 Hz, 1H, 6-H), 
3.50 (ddd, J1=J2= 4.8 Hz, J3 = 6.8 Hz, 1H, 5-H), 2.73 (m, 1H, 3-HA ), 2.45 (m, 1H, 3-HB), 2.38-2.20 (m, 2H, 
4-CH2) ppm . 13C-NMR (100 MHz, CDCl3): δ  = 170.16, 143.79, 137.62, 134.11, 129.40, 128.52, 127.13, 
126.18, 125.99, 64.35, 51.37, 28.21, 19.00 ppm. Ms (m/z): 321, 305, 179, 164, 150, 110. C15H15NO3S2 
(321.05) calculated: C 56.05, H 4.70, N 4.36; found: C 56.22, H 4.68, N 4.37. 
(5S*, 6R*)-5-(phenylsulfonyl)-6-(pyridin-3-yl)piperidin-2-one 3e: white solid. m.p. = 205°C. IR 
(CHCl3): 1674 cm-1. 1H-NMR (400 MHz, CDCl3): δ = 8.55 (d, J = 2.0 Hz, 1H, Py), 8.53 (dd, , J1=1.6 Hz, 
J2 = 4.8 Hz, 1H, Py), 7.80 (m, 2H, Ar), 7.70 (m, 1H, Py), 7.66 (m, 1H, Ar), 7.53 (m, 1H, Ar), 7.33 (dd, 
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J1=5.2 Hz, J2 = 8.0 Hz, 1H, Py), 6.34 (bs, 1H, NH), 5.20 (dd, J1 = 2.0 Hz, J2 = 6.4 Hz, 1H, 6-H), 3.52 (q, J= 
6.4, 1H, 5-H), 2.75 (m,1H, 3-HA), 2.52  (m, 1H, 3-HB ), 2.22 (m, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, 
CDCl3): δ  = 170.50, 149.47, 148.07, 137.29, 134.83, 134.34, 129.57, 128.51, 123.89, 63.47, 53.43, 28.34, 
19.15 ppm. Ms (m/z): 316, 175, 141, 78. C16H16N2O3S (316.09) calculated: C 60.74, H 5.10, N 8.85; found: 
C 60.56, H 5.12, N 8.87. 
 (3S*, 5S*, 6R*)-3-chloro-6-phenyl-5-(phenylsulfonyl)piperidin-2-one 3f: white solid. m.p = 150°C. 
IR (CHCl3): 1686 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 7.69 (m, 2H, Ar), 7.57 (m, 1H, Ar), 7.43 (m, 2H, 
Ar), 7.25 (m, 3H, Ar), 7.16 (m, 2H, Ar), 5.98 (bs, 1H, NH), 5.03 (dd, J1= 1.6 Hz, J2= 7.2 Hz, 1H, 6-H), 
4.71 (t, J = 5.2 Hz, 1H, 3-H), 3.87 ( ddd, J1= 4.4 Hz, J2= 7.2 Hz, J3= 8.8 Hz, 1H, 5-H), 2.67 (m, 2H, 4-CH2) 
ppm. 13C-NMR (100 MHz, CDCl3): δ = 166.03, 138.39, 137.42, 134.14, 129.34, 129.11, 129.05, 128.33, 
127.13, 61.05, 56.43, 51.16, 29.43 ppm. Ms (m/z): 349, 314, 258, 208, 158, 91, 77. C17H16ClNO3S (349.05) 
calculated: C 58.37, H 4.61, N 4.00; found: C 58.19, H 4.59, N 4.02.  
(3S*, 5S*, 6R*)-3-bromo-6-phenyl-5-(phenylsulfonyl)piperidin-2-one 3g: Yellow oil. IR (CHCl3): 
1672 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 7.64 (m, 2H, Ar), 7.56 (m, 1H, Ar), 7.40 (m, 2H, Ar), 7.24 
(m, 5H, Ar), 6.20 (bs, 1H, NH), 5.04 (dd, J1 = 2.0 Hz, J2 = 8.4 Hz, 1H, 6-H), 4.73 (t, J = 5.2 Hz, 1H, 3-H), 
3.97 (q, J1= 6.8 Hz,  1H, 5-H), 2.72 (dd, J1= 5.2 Hz, J2= 6.8 Hz, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, 
CDCl3): δ =166.39, 138.23, 137.57, 134.02, 129.25, 129.15, 129.04, 128.24, 127.37, 61.23, 56.81, 40.67, 
29.98 ppm. Ms (m/z): 395, 393, 314, 254, 252, 141, 77. C17H16BrNO3S (393.00) calculated: C 51.79, H 
4.09, N 3.55; found: C 51.67, H 4.11, N 3.54. 
(3S*,5S*,6R*)-6-phenyl-5-(phenylsulfonyl)-3-(phenylthio)piperidin-2-one 3h: Yellow oil. IR 
(CHCl3): 1672 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 7.71 (m, 2H,Ar), 7.61 (m, 1H, Ar), 7.46 (m, 2H, 
Ar), 7.34 (m, 4H, Ar), 7.20 (m, 4H, Ar), 6.95 (m, 2H, Ar), 6.42 (bs, 1H, NH), 5.07 (dd, J1 = 2.4 Hz, J2 = 
5.6 Hz, 1H, 6-H), 4.19 (dd, J1 = 5.6 Hz, J2 = 8.0 Hz, 1H, 3-H), 3.65 (ddd, J1= 4.4 Hz, J2= 5.6 Hz, J3= 7.2 
Hz, 1H, 5-H), 2.44 (ddd, J1= 5.6 Hz, J2= 7.2 Hz, J3= 12.4 Hz, 1H, 4-HA), 2.32 (ddd, J1= 4.4 Hz, J2= 8.0 Hz, 
J3= 12.4 Hz, 1H, 4-HB) ppm. 13C-NMR (100 MHz, CDCl3): δ=168.85, 139.07, 137.33, 134.66, 134.08, 
133.23, 129.37, 129.32, 128.99, 128.79, 128.64, 128.42, 126.69, 62.36, 55.53, 45.31, 25.77 ppm. Ms (m/z): 
423, 326, 281, 248, 204, 172, 144, 129, 91, 77. C23H21NO3S2 (423.10) calculated: C 65.22, H 5.00, N 3.31; 
found: C 65.48, H 5.02, N 3.30. 
 
Reaction of the azadiene 1a, c-f, h-i with the sulphone 2b, under MAOS conditions as general 
procedure.  
Azadiene 1a, c-f, h-i (1 mmol) was dissolved in 10 mL of anhydrous toluene and was put in a flask for 
microwave oven synthesis (Milestone). 1,1-Bis(phenylsulfonyl)ethylene 2b (0.31 g, 1 mmol) was added 
and the mixture was submitted to microwave irradiation for 20’ at 500 Watt power. The solvent was 
evaporated and the residue was purified by flash chromatography (eluent CH2Cl2/ethylacetate, 80/20) to 
afford the products 5a, c-f, h-i. 
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 6-phenyl-5,5-bis(phenylsulfonyl)piperidin-2-one 5a: m.p. = 218°C. IR (CHCl3): 1641 cm-1. 1H-
NMR (400 MHz, CDCl3): δ  = 8.19 (m, 2H, Ar), 7.76 (m, 1H, Ar), 7.64 (m, 2H, Ar), 7.55 (m, 1H, Ar), 7.48 
(m, 2H, Ar), 7.36-7.22 (m, 7H, Ar), 6.53 (bs, 1H, NH), 5.25 (d, J = 3.6 Hz, 1H, 6-H), 2.94 (m, 3H, 3-CH2, 
4-HA), 2.80 (m, 1H, 4-HB) ppm. 13C-NMR (100 MHz, CDCl3): δ  = 169.62, 138.41, 136.99, 136.23, 135.19, 
134.12, 131.27, 130.67, 130.20, 129.17, 128.44, 128.31, 90.24, 58.48, 27.74, 23.36 ppm. Ms (m/z): 454, 
313, 171, 143, 115, 95, 77. C23H21NO5S2 (455.09) calculated: C 60.64, H 4.65, N 3.05; found: C 60.47, H 
4.67, N 3.05.  
 6-(4-nitrophenyl)-5,5-bis(phenylsulfonyl)piperidin-2-one 5c: white solid. m.p. = 160°C. IR 
(CHCl3): 1676 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 8.15 (m, 4H, Ar), 7.80 (m, 1H, Ar), 7.73 (m, 2H, 
Ar), 7.67 (m, 3H, Ar), 7.49 (m, 4H, Ar), 6.74 (bs, 1H, NH), 5.28 (d, J = 2.8 Hz, 1H, 6-H), 3.05 (m, 1H, 3-
HA ), 2.86 (m, 3H, 4-CH2, 3-HB) ppm. 13C-NMR (100 MHz, CDCl3): δ  = 169.83, 148.17, 143.22, 138.18, 
136.24, 135.61, 134.86, 131.15, 130.99, 130.98, 129.52, 128.58, 123.40, 89.71, 57.95, 29.69, 23.47 ppm; 
Ms (m/z): 499, 438, 359, 218, 78.C23H20NO7S2 (500.07) calculated: C 55.19, H 4.03, N 5.60; found: C 
55.39, H 4.01, N 5.62.  
5,5-bis(phenylsulfonyl)-6-(thiophen-2-yl)piperidin-2-one 5d: white solid; m.p. = 225°C; IR 
(CHCl3): 1676 cm-1; 1H-NMR (400 MHz, CDCl3): δ [ppm] = 8.13 (d, 2H, J=7.2 Hz, Ar), 7.73 (m, 3H, Ar), 
7.62 (m, 3H, Ar), 7.45 (m, 2H, Ar), 7.29 (d, 1H, J=5.2 Hz, Th), 7.17 (d, 1H, J=3.6 Hz, Th), 6.92 (dd, J1 = 
3.6 Hz, J2 = 5.2 Hz, 1H, Th), 6.12 (bs, 1H, NH), 5.55 (d, J = 3.2 Hz, 1H, 6-H), 3.05 (m, 1H, 3-HA), 2.83 (m, 
1H, 3-HB), 2.76 (m, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, CDCl3): δ = 169.64, 138.68, 138.46, 136.89, 
135.29, 134.42, 131.32, 130.93, 130.72, 129.26, 128.48, 127.99, 126.53, 89.75, 54.64, 29.69, 24.40 ppm. 
Ms (m/z): 461, 369, 351, 319, 254, 177, 153, 135, 125, 111, 97, 77. C21H19NO5S3 (461.04) calculated: C 
54.64, H 4.15, N 3.03; found: C 54.45, H 4.14, N 3.05. 
 5,5-bis(phenylsulfonyl)-6-(pyridin-3-yl)piperidin-2-one 5e: white solid. m.p. = 215°C; IR (CHCl3): 
1677 cm-1. 1H-NMR (400 MHz, CDCl3): δ = 8.55 (dd, J1 = 2.0 Hz, J2 = 4.8 Hz, 1H, Py), 8.51 (d, J = 2.0, 
1H, Py), 8.16 (m, 2H, Ar), 7.79 (m, 1H, Ar), 7.72 (m, 1H, Py), 7.66 (m, 5H, Ar), 7.45 (m, 2H, Ar), 7.23 (dd, 
J1 = 4.8 Hz, J2 = 8.0 Hz, 1 H, Py), 6.26 (bs, 1H, NH), 5.25 (d, J = 3.2 Hz, 1H, 6-H), 2.98 (m, 1H, 3-HA), 
2.88 (m, 1H, 3-HB), 2.82 (m, 2H, 4-CH2) ppm. 13C-NMR (100 MHz, CDCl3): δ  = 170.24, 150.41, 149.29, 
145.21, 137.91, 136.36, 135.40, 134.62, 132.73, 131.04, 130.70, 129.29, 128.51, 123.34, 89.30, 56.02, 
27.40, 23.32 ppm. Ms (m/z): 456, 315, 174, 77. C22H20N2O5S2 (456.08) calculated: C 57.88, H 4.42, N 6.14; 
found: C 57.70, H 4.43, N 6.17. 
(3S*, 6R*)-3-chloro-6-phenyl-5,5-bis(phenylsulfonyl)piperidin-2-one 5f: white solid. m.p = 155°C. 
IR (CHCl3): 1687 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 8.21 (m, 2H, Ar), 7.80 (m, 1H, Ar), 7.68 (m, 2H, 
Ar), 7.59 (m, 1H, Ar), 7.52 (m, 2H, Ar), 7.40 (m, 2H, Ar), 7.31 (m, 1H, Ar), 7.26 (m, 4H, Ar), 6.68 (d, 
J=3.6, 1H, NH), 5.14 (d, J = 3.6 Hz, 1H, 6-H), 4.99 (dd, J1 = 8.0 Hz, J2 = 10.4 Hz, 1H, 3-H), 3.50 (dd, J1 = 
8.0 Hz, J2 = 14.8 Hz, 1H, 4-HA), 3.30 (dd, J1 = 10.4 Hz, J2 = 14.8 Hz, 1H, 4-HB). 13C-NMR (100 MHz, 
CDCl3): δ  = 166.30, 137.91, 136.03, 135.61, 135.13, 134.45, 131.34, 130.64, 130.15, 129.47, 129.38, 
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128.64, 128.53, 90.50, 58.85, 50.22, 33.49. Ms (m/z): 490, 453, 349, 312, 246, 207, 181, 146, 77. 
C23H20ClNO5S2 (489.05) calculated: C 56.38, H 4.11, N 2.86; found: C 56.54, H 4.11, N 2.86. 
 (3S*, 6R*)-6-phenyl-5,5-bis(phenylsulfonyl)-3-(phenylthio)piperidin-2-one 5h: white solid. m.p = 
210°C. IR (CHCl3): 1672 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 8.20 (m, 2H, Ar), 7.77 (m, 1H, Ar), 7.64 
(m, 2H, Ar), 7.57 (m, 2H, Ar), 7.49 (m, 1H, Ar), 7.38 (m, 1H, Ar), 7.27 (m, 3H, Ar), 7.21 (m, 3H, Ar), 6.99 
(m, 3H, Ar), 6.61 (m, 2H, Ar), 6.23 (d, J = 3.2 Hz, 1H, NH), 5.29 (d, J = 3.2 Hz, 1H, 6-H), 4.38 (dd, J1 = 
7.2 Hz, J2 = 12.0 Hz, 1H, 3-H), 3.29 (dd, J1 = 7.2 Hz, J2 = 14.4 Hz, 1H, 4-HA), 2.78 (dd, J1 = 12.0 Hz, J2 = 
14.4 Hz, 1H, 4-HB) ppm. 13C-NMR (100 MHz, CDCl3): δ  = 167.40, 137.43, 137.31, 136.09, 135.29, 
135.25, 133.85, 131.58, 130.70, 130.44, 130.25, 129.33, 129.18, 129.15, 129.08, 128.46, 128.32, 90.86, 
58.89, 44.44, 30.93 ppm. Ms (m/z): 563, 421, 369, 343, 312, 280, 246, 171, 143, 110, 95, 78.C29H25NO5S3 
(563.09) calculated: C 61.79, H 4.47, N 2.48; found: C 61.58, H 4.48, N 2.48. 
 (3S*, 6R*)-3-chloro-6-(4-fluorophenyl)-5,5-bis(phenylsulfonyl) piperidin-2-one 5i: white solid. 
m.p. = 200°C. IR (CHCl3): 1694 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 8.16 (m, 2H, Ar), 7.98 (d, J = 3.6 
Hz, 1H, NH), 7.74 (m, 1H, Ar), 7.63 (m, 2H, Ar), 7.55 (m, 3H, Ar), 7.40 (m, 2H, Ar), 7.23 (m, 2H, Ar), 
6.90 (m, 2H, Ar), 5.18 (d, J = 3.6 Hz, 1H, 6-H), 4.88 (dd, J1 = 8.0 Hz, J2 = 9.6 Hz, 1H, 3-H), 3.50 (dd, J1 = 
8.0 Hz, J2 = 14.8 Hz, 1H, 4-HA), 3.26 (dd, J1 = 10.4 Hz, J2 = 14.8 Hz, 1H, 4-HB) ppm. 13C-NMR (100 MHz, 
CDCl3): δ  = 164.10, 161.61, 137.73, 135.49, 135.40, 134.41 131.86, 131.78, 131.14, 130.97, 130.94, 
130.26, 129.27, 128.42, 115.39, 115.17, 89.99, 57.54, 49.91, 32.85 ppm. Ms (m/z): 438 (M+ =508), 366, 
349, 330, 264, 225, 199, 164, 150,125, 97, 77. C23H19ClFNO5S2 (507.04) calculated: C 54.38, H 3.77, N 
2.76; found: C 54.24, H 3.75, N 2.77. 
 
Desulfonylation procedure. Preparation of the 6-phenylpiperidin-2-one 6. 
Compound 5a (0.11 g, 1 mmol) was dissolved in methanol (20 mL). KH2PO4 (210 mg) and sodium 
amalgam (Hg 0.44 g, Na 27 mg) were added and the reaction mixture was stirred at r.t for 3h. The mixture 
was filtered on a Celite pad and the solvent eliminated under vacuo. The resulting crude mixture was 
purified by flash chromatography on silica gel (ethyl acetate/MeOH 95:5) to afford the desired piperidin-2-
one 6 in 54%  yield. 
IR (CHCl3): 1654 cm-1. 1H-NMR (400 MHz, CDCl3): δ  = 7.36 (m, 2H), 7.29 (m, 3H), 5.98 (bs, 1H), 
4.54 (dd, J1 = 4.8 Hz, J2 = 9.2 Hz, 1H), 2.45 (m, 2H), 2.10 (m, 1H), 1.91 (m, 1H), 1.80 (m, 1H), 1.68 (m, 
1H) ppm. 13C-NMR (100 MHz, CDCl3): δ = 172.39, 142.41, 128.83, 127.95, 126.04, 57.79, 32.12, 31.20, 
19.63 ppm. Ms (m/z): 175, 174, 146, 118, 104, 77. C11H13NO (175.10) calculated: C 75.40, H 7.48, N 7.99; 
found: C 75.32, H 7.44, N 7.85. 
 
Computational methods 
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Due to the presence of  non-bonded interactions DFT calculations were carried out using the Truhlar’s 
hybrid functional M062X 76 together with the 6-311+G(d,p)77 basis set within the framework of the 
Gaussian 09 suite of programs. 77 All the molecular structures were fully optimized using the Berny 
analytical gradient optimization method and the stationary points characterized by frequency calculation. 
The intrinsic reaction coordinate (IRC) was used to trace the path of the chemical reactions. The 
Thermochemical Analysis was performed at different temperatures (198.15, 298.15 and 398.15 K) starting 
from the frequency calculations. The electrophilicity indices were calculated at the B3LYP/6-31g* 
computational level to compare the values with the reported classification of electrophilicity. The global 
index ω is given by the expression ω = μ2/2η in terms of the electronic chemical potential μ and the 
chemical hardness η. The absolute electronegativity χ is the negative of the chemical potential μ, the 
softness S is the inverse of the hardness and the ΔNmax, -μ/η, is the maximum amount of electronic charge 
that the electrophile system may accept. These quantities were approximated by using the one electron 
energies of the frontier molecular orbital HOMO and LUMO, εH and εL, as μ ~ ( εH + εL )/2 and η ~ ( εH 
- εL )/2, respectively.  
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Chapter 4 
N-Metallo-ketene imines (metallo= Si, Sn, Al) in the 
preparation of highly functionalized derivatives as possible 
building blocks in the preparation of nitrogen containing 
targets 
4.1 Introduction 
Ketenimines, belonging to a more general class of compounds known as cumulene, molecules 
presenting at least two or more cumulative double bonds, were first reported by Staudinger as long as ago 
1919.1,2 They can be represented by the resonance structures 1 and 2, which emphasize the nucleophile 
properties of the heteroatom and the β-carbon, and by structure 3, which accounts for the electrophilic 
nature of the α-carbon (Scheme 1). Ketenimines are known with N-substituted -alkyl, -aryl, -hydrogen, -
phosphorus, -nitroso, and –boron substituent.1 They can be easily converted to amides, imidates and 
amidines by reaction with amines, alcohols and water respectively. Because of their property as 
nucleophiles and/or electrophiles, depending from the reactant/counterpart and from the variability of the 
substituent groups on the ketenimines, they are widely employed in organic synthesis for the preparation of 
different heterocyclic compounds, as well as acyclic ones.  
 
Scheme 1 
Variously substituted ketene imines can be prepared by several different reactions: (1) substitution 
reactions using heterocumulenes; (2) alkylation of nitrile anions with suitable electrophilic alkylating 
reagents; (3) addition reaction of isocyanides; (4) dehydration of secondary amides and (5) rearrangement 
reactions.1 Some of the main developments in the study of the chemical behavior of ketenimines, as well of 
their syntheses, have been summarized in a number of available reviews. 1,3-14 
4.1.1 N-metallo ketene imines 
Among classical keteneimines, N-metallo keteneimines (MKIs) are a special class of ketene imines 
bearing as substituent at iminic nitrogen a metal such as Si,15 Sn,16 Cu,17 Ir,18 and Fe.19 Because of the very 
nature of the metal linked to the nitrogen and its alkyl/aryl different groups, the reactivity of such kind of 
reagents is expected to be completely different on the variation of the said metal and its substituents. In an 
over simplification, N-metallo ketene imine, particularly N-silylketene imine, can be considered a stable
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 neutral form of the corresponding metallated (Li, Na, K) nitrile. Due to their relatively easy preparation 
and stability, trialkyl(aryl)-silyl-ketene imines are the most popular among metallo-ketene imines and are 
finding out increasing applications in organic synthesis. One of the most successful application, allowing 
the construction of a chiral quaternary stereogenic center, has been reported in a serie of elegant papers by 
Denmark (see below).15,20 Our interest in such kind of intermediates rose from our previous experience in 
the corresponding N-silylimines.  
4.1.2 Synthesis and Applications on N-trialkylsilyl ketene imines 
Nitriles play significant roles in the different scope of pharmaceuticals.21 The nitrile group always 
appears to play important effect in key bonding with pharmaceuticals: the hydrogen bonding with the 
blockbuster drug anastrazole22 (1, Figure 1), or the covalent attachment with anti-diabetic drug 
vildagliptin21,23,24  (2, Figure 1) are among the most significant examples. A lots of nitrile-containing 
pharmaceuticals, especially those bearing cyano group at the all-carbon quaternary centers, play important 
roles in the treatment of different diseases, such as Levocabastine25 (3, Figure 1) acting as an antihistamine 
in the treatment of allergic conjunctivitis, Cilomilast26 (4, Figure 1) for the treatment of respiratory 
disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD), Anastrozole27 in the 
treatment of breast cancer and Verapamil28,29 (5, Figure 1) an L-type calcium channel blocker using in the 
treatment of hypertension, angina pectoris, cardiac arrhythmia, and most recently, cluster headaches. 
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Figure 1 
In the past several decades, impressive progress has been made in the field of stereoselective synthesis. 
However, synthesis of carbon atoms bonded to four different carbon substituents (all-carbon quaternary 
centers), especially those enationmerically enriched quaternary center, is a continuing significant challenge 
for the organic chemists.30 The difficulties for the rapid and selective creation of such centers arise from the 
steric repulsion between the carbon substituents and the steric environments presented by the non-hydrogen 
substituents.30 
Aldol-type reaction in promoting C-C bond with the control of the stereoisomery during the formation 
of a new stereocenter from the original sp2 carbonyl moiety is a well established methodology and 
constitutes, from several years, a very powerful tool in the paraphermalia of organic synthesis directed 
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towards the formation of new C-C bond.31 Although aldol reaction is an useful method in organic synthesis, 
the application of this reaction in the generation of an all-carbon quaternary stereogenic center is relatively 
rare because of the lack of need and inability to obtain geometrically defined α,α-disubstituted enolate or 
enolate equivalents.30 In order to solve such limitations, Denmark et al. developed a catalysts system 
combining silyl ketene imines (SKIs) as nucleophile with aldehydes in a novel Lewis base catalyzed aldol 
reaction to obtain excellent diastereo- and enantioselectivities in the construction of quaternary stereogenic 
centers, beside the new formation of a new stereocenter, bearing an hydroxyl functionality, arising from the 
original sp2 of the aldehyde.32 
Silyl ketene imines (SKIs) can be easily prepared through the N-alkylation of metallated nitriles and a 
suitable silylating reagent (Scheme 2). The characteristic feature of SKIs is the pair of orthogonal 
substituent planes that imparts an axis of chirality when R1 and R2 are dissimilar, and results in the 
formation of a racemic mixture of P and M enantiomers (Scheme 2).15 
 
Scheme 2 
Because of this unique structure, SKI has the potential to offer significant advantages in the formation 
of quaternary stereogenic carbon atoms. Despite SKIs were known as nucleophiles, only until recent years 
they were applied as nucleophiles in the catalytic, asymmetric reactions. Based on their previous 
researches33,34, Fu’s group applied the SKIs with different electrophiles via a catalytic enantioselective 
intermolecular acylation to construct all-carbon quaternary stereocenters with good enantioselectivity 
(Scheme 3).35 
 
Scheme 3 
 
Scheme 4 
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Then Demark’s group reported the enatioselective preparation of quaternary nitriles via Lewis base 
catalyzed additions with SKIs and aldehydes (Scheme 4).32 Afterwards, their group reported the application 
of SKIs with unsaturated electrophiles under Lewis base catalyst system to afford the moderate 
stereoselectivities in the construction of quaternary nitriles (Scheme 5). 36 
 
Scheme 5 
Leighton and co-workers reported preparation of β-hydrazido nitriles bearing a quaternary stereogenic 
center by additions of SKIs to acyl hydrazones via Mannich reaction with good diastereo- and 
enantioselectivities (Scheme 6).37 The method has been applied to the synthesis of pyrrolidines bearing 
quaternary nitrile (Scheme 7). 38  
 
Scheme 6 
 
Scheme 7 
There are also some other applications with SKIs in the catalytic, enantioselective reactions with 
achieved good diastero- and enatioslectivities.15,17,39-41 
Generally, two main approaches may be identified for achieving high stereocontrol in this C-C bond 
forming reaction: one is the use of a catalyst system.15,42,43 All the examples mentioned above belong to this 
synthetic approach. Another consists in reaching this goal “via” the fishing the proper starting material, 
30,44-48 which presents at least one stereogenic center to be used as source of high stereochemical induction. 
Usually in this approach the proper materials belong to the natural chiral pool and must be easy accessible 
and of low cost. Although SKIs have been utilized in some uncatalyzed reaction,49-52 so far, at our 
acknowledge, there is no applications to the synthesis of enantiomerically pure compounds (epc) through 
the use of SKIs and optically pure starting materials (chiral SKIs or/and chiral electrophiles) in the 
construction of the quaternary carbon center to achieve the sterocontrol in the final product.15 
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4.2 Present work 
4.2.1 Section A：Reaction of silylketene imines and aldehydes: Synthesis of β-hydroxy 
nitriles 
Based on the background of SKIs above reported, we started our research, adopting the second 
strategy, by using silyl ketene imines (SKIs) with O-protected α-hydroxy aldehydes, which already present 
a chiral center in the starting material, in an uncatalyst aldol-type reaction  in an effort of generating, in 
high yields and high stereo induction, β-hydroxy nitriles (Scheme 8). β-hydroxy nitriles are useful organic 
intermediate for asymmetric synthesis because of the cyano group is a functional precursor group of amino 
and carbonyl groups.53 Our purpose on this project is accounting on the chiral source bearing on the starting 
aldehydes may introduce the stereo-induction on the formation of the new hydroxyl group or even better on 
the quaternary carbon center (when R1 and R2 are different). 
 
Scheme 8 
Previous studies have documented that SKIs are easily prepared in high yields by deprotonation with 
LDA of disubstituted alkyl or aryl nitriles followed by trapping the resulting anion with a trialkylsilyl 
chloride. The choice of the alkylsilyl groups and the nature of the substituents of the starting nitrile are 
mandatory for the site of silylation of the lithium anion obtained. In this frame, Frainnet54 reported that: a) 
the sole formation of the N-trimethylsilyl ketene imines achieved by using diphenylacetonitrile as starting 
nitrile and TMSCl as silylating agent; b) a mixture of C-silylated and N-silylated products is obtained by 
using 2-phenylpropane nitrile and TMSCl; c) almost exclusive C-silylation was obtained by using 2-
phenyl-butane nitrile or 2-phenylhexane nitrile and TMSCl as silylating agent. On these bases, it has been 
reported that to avoid the formation of C-silylated derivatives, a very bulky silylating agent, like t-
butyldimethylsilyl (TBDMS) or triisopropylsilyl (TIPS) chloride, must be used.35,55,56 Being well aware of 
these drawbacks, the guideline of this study was to ascertain if, with stable diphenyl-N-trialkyl silylketene 
imines, an uncatalyzed aldol-type reaction may be achieved thanks to the possibility of a silatropism from 
the imine nucleophile to the aldehyde electrophile57 via a Zimmerman-Traxler six-membered ring transition 
state.58 Accordingly with this goal, the very first attempt we performed was to test if the metallated 
diphenylacetonitrile (1a), obtained by reaction of diphenylacetonitrile 1 with LDA, gave rise to the 
formation of an aldol adduct after reaction with (S)-2-tert-butyldimethylsilyloxypropanal 3a (Scheme 9, 
path a, Table 1, entry 1). No product but starting materials were detained into the crude reaction mixture 
after 2 days at room temperature. The next step of our study was to try a catalyst-free reaction of N-
TBDMS-ketene imine (2a), prepared according literature procedure, and aldehydes (3a). The reaction was 
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performed starting from -78 °C and leaving the temperature to reach room temperature spontaneously: 
After 2 days, once again, no reaction occurred. The substitution of the protecting group on the hydroxy-
functionality of aldehyde with a less hindered one, as the benzyl group (3b), gave the same results (Scheme 
9 path b and Table 1 entries 2 and 3). The simple substitution of TBDMS-keteneimine (2a) with the less 
hindered TMS-keteneimine (2b) allowed the reaction to happen (Scheme 9, path c and Table 1 entry 4).   
 
Scheme 9. Reaction of different nucleophiles with aldehydes 3. Reagents and Conditions. i: THF, LDA, -
78 °C; a: THF, 3a, -78 °C to r.t, 2 days; b: THF, TBDMSCl, -78 °C, r.t 10 min and after add 3a or 3b at r.t. 
2 d.; c: THF, TMSCl,-78°C, 10 min r.t. and after see Table 1 and experimental section. 
Table 1 Reaction of aldehydes 3a-3d with differnt nucleophiles 
Entry nucleophile Aldehyde Products 
dra,b 
(4/5) 
Total Yields 
(%) 
J H3-H4(4) 
J H3-H4(5) 
 δH3-H4(4) 
 δH3-H4(5) 
1 1a 3a No reaction -- 0   
2 2a 3a No reaction -- 0   
3 2a 3b No reaction -- 0   
4 2b 3a 
 
4a 
 
5a 
97:3a 65 
2.8 
0.8 
4.43-4.16 
4.66-3.99 
45:55b 70 
5 2b 3b 
 
4b 
 
5b 
100:0a 83 
4.4 
5.2 
4.52-3.68 
4.60-3.07 
68:32b 75 
6 2b 3c 
 
4c 
 
5c 
70:30a 75 
2.4 
0.8 
4.53-4.31 
4.77-4.02 
5:95b 85 
7 2b 3d 
 
4d 
 
5d 
65:35a 62 
1.6 
0.0 
4.50-4.08 
4.89-3.92 
1:99b 67 
a: Method A: Adding the aldehyde 3a-c to the imine 2b at room temperature. b: Method B: Adding the aldehyde 3a-3d to the 
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imine 2b at -78°C and after 3 hrs at this temperature, it was left to reach spontaneously r.t. 
 
Scheme 10. Preparation of acetonides 7a and 7b from 4a and 5a. Reagents and Conditions: i: HCl (1N), 
ACN, 30 min, r.t.; ii: Pyridin-p-toluensulphonate (2 eq.), 2,2-dimethoxypropane, acetone, overnight, r.t. 
 
Chart 1. Preparation of diol 6a from 4b, 4c, 4d respectively. Reagents and Conditions: i: Pd/C, Pd(OAc)2, 
MeOH: ii: HClaq(1N), CH3CN, r.t.)  
From stereochemical point of view, as far as is concerned the formation of the new chiral center, the 
highest sterocontrol is achieved on using (S)-2-(benzyloxy)propanal derivative (3b) at r.t.. In this case an 
adduct with syn-relationship between the benzyloxy group and the new TMS-protected hydroxyl 
functionality (Table 1 entry 5) is obtained. On the other hand, a total anti-selectivity (for the attribution of 
the stereorelationship see below) is achieved by the use of an aldehyde bearing an extremely hindered 
protecting group as TBDPhS (tert-butyldiphenylsilyl) (3d) and a reaction temperature of -78 °C (Table 1 
entry 7). The stereorelationship of the two hydroxyl functionalities, due to the doubtful value of the J H3-H4 
(Table 1), was deducted and ascertained by the elaboration of the diastereomeric compounds 4a and 5a to 
their acetonide derivatives 7a and 7b (Scheme 10) and relative NOE’s study. In detail the elaboration of 4a 
and 5a to the corresponding diols 6a and 6b was performed by treatment with hydrogen chloride 1N in 
acetonitrile. The diols so obtained were converted into the acetonides 7a and 7b by reaction with 2,2-
dimethoxypropane in the presence of pyridinium p-toluenesulfonate (PPTS). Taking advantage of NOE’s 
experiments, the attribution of the relative stereochemistry of the substituents on the position 4 and 5 of the 
dioxolane rings 7a and 7b was straightforward (see Scheme 10). For compound 7a, the NOE effects 
between -CH3/C-(5)H and -CH3/C-(4)H are almost of the same value, which is consistent with a trans-
configuration according to the geometry analysis. Consequentially, for compound 7b, since the NOE effect 
between -CH3/C-(5)H is about ten times larger than the NOE effect between -CH3/C-(4)H, the relative cis-
configuration between the two substituents on the C4 and C5 must be attributed. Accordingly the syn-
stereoconfiguration has been attributed to compound 4a while the anti-configuration has been attributed to 
compound 5a. The stereorelationship for the other diastereomeric compounds (4b, 4c and 4d) were 
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assigned by elaborating them to the corresponding diol 6a. Compound 4b was elaborated to the 
corresponding dihydroxy derivatives 6a via hydrogenolysis by means of a mixture of Pd/C and Pd(AcO)259 
(chart 1) whereas the silyl protected compounds 4c and 4d were processed to the diols 6a by simple 
hydrogen chloride/acetonitrile treatment. Consequently even the absolute configurations of the isomer 5b, 
5c and 5d were assigned. 
It has been reported that the reaction of an alkali phenyl acetonitrile does not add satisfactorily to 
benzophenone due to the weakly basic nature of the phenylacetonitrile carbanion.60,61 However, magnesium 
and aluminum halide derivatives of phenyl acetonitrile underwent addition to benzophenone. As a matter of 
fact, it has been presumed that, under the latter conditions, the coordinating capacities of the metallic 
cations (e.g. magnesium or aluminum) play an important role. In our case, in a blank experiment, as we 
mentioned above, the adduct of the lithium anion of diphenylacetonitrile 1a and aldehyde 3a failed to be 
isolated (see Scheme 9, path a. Table 1 entry 1). However, the corresponding TMS-ketene imine 2b adds 
spontaneously to aldehyde 3a to form the final products 4a and 5a (see Table1, entry 4). In the light of 
these results we can presume that, in the actual case, the N-silyl group plays an important role in this 
uncatalyzed reaction because of the silylatropism, from the imine nitrogen to the carbonylic oxygen, 
generating a stable β-silyloxy derivative (Fig.2).  
 
Fig 2: For the sake of simplicity in the figure has been reported the hypothesized transition state between 
the silylimine and formaldehyde 
As above reported and based on this working hypothesis, we envision that the real driving force of this 
uncatalyzed reaction is represented by the transfer ability of the silyl group from the SKI to the forming 
hydroxyl group of the aldehyde via the formation of a Zimmerman-Traxler type transition state with a 
hypervalent silicon57 working as alkylating agent. By this way, two important advantages are reached: to 
furnish the necessary energy for the reaction-taking place and to obtain a final product already protected on 
the hydroxyl functionality as TMS-derivative. It must be stressed out that this second advantage avoids a 
retro reaction which is well known to happen in the presence of a catalytic amount of base.60 The hindered 
TBDMS group in the SKI 2a lowers down the transfer ability of the silyl group resulting in a failure in the 
formation of the final target (see above Scheme 9, Table 1 entries 2 and 3). These observations should be 
considered a further robust support of our mechanistic hypothesis. 
The aldol type reaction described has been applied to a range of O-protected α-hydroxy aldehydes. 
The results are reported in Scheme 11 and Table 2 
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Scheme 11 Reaction of aldehydes 3e-3k with ketene imine 2b 
Table 2 Reaction of aldehydes 3e-3k with keteneimine 2b 
Entry Aldehyde Product de Yield(%) J H3-H4  δ H3-H4 
1 3e 
NC
Ph Ph
i-Pr
OBn
OTMS
 
4e 
>98 68 4.4 4.69 – 3.37 
2 3f 
NC
Ph Ph
t-Bu
OTBS
OTMS
 
4f 
-- 0   
3 3g 
NC
Ph Ph
t-Bu
OBn
OTMS
 
4g 
>98* 65 1.2 5.02 – 3.30 
4 3h 
 
5h 
80 81 8.0 4.58 – 4.15 
5 3i 
NC
Ph Ph
Ph
OTBS
OTMS
 
4i 
>98 78 2.4 5.10 – 4.78 
6 3j 
NC
Ph Ph OTBS
OTMS
Cl
 
4j 
>98* 73 2.8 4.95 – 4.62 
7 3k 
NC
Ph Ph OTBS
OTMS
OMe
 
4k 
>98* 68 2.8 4.01 – 4.72 
*: For the sack of simplicity, only one diastereomers were reported in the table 
These results reported in the Table 2 show a satisfactory formation of the aldol-type adducts. From 
stereochemical point of view, the trend is similar to that previously observed, except for entry 4. Entry 2 of 
Table 2 warrants some comments: in this entry is reported the reaction of the aldehyde 3f presenting two 
hindered groups on the aldehyde (the alkyl side chain and the TBDMS on the hydroxyl functionality). 
According to the already discussed intolerance of this reaction to the sterical demanding, it was not 
surprising that no reaction took place. In fact, the simple substitution of the TBDMS with a less sterical 
demanding benzyl group allowed the reaction to happen (Table 2 entry 3). The stereorelationship of the 
two hydroxyl functionalities of the products 4e and 4i have been attributed by Noe experiments after their 
elaboration to the corresponding acetonide 10 and 12 respectively (Scheme 12 eqs 1 and 2). The 
configuration of 4g was attributed by comparison the value of the J3-4 of the di-hydroxy derivative 14 with 
the corresponding J of the product 9 (Scheme 12 eq 3). The configurationsof 4j and 4k were attributed by 
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simply comparing the values of their J3-4 with that of product 4i. Finally the configurations of 4h and 5h 
were inferred by literature data of the corresponding mono-hydroxy derivatives 15 and 1662,63 (Scheme 13).  
 
Scheme 12. Preparation of products 10, 12 and 14 from 4e, 4i and 4g respectively. Reagents and 
Conditions:  i: Pd/C (10%)/Pd(OAc)2, MeOH, H2; ii: HClaq, 1N, CH3CN, r.t., 30 min. iii: PPTS, 2,2-
dimethoxypropane, acetone, r.t. 
 
Scheme 13. Preparation of products 15 and 16. Reagents and Conditions: i: KF/HF(50%),CH2Cl2/ACN 
(9/1), r.t. 
To further elaborate the scope of this reaction, a survey of the nitrile structure, with different aromatic 
substituents, was undertaken (Scheme 14 and Table 3). The addition of the corresponding N-trimethylsilyl 
ketene imines, prepared as above described, to a number of α-O-protected hydroxy aldehydes 3b and 3i 
was examined. Generally speaking the aldol products were isolated in satisfactory yields, electron poor and 
electron rich ketene imines have been used. The main drawback in this last series was the lack of the 
selectivity in the formation of the quaternary stereocenter bearing the cyano group whereas a total 
stereoselectivity in the formation of the C-3 stereocenter remains active. For the sake of simplicity only few 
examples in the list have been fully characterized by X-Ray analysis. Product 17c was characterized by the 
relative acetonide derivative 20 (scheme 15, X-Ray strcture see figure 2). Product 18h was characterized by 
the relative mono-hydroxide derivative. Product 17e, 18g, 18i and 17k were characterized as such (figure 
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2). For other products in the list an arbitrary attribution of the absolute configuration of the C1 stereocenter 
has been adopted. 
 
Scheme 14. Reaction of different aldehydes 3 with different asymmetric SKIs 2 
Table 3. Different aldehydes 3 with asymmetric SKIs 2 
Entry SKI# R1 Aldehyde Products dr(17/18) Yield(%) 
1 2ca 4-C6H4 3b 17a/18a&,$ 50/50 58 
2 2da 3- C6H4 3b 17b/18b&,$$ 52/48 65 
3 2ea 2- C6H4 3b 17c/18c 70/30 54 
4 2fa 4-BrC6H4 3b 17d/18d& 55/45 54 
5 2ga 4- OC6H4 3b 17e/18e 50/50 65 
6 2ha 4- CF3C6H4 3b 17f/18f& 60/40 61 
7 2ia 4- NO2C6H4 3b 17g/18g 64/36 57 
8 2ja 3-pyridine 3b 17h/18h 65/35 67 
9 2ka 2-ClC6H4 3b 17i/18i 80/20 44 
12 2da 3- C6H4 3i 17j/18j& 50/50 85 
13 2ja 3-Pyridine 3i 17k/18k 80/20 40 
#: The corresponding nitriles 2c (67%), 2d (76%), 2e (68%), 2f (44%), 2g (57%), 2h (61%), 2i (78%), 2j (73%), 2k (47%) 
were prepared from the corresponding ketones by TosMic methodology. &: Because the lack of diastereo-selectivity and the 
difficulty in isolating the pure diastereoisomer by column chromatography, no effort was taken to attributed for each 
compound the right configuration. $: Identified as the corresponding mono-hydroxide derivatives 17a1 and 18a1. $$: Identified 
as the corresponding mono-hydroxide derivatives 17b1 and 18b1 
 
 
Scheme 15. Preparation of acetonide derivative 20 from 17c. Reagents and Conditions:  i: Pd/C (10%), 
MeOH, H2; ii: PPTS, 2,2-dimethoxypropane, acetone, r.t. 
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Figure 2. X-Ray structures of compounds 17e, 17i, 17k, 18g, 18h-monohydroxide derivative and 20  
4.2.2 Section B: Reaction of silylketene imines and isocyanates: Synthesis of α-cyano-β-
carboxyamides (malonamides) 
Despite silylketene imines are known from a long time,64 very few reports have appeared in literature 
describing their use as nucleophile.65,66 Frainnet reported the addition of SKIs to acyl chlorides,  aldehydes 
and ketones.49 Würthwein50 reported the acylation reactions of N-trimethylsilyl ketene imines with different 
acyl halides in the synthesis of N-acylketene imines and/or α-cyano ketones, depending from the reaction 
conditions. Fu et al. have described the enantioselective acylation of SKIs, catalyzed by a chiral 4-
(pyrrolidino)pyridine derivative.35 Chiral silicon Lewis acid mediated asymmetric Mannich reaction of 
SKIs with acyl hydrazone have been described by Leighton.67,68 More recently list reported a catalytic 
asymmetric protonation of SKIs by a chiral phosphoric acid.69 
In collaboration with other PhD students of the same research group during the period of my PhD 
thesis, I have participated in a project having as main goal the synthesis of malonimides, with a quaternary 
stereocenter, from the corresponding malonamide. In the light of our experiences on SKIs, we felt that 
these reagents may generate malonic amide derivatives by reaction with SKIs. In this section are reported 
the highlights of the results obtained.70 
There are only few applications between isocaynate as a electrophlies and ketenimines71 and no 
literature has been published by using SKIs and isocyanates in an uncatalyzed reaction.15 The reaction with 
these two reactants should generate malonic amide derivatives bearing a quaternary center (when R1 and R2 
Chapter 4 
70 
 
are different) (Scheme 16). Taking into account the versatility and the wide range of functionalities that are 
easily achieved through manipulation of the nitrile group and the amide group, the importance of these 
intermediates as starting materials for the elaboration of more complex scaffolds is evident.53,72 
 
Scheme 16 
Silyl ketene imines 21 are easily generated by the reaction of a nitrile with a silylating agent,65,66 in the 
presence of a base such as lithium diisopropyl amide (LDA) or n-butyllithium. Following removal of 
diisopropyl amine under vacuum (if necessary), the reaction mixture was treated with isocyanate 22 in 
toluene to produce the target nitrile malonic amides 23 in reasonable to good yields. (Scheme 16, table 4) 
Table 4. Reaction of ketene imine 21 and isocyanate 22 
a: The corresing nitriles of 21b (44%), 21c (76%), 21d (68%), 21e (67%), 21f (57%), 21g, (47%), 21h (73%) and 21i (46%) 
were prepared from the corresponding ketonesusing tosylmethyl isocyanide (TosMIC).73 b: Method A: n-BuLi, isocyanate, 
THF, toluene. Method B: n-BuLi, TMSCl, isocyanate, THF, toluene. Method C: LDA, TMSCl, isocyanate, toluene. Method 
D: LDA, TBDMSCl, isocyanate, toluene. c : Yields of isolated pure products. 
The reactions of nitrile anions generated using n-butyllithiumin tetrahydrofuran, in the absence of 
trimethylsilyl chloride, resulted in formation of the target compounds, but in lower yields, accompanied by 
the formation of significant quantities of side products (Table 4, entry 1, Method A). Addition of 
trimethylsilyl chloride to the nitrile anion (Table 4, entry 2, Method B), prior to treatment with the 
electrophile, led to an increased yield of the target product. This indicates that formation of the intermediate 
N-trimethylsilyl ketene imine plays an important role in the overall process. The use of tert-
butyldimethylsilyl chloride (TBDMSCl) instead of trimethylsilyl chloride was expected to give the 
corresponding N-tert-butyldimethylsilyl ketene imine (Table 4, entry 4, Method D). However, the reactivity 
of the resultant ketene imine was decreased significantly, probably due to the very bulky nature of the tert-
Entry 
Ketene imines a 
R3b Method Product Yieldc(%)  R1 R2 
1 (21a)Ph Ph (22a)4-OC6H4 A 23a 35  
2 (21a)Ph Ph (22a) 4-OC6H4 B 23a 65  
3 (21a)Ph Ph (22a)4-OC6H4 C 23a 71  
4 (21a)Ph Ph (22a)4-OC6H4 D 23a 0  
5 (21b)4-BrC6H4 Ph (22a)4-OC6H4 C 23b 65  
6 (21c)3-C6H4 Ph (22a)4-OC6H4 C 23c 58  
7 (21d)2-C6H4 Ph (22a)4-OC6H4 C 23d 64  
8 (21e)4-C6H4 Ph (22a)4-OC6H4 C 23e 75  
9 (21f)4-OC6H4 Ph (22a)4-OC6H4 B 23f 70  
10 (21g)2-ClC6H4 Ph (22a)4-OC6H4 B 23g 68  
11 (21h)Pyridine-3-yl Ph (22a)4-OC6H4 B 23h 80  
12 (21a)Ph Ph (22b)Ph C 23i 73  
13 (21a)Ph Ph (22c)Bn B 23j 50  
14 (21a)Ph Ph (22d)1-phenylethyl B 23k 78  
15 (21f)4-OC6H4 Ph (22c)Bn B 23l 40  
16 (21h)Pyridine-3-yl Ph (22e)2-C6H4 B 23m 53  
17 (21i)4-OC6H4 4-OC6H4 (22a)4-OC6H4 B 23n 61  
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butyldimethylsilyl group; this would render the silatropism step, which is thought to be the driving force of 
the whole process (vide infra), difficult.  From these results, it was apparent that, in this catalyst-free 
amidation, the presence of the trimethylsilyl group was essential for the success of the reaction. A possible 
explanation assumes that the reaction proceeds via silatropism, probably by way of the pathway depicted in 
Scheme 17. As the key step, the isocyanate oxygen desilylates the ketene imine moiety to generate an 
incipient nitrile anion. The resulting intermediate 24 affords, after aqueous work-up, the target product 
23.74 Whether this proposed step is concerted or not is hard to predict at this stage. Density functional 
theory (DFT) calculations in order to clarify the mechanistic aspects are in progress and the results will be 
reported in due course. A wide range of both aromatic nitriles (Table 4, entries 5–11 and 17) and 
isocyanates (Table 4, entries 11–14 and 16) have been employed in this reaction.  
 
Scheme 17 
 
4.2.3 Section C: Synthesis of other N-metallo ketene imine: Synthesis of γ-hydroxy nitriles 
from Al-ketene imines and epoxides. 
As anticipated in the introduction of this chapter there are different ketene-imines characterized from a 
direct linkage between the iminic nitrogen and a metallo75: Sn,76 Cu,77 Fe,78 to don’t report keteneimine 
complexes with metal arising from a carbene complexes and isocyanades. Since organometallic complexes 
are outside the scope of this Thesis they will not be treated. On the metallo ketene imines above reported, 
few of them have found applications in organic chemistry: We can already anticipated that in the frame of 
our general program on the synthesis and use of metallo ketene imines we have started a project on tin 
ketene imines: since the relative results will be the core of the W.L. Qin’ thesis, a PhD student of the same 
research group, no mention will be made on this metallo ketene imine in this Thesis. As far as is concerned 
in this Thesis, in the following section I will report our very preliminary studies on another class of 
metallo-ketene imines, at our acknowledge never reported in the literature: N-aluminium ketene imines. 
The corresponding aluminium imines are stable intermediates, easily obtainable via reduction of alkyl 
or aryl nitrile by aluminium hydride (Scheme 18). 79-82 
 
Scheme 18 
Based on these informations and our own experiences on the aluminium-imines we felt that the 
corresponding ketene imines could be stable intermediates and could be prepared from the corresponding 
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alkali metal ketene imines (alkali= Li, Na, K) by a suitable exchange of the alkali metal with a dialkyl 
aluminium halides, in analogy to what is done for the preparation of silyl ketene imines (Scheme 19).64,65  
 
Scheme 19 
Following the above reported working plane, we started, at the very beginning, with the preparation of 
suitable aluminium imines from commercially available nitrile and dialkyl aluminium halides. Accordingly, 
the 2-phenyl-propane nitrile 25 was treated with LDA (Lithium diisopropyl amide) to give the 
corresponding nitrile anion83-85 which was treated in situ with commercially available diethyl aluminium 
chloride to give the corresponding aluminium ketene imine, identified by its Ir stretching at 2087 cm-1 
(characteristic of C=C=N functional moiety) (Scheme 20). No further studies were performed, at this very 
preliminary stage, for fully identify the aluminium ketene imine on the basis of its stability, 1H NMR, Mass, 
13C NMR, since, in the light of the scope of our project, we preferred to test its reactivity by a reaction with 
a suitable electrophiles. 
 
Scheme 20 
Among different classes of electrophiles available for this purpose one of the most interesting and 
easily available from market or in house preparation is that of epoxides.86 The fact that recent 
methodologies by Sharpless or Jacobsen87-89 allow the preparation of epc (enantiomerically pure 
compounds) derivatives, renders this class of electrophiles very interesting. As a matter of fact their 
reactions with C-nucleophiles open the stream to an almost numberless differently functionalized derivative. 
Opening of the epoxides by nucleophiles is a quite old reaction: one of the most popular is the opening of 
epoxides by acid halides to obtain the corresponding epi-halidrines. The regiochemistry of the reaction 
depends from the sterical demanding of the substituents of epoxides, from the reaction conditions and, last 
but not least, from the presence of a catalyst. At this stage of our studies we chose to use terminal epoxides 
since, for steric reasons, only one regioisomer is usually obtained. 
The reaction of alkali metal nitriles and terminal epoxides, has been already reported and results in a 
mixture of cyclic and acyclic products (Scheme 21). Product 28 arise from a classical opening reaction 
whilst products 29 and 30 arise from a, difficult to avoid (in the basic reaction conditions present), 
subsequent cyclization to imino ester 29 and/or lactone 30, derived in turn, from the imino hydrolysis.90 
The factors influencing the reaction and the possible solution have been discussed and reported in 
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literature91-94. On the other hand reaction of epoxide with trimethylsilylacetonitrile anion has been reported 
as well.95 Well aware of these informations our first concern was to try the opening-reaction of epoxides by 
a “neutral” N-trimethylsilyl ketene imines (Scheme 22).  
 
Scheme 21. 
 
Scheme 22 
Ascertained that neutral silylketene imines are inert “versus” epoxides, our next attempt was to check 
the reactivity of aluminium ketene imines, prepared as above reported, “versus” terminal epoxides: We 
anticipated that aluminium ketene imines must be more reactive than the corresponding silyl ketene imines 
due to the enhanced oxophile character of aluminum in comparison with silyl. It was extremely gratifying 
to find out that the reaction between aluminium ketene imine 31a and 2-methyloxirane was successful 
according the mechanism reported in scheme 23 (table 5, entry 1). It must be stressed out that no 
cyclization product of any nature was found in the reaction mixture. Since we found out this reaction taking 
place at this condition, we decided to employ another aluminium ketene imine 25a, preparing from 
asymmetric α-methyl acetonitrile, with 2-methyloxirane in the same reaction, from which should generated 
a quaternary carbon center in the final target. The result is show in table 5, entry 2. As we can see, there are 
satisfactory formation of final adducts, but no diastereo-selectivity. In order to check if there is any 
affection in the yield and the diastereo-selectivity by the solvent, taking place of THF, toluene was adopted 
for the reaction (table 5, entry 3). It is showed that there was a slight improvement on the diastereo-
selectivity. But we found there were more side products appeared in the reaction by using toluene 
comparing with the reaction in THF. Then an effort to attempt to increase the diastereo-slectivity with Al-
salen catalyst was experienced (table 5, entry 4). The result showed that there was no significant 
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improvement on the diastereo-selectivity with this catalyst. With all these preliminary results obtained, we 
consider Method A as a suitable condition for the next studies without further optimization at this stage. 
 
Scheme 23 
Table 5. Reactions between different nucleophiles and epoxide 
Entry Nucleophile Producta dr 32/33 Solvent Method Yield(%) 
1 31a  
32a 
- THF A 58 
2 25a  
32b 
 
33b 
50:50 THF A 60 
3 25a 32b 33b 40/60 Toluene B 40 
4 25a 32b 33b 40/60 Toluene C 50 
a: for the sack of simplicity, only two diastereomers were reported in the table 
The results obtained using different epoxides with aluminium ketene imine 25a are reported (scheme 
24, table 6). From table 6, it is evident that the best aluminium ketene imine is that derived from the 
reaction of lithium ketene imine and diethylaluminum chloride. At this stage it is clear from the results 
obtained that, whereas the formation of cyclized product has been avoided thanks’ to the use of “neutral” 
nucleophiles as musty be considered aluminium ketene imines, some other important drawbacks must be 
taken into account: the scarce control in the diastereoselectivity of the reaction and the relatively (if one 
consider the three step one pot reaction) low yields. Work is under way to solve these problems and to 
apply this relatively new reaction to epc compounds.  
 
Scheme 24 
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Table 5 reaction of ketene imine 25a with different epoxides 
Entry R1 Productsa 
Dr 
32:33 Yield (%) 
1 
O
  32c 
 
33c 
50:50 33 
2 
  
32d 
 
33d 
25:75 49 
3 O   
32e 
 
33e 
50:50 42 
4 O
(CH2)9CH3   32f 
 
33f 
50:50 50 
5 (CH2)9CH3   
32g 
 
33g 
50:50 50 
6 (CH2)3CH3   
32h 
 
33h 
50:50 31 
a: for the sack of simplicity, only two diastereomers were reported in the table 
 
4.3 Experimental section 
All starting materials, unless otherwise stated, were purchased and used without any further 
purification. Solvents were distilled and dried according to standard procedures. Column chromatography 
was performed using Merck KGaA Silicagel 60 (230-400 Mesh-ASTM). Melting points were obtained 
using a Stuart Scientific SMP3 Melting Point apparatus. Optical rotations were obtained using a Unipol 
L1700 Schmidt+Haensch polarimeter. IR spectra were recorded on a Nicolet 380 FT-IR infrared 
spectrometer. NMR spectroscopy was performed on Varian-Mercury 400 and Varian-Mercury 200 
spectrometer using the residual signal of the solvent as the internal standard. The chemical shifts are 
reported in ppm and coupling constants (J) are reported in Hz. GC–MS spectra were recorded using 
Agilent Technologies 6850 and 5975 GC-Mass instrumentation. LC–MS spectra were obtained using an 
Agilent Technologies MSD1100 single-quadrupole mass spectrometer. Elemental analyses were obtained 
using a Flash 2000, series CHNS/O Analyzer (Thermo Scientific). 
4.3.1 Experimental data for the preparation of β-hydroxy nitriles (Section A.) 
(S)-2-(tert-butyldimethylsilyloxy)propanal (3a), (S)-2-(benzyloxy)propanal (3b), (S)-2-
(triisopropylsilyloxy)propanal (3c), (S)-2-(tert-butyldiphenylsilyloxy)propanal (3d), (S)-2-(benzyloxy)-3-
methylbutanal (3e) and (S)-2-(tert-butyldimethylsilyloxy)-2-phenylacetaldehyde (3i) were prepared 
according to the general procedure of our group’s previous.96,97 (R)-1-(2,2-dimethyl-1,3-dioxolan-4-
yl)ethanone (3h) was prepared according to the reported procedure.98 2-(benzyloxy)-3,3-dimethylbutanal 
(3g), 2-(tert-butyldimethylsilyloxy)-3,3-dimethylbutanal (3f), 2-(tert-butyldimethylsilyloxy)-2-(4-
chlorophenyl)acetaldehyde (3j), 2-(tert-butyldimethylsilyloxy)-2-(4-methoxyphenyl)acetaldehyde (3k) 
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were prepared according to the general procedure by Mildland97 except benzyl bromide was used insted of 
benzyl chloride in the preparation of aldehyde 3g. 2-phenyl-2-p-tolylacetonitrile (2c), 2-phenyl-2-m-
tolylacetonitrile (2d), 2-phenyl-2-o-tolylacetonitrile (2e), 2-(3-bromophenyl)-2-phenylacetonitrile (2f), 2-
(3-methoxyphenyl)-2-phenylacetonitrile (2g), 2-phenyl-2-(3-(trifluoromethyl)phenyl)acetonitrile (2h), 2-
(3-nitrophenyl)-2-phenylacetonitrile (2i), 2-phenyl-2-(pyridin-3-yl)acetonitrile (2j), 2-(3-chlorophenyl)-2-
phenylacetonitrile (2k) were prepared from the corresponding ketones by TosMic methodology.70,73 The 
diastereomeric ratios reported into Tables 1, 2 and 3 have been calculated by HPLC (Agilent, Poroshell 120. 
SB-C18. 2.7 m, 3.0 x 100 mm)  and 1H NMR on the crude reaction mixture taking into account the 
doubtless peaks of each diatereomer. X-Ray was performed on SMART ApexⅡ X-Ray diffractomer. 
Preparation of N-(2,2-diphenylvinylidene)-1,1,1-trimethylsilanamine 2b. 
Trimethylsilyl ketene imine 2b was prepared according literature procedure.54,99  In detail BuLi (1.23 
mmol, 0.49 mL of 2.5M in n-hexane) was added to a THF solution (3 mL) of diisopropyl ethyl amine (1.35 
mmol, 0.19 mL) at -78oC under nitrogen atmosphere. Diphenylacetonitrile (238 mg, 1.23 mmol), dissolved 
in 1 mL of THF, was dropped into the base solution at -78oC. The colour of the reaction became yellow. 
After 5min, a solution of TMSCl (1.35 mmol, 0.17 mL) in THF (1 mL) was added to the reaction mixture. 
A sample of the resulting keteneimine 2b was characterized by its IR, 1H and 13C NMR spectra. 
IR (film): 2038 cm-1. 1H NMR (400 MHz, C6D6): δ =0.22 (s, 9H), 7.12-7.24 (complex pattern, 2H), 
7.37 (m, 4H), 7.62 (m, 4H). 13C NMR (100 MHz, C6D6): δ =-0.30, 61.27, 124.74, 127.08, 129.24, 136.61, 
180.63. 
Preparation of (3S, 4S)/(3R, 4S)-4-(tert-butyldimethylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitriles 4a/5a from 2b. 
Method A:  
To the keteneimine 2b, a solution of (S)-2-(tert-butyldimethylsilyloxy)propanal 3a (231mg, 
1.23mmol) in THF (1 mL) was added at r.t..The reaction was kept at r.t. overnight. The solvent was 
removed under vacuum to get the crude mixture which was purified by the flash chromatography (n-
hexane: AcOEt= 50:1) to give 4a and 5a (4a: 285 mg, 5a: 9 mg, ratio: 4a/5a=97/3, overall yields 65%).  
Method B: 
To the keteneimine 2b, a solution of (S)-2-(tert-butyldimethylsilyloxy)propanal 3a (231mg, 
1.23mmol) in THF (1 mL) was added at-78oC. The reaction was kept at this temperature for 3hrs, then it 
was left to reach r.t. spontaneously and kept overnight. The solvent was removed under vacuum to get the 
crude product which was purified by flash chromatography (n-hexane: AcOEt= 50:1) to give 4a and 5a 
(4a: 175mg, 5a: 215 mg, ratio: 4a/5a=45/55, overall yields 70%). 
Spectral data for (3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitrile 4a as follows: 
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White solid. mp: 106-107 oC. : -16.80 (c: 1.0g/100 mg, CHCl3). IR (film): 2242cm-1. 1H NMR (400 
MHz, CDCl3): δ =-0.16 (s, 9H), -0.13 (s, 3H), -0.07 (s, 3H), 0.85 (s, 9H), 1.21 (d, J=6.4 Hz, 3H), 4.16 (dq, 
J1=2.8 Hz, J2=6.4 Hz, 1H), 4.43 (d, J=2.8 Hz, 1H), 7.24-7.36 (m, 6H), 7.50 (d, J=7.2 Hz, 2H), 7.70 (d, 
J=7.6 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ =-4.41, -4.17, 0.12, 18.20, 22.00, 26.12, 57.35, 69.37, 
81.88, 121.31, 127.62, 127.86, 128.16, 127.43, 127.50, 138.63, 139.04. MS (EI): m/z= 438 [M-CH3]. 
Elemental Analysis: Calcd. for C26H39NO2Si2: C, 68.82; H, 8.66; N, 3.09; Si, 12.38; Found: C, 68.92; H, 
8.67; 
Spectral data for (3R, 4S)-4-(tert-butyldimethylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitrile 5a as follows: 
Colourless oil. : +8.72(c: 1.0g/100 mg, CHCl3). IR (film): 2242 cm-1. 1H NMR (400 MHz, 
CDCl3):δ = -0.08 (s, 9H), -0.02 (s, 6H), 0.90 (s, 9H), 1.21 (d, J=7.0 Hz, 3H), 3.99 (dq, J1=7.0 Hz, J2=0.8 
Hz, 1H), 4.66 (d, J=0.8 Hz, 1H), 7.23-7.41 (complex pattern, 6H), 7.49-7.57 (m, 4H). 13C NMR (100 MHz, 
CDCl3): δ =-4.79, -4.20, -0.04, 17.98, 18.00, 25.89, 57.01, 69.90, 82.34, 121.27, 127.55, 127.67, 127.85, 
128.04, 128.33, 128.84, 138.08, 138.85. MS (EI): m/z= 438 [M-CH3]. Elemental Analysis: Calcd. for 
C26H39NO2Si2: C, 68.82; H, 8.66; N, 3.09; Si, 12.38; Found: C, 68.94; H, 8.68; 
Preparation of (3S, 4S)/(3R, 4S)-4-(benzyloxy)-2,2-diphenyl-3-(trimethylsilyloxy)pentanenitriles 
4b and 5b 
Following Method A starting from diphenylacetonitrile (193 mg, 1.0 mmol) and (S)-2-
(Benzyloxy)propanal 3b (164 mg, 1.0 mmol), product 4b (356mg, yield: 83%) was isolated as single 
diastereoisomer after the flash chromatography (cyclohexane: ether= 7:1).  
Following Method B starting from diphenylacetonitrile (193 mg, 1.0 mmol) and (S)-2-
(Benzyloxy)propanal 3b (164 mg, 1.0 mmol), 4b and 5b were obtained as the crude reaction mixture. This 
mixture was purified by flash chromatography (cyclohexane: ether= 7:1). From this step 4b was isolated as 
siloxyl derivative (219mg, yield: 51%), whereas 5b was isolated as the corresponding mono-hydroxide 
derivative 5b1 (86mg, yield: 24%, ratio: 4b/5b1=68/32). As a matter of fact, hydrolysis of the 
trimethylsilyloxy group occurred during the flash chromatography. It must be stressed out that this one was 
a single case 
Spectral data for (3S, 4S)-4-(benzyloxy)-2,2-diphenyl-3-(trimethylsilyloxy)pentanenitrile 4b as 
follow: 
White solid, mp: 93-94 oC. : +10.36 (c: 1.1g/100 mg, CHCl3). IR (film): 2246 cm-1. 1H NMR (400 
MHz, CDCl3): δ =-0.22 (s, 9H), 1.11 (d, J=6.4 Hz, 3H), 3.68 (m, 1H), 4.26 (d, J=12.0 Hz, 1H), 4.38 (d, 
J=12.0 Hz, 1H),4.52 (d, J=4.4 Hz, 1H), 7.19-7.35 (m, 11H), 7.44 (d, J=7.2 Hz, 2H), 7.70 (d, J=7.6 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ = 0.15, 17.31, 57.21, 71.02, 76.07, 81.46, 121.47, 127.23, 127.66, 127.80, 
127.88, 128.09, 128.14, 128.59, 128.69, 137.99, 138.39, 138.70. MS (ESI): m/z = 430 [M+H]+. Elemental 
Analysis: Calcd. for C27H31NO2Si: C, 75.48, H, 7.27, N, 3.26, Si, 6.54, Found: C, 75.78, H, 7.29. 
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Spectral data for (3R, 4S)-4-(benzyloxy)-2,2-diphenyl-3-hydroxy pentanenitrile 5b1 
Colourless liquid. : +131.1 (c:10 g/100 mg, CHCl3). IR (film): 2238 cm-1. 1HNMR (400 MHz 
CDCl3,): δ =1.18 (d, J=6.4 Hz, 3H), 3.49 (d, J=9.2 Hz, 1H, OH), 3.55 (dq, J1=2.0 Hz, J2=6.4 Hz, 1H), 4.39 
(dd, J1=2.0 Hz, J2=8.8 Hz,1H), 4.41 (d, J=10.8 Hz, 1H), 4.51 (d, J=10.8 Hz, 1H), 7.27-7.39 (m, 13H), 7.56 
(d, J=8.8 Hz, 2H). 13CNMR (100 MHz, CDCl3):δ = 17.96, 56.94, 71.17, 72.58, 77.47, 120.85, 127.27, 
127.83, 127.85, 128.00, 128.02, 128.19, 128.35, 128.66, 129.02, 137.39, 138.59, 139.22. MS (ESI): m/z 
=380 [M+Na+]. Elemental Analysis: Calcd. for C24H23NO2: C, 80.64, H, 6.49, N, 3.92, Found: C, 80.88, H, 
6.51. 
 
Preparation of (3S, 4S)/(3R, 4S)-2,2-diphenyl-4-(triisopropylsilyloxy)-3-
(trimethylsilyloxy)pentanenitriles 4c/5c. 
Method A: BuLi (1.1 mmol, 0.44mL of 2.5M in n-hexane) was added into a solution of diisopropyl 
ethyl amine (1.21 mmol, 0.155mL) in 3 mL of THF at -78oC. Then a solution of diphenylacetonitrile (212 
mg, 1.1 mmol) in THF (1 mL) was dropped into the base solution at -78oC. The colour of the reaction 
becomes yellow. After 5 min, a solution of TMSCl (0.14mL, 1.1 mmol) in 1mL of THF was added to the 
reaction. The reaction mixture was allowed to reach r.t. spontaneously. A solution of (S)-2-
(triisopropylsilyloxy)propanal 3c (253 mg, 1.1 mmol) in THF (1 mL) was dropped. The reaction was kept 
at r.t. overnight. The solvent was removed under vacuum to get a crude mixture which was purified by 
flash chromatography (hexane: CH2Cl2= 7:1) to get pure compounds 4c and 5c (4c: 381, 5c: 163g, total 
yield: 75%,  ratio: 4c/5c=70/30) 
Method B: Following this method a 5/95 ratio 4c/5c in 85% overall yields were obtained.  
Spectral data for (3S, 4S)-2,2-diphenyl-4-(triisopropylsilyloxy)-3-(trimethylsilyloxy)pentanenitrile 
4c as follow: 
White solid; mp: 67-73 oC. : -12.0 (c: 1.0g/100 mg, CHCl3).IR (film): 2239 cm-1. 1H NMR (400 
MHz, CDCl3): δ =-0.16 (s, 9H), 0.97-1.01 (Complex pattern, 21H), 1.26 (d, J=6.4 Hz,3H), 4.31(dq, J1=2.4 
Hz, J2=6.4 Hz, 1H), 4.53 (d, J=2.4 Hz, 1H), 7.22-7.36 (complex pattern, 6H), 7.51 (m, 2H), 7.54 (m, 2H). 
13C NMR (100 MHz, CDCl3): δ =0.07, 13.09, 18.09, 18.15, 18.23, 21.26, 57.14, 70.32, 81.63, 121.15, 
127.58, 127.63, 127.90, 128.10, 128.41, 128.45, 138.60, 139.13. MS: m/z= 495 [M]. Elemental Analysis: 
Calcd. for C29H45NO2Si2: C, 70.25; H, 9.15; N, 2.82; O, 6.45; Si, 11.33; Found: C,70.38; H, 9.17. 
Spectral data for (3R, 4S)-2,2-diphenyl-4-(triisopropylsilyloxy)-3-
(trimethylsilyloxy)pentanenitriles 5c. 
Colourless oil. : -7.4 (c: 1.0g/100 mg, CHCl3). IR (film): 2238 cm-1. 1H NMR (400 MHz, CDCl3): 
δ =-0.06 (s, 9H), 1.01 (Complex pattern, 21H), 1.25 (d, J=6.4 Hz, 3H), 4.02(dq, J1=0.8 Hz, J2=6.4 Hz, 1H), 
4.77 (d, J=0.8 Hz, 1H), 7.29-7.38 (complex pattern, 6H), 7.51 (m, 2H), 7.56 (m, 2H). 13C NMR (100 MHz, 
CDCl3): δ =0.13, 12.44, 18.05, 18.15, 18.21, 57.34, 69.85, 82.46, 121.27, 127.44, 127.77, 127.94, 127.80, 
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128.43, 128.88, 137.98, 138.57. MS: m/z= 495 [M]. Elemental Analysis: Calcd. for C29H45NO2Si2: C, 
70.25; H, 9.15; N, 2.82; O, 6.45; Si, 11.33; Found: C, 70.42; H, 9.17. 
 
Preparation of (3S, 4S)/(3R, 4S)-4-(tert-butyldiphenylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitrile 4d/5d. 
Method A: Following Method A, starting from diphenylacetonitrile (386 mg, 2.0 mmol) and (S)-2-
(tert-butyldiphenylsilyloxy)propanal 3d (624  mg, 2.0  mmol), products 4d and 5d were obtained by the 
flash chromatography (petroleum ether :ether = 20:1) (4d: 750 mg,  5d: 404 mg, total yield: 62%, ratio: 
4d/5d=65/35). 
Method B: Following this method a 1/99 ratio 4d/5d in 67% overall yields were obtained. 
Spectral data for (3S, 4S)-4-(tert-butyldiphenylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitrile 4d as follow: 
White solid. mp:112-116oC. : -7.10 (c: 1.0g/100 mg, CHCl3). IR (film): 2248 cm-1. 1H NMR (400 
MHz, CDCl3): δ =-0.23 (s, 9H), 0.87 (d, J=6.8 Hz, 3H), 0.94 (s, 9H), 4.08 (dq, J 1=1.6 Hz, J2=6.8 Hz, 1H), 
4.50 (d, J=1.6 Hz, 1H), 7.19-7.37 (complex pattern, 15H), 7.57-7.71 (m, 5H). 13C NMR (100 MHz, 
CDCl3): δ =0.04, 19.17, 20.86, 26.78, 57.67, 71.09, 81.47, 121.11, 12719, 127.53, 127.63, 127.64, 127.75, 
127.78, 128.63, 129.29, 129.47, 133.28, 134.90, 135.57, 135.99, 138.22, 139.73. MS: m/z=600 [M+Na+]. 
Elemental Analysis: Calcd. For C36H43NO2Si2: C, 74.82; H, 7.50; N, 2.42; Si, 9.72; Found: C, 75.04; H, 
7.52. 
Spectral data for (3R, 4S)-4-(tert-butyldiphenylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitrile 5d as follow: 
White solid. mp:142-145oC. : -2.80 (c: 1.0g/100 mg, CHCl3). IR (film): 2240 cm-1.1H NMR (400 
MHz, CDCl3): δ =0.05 (s, 9H), 1.08 (d, J=6.4 Hz, 3H), 1.10 (s, 9H), 3.92 (q, J=6.0 Hz, 1H), 4.89 (s, 1H), 
7.11-7.59 (m, 20H). 13C NMR (100 MHz, CDCl3): δ =0.14, 17.89, 19.00, 27.06, 57.51, 71.10, 82.17, 
121.02, 127.35, 127.40, 127.49, 127.66, 127.72, 127.82, 128.39, 128.78, 129.63, 133.47, 133.71, 135.71, 
135.85, 135.97, 137.34, 138.91.MS: m/z= 600 [M+Na+]. Elemental Analysis: Calcd. for C36H43NO2Si2: C, 
74.82; H, 7.50; N, 2.42; Si, 9.72; Found: C, 75.00; H, 7.52. 
 
Preparation of (3S, 4S)-3,4-dihydroxy-2,2-diphenyl pentanenitrile 6a; 
1ml of 1M HCl was added into a solution of (3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,2-diphenyl-3-
(trimethylsilyloxy)pentanenitrile 4a (180 mg, 0.4 mmol) in acetonitrile (6mL). The reaction mixture was 
kept at r.t for 0.5hr. Then the solvent was removed under vacuum to get pure 6a as colourless oil (110 mg, 
yield: 95%) 
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Colorless oil. : +78.45(c: 1.1g/100 mg, CHCl3). IR (film): 2239 cm-1. 1H NMR (400 MHz, 
CDCl3):δ =1.22 (d, J=6.4 Hz, 3H), 1.92 (bs, 1H, OH), 3.37 (bs, 1H, OH), 4.00 (dq, J1=6.4 Hz, J2=1.2 Hz, 
1H), 4.39 (d, J=1.2 Hz, 1H), 7.31-7.45 (m, 8H), 7.56 (m, 2H). 13C NMR (100 MHz, CD3OD): δ =21.65, 
58.36, 67.61, 77.68, 122.89, 128.59, 128.91, 129.11, 129.21, 129.84, 130.12, 140.77, 141.77. MS (ESI): 
m/z=290 [M+Na+]. Elemental Analysis: Calcd. for C17H17NO2: C, 76.38; H, 6.41; N, 5.24; O, 11.97; 
Found: C, 76.50; H, 6.42. 
 
Preparation of (3R, 4S)-3,4-dihydroxy-2,2-diphenylpentanenitrile 6b 
Starting from (3R,4S)-4-(tert-butyldimethylsilyloxy)-2,2-diphenyl-3-(trimethylsilyloxy) pentanenitrile 
5a (30 mg, 0.07 mmol), following the same procedure for preparing compound 6a, compound 6b was 
obtained (16 mg, yield:89 %).  
Colorless oil. : -69.60 (c: 1.0g/100 mg, CHCl3). IR (film): 2243 cm-1. 1H NMR (400 MHz, CDCl3): 
δ = 1.35 (d, J=6.4 Hz, 3H), 1.69 (bs, 1H, OH), 2.50 (bs, 1H, OH), 3.77 (dq, J1=4.0 Hz, J2=6.4 Hz, 1H), 
4.69(d, J=4.0 Hz, 1H), 7.30-7.46 (complex pattern, 8H), 7.60 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 
=17.94, 55.83, 68.32, 77.58, 120.61, 127.07, 127.61, 128.27, 128.31, 129.05, 129.19, 137.36, 138.24. MS 
(ESI): m/z= 290 [M+Na+]. Elemental Analysis: Calcd. for C17H17NO2: C, 76.38; H, 6.41; N, 5.24; O, 
11.97; Found: C, 76.48; H, 6.42. 
 
Preparation of 2,2-diphenyl-2-[(4S,5S)-2,2,5-trimethyl-1,3-dioxolan-4-yl]acetonitrile 7a 
(3S, 4S)-3,4-dihydroxy-2,2-diphenylpentanenitrile 6a (0.44 mmol, 117 mg), PPTS (0.88 mmol, 220 
mg) and 2,2-dimethoxypropane (1.0 mL) were mixed together into 5mL of anhydrous acetone. The 
reaction mixture was kept stirring at r.t. overnight, decomposed with saturated NH4Cl solution, extracted 
with AcOEt (15mL×3). The organic phase was dried with anhydrous Na2SO4 and concentrated under 
vacuum to get the crude product which was purified by flash chromatography (cyclohexane : ether = 4:1) to 
get product 7a (86 mg, yield: 63 %). 
White solid.mp: 120-124oC. : +3.30 (c: 1.0g/100 mg, CHCl3). IR (KBr): 2247 cm-1. 1H NMR (400 
MHz, CDCl3):δ = 0.57(d, J=6.0 Hz, 3H), 1.49 (s, 3H), 1.52 (s, 3H), 4.20 (dq, J1=6.0 Hz, J2=8.4 Hz, 1H), 
4.41 (d, J=8.4 Hz, 1H), 7.30-7.41 (complex pattern, 8H), 7.53 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 
=18.47, 26.73, 27.83, 55.56, 74.93, 83.71, 109.18, 120.29, 127.25, 128.13, 128.25, 128.76, 129.00, 137.03, 
138.92. MS: m/z=330 [M+Na+]. Elemental Analysis: Calcd. for C20H21NO2: C, 78.15, H, 6.89, N, 4.56, 
Found: C, 78.29, H, 6.90 
 
Preparation of 2,2-diphenyl-2-[(4R, 5S)-2,2,5-trimethyl-1,3-dioxolan-4-yl]acetonitrile 7b 
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(3R, 4S)-3,4-dihydroxy-2,2-diphenyl pentanenitrile 6b (0.15 mmol, 41 mg), PPTS (0.30 mmol, 75 mg) 
and 2,2-dimethoxypropane (0.6mL) were mixed together into 5mL of anhydrous acetone. The reaction 
mixture was processed as for 7a. The crude product was purified by flash chromatography (cyclohexane : 
ether = 4:1) to get product 7b (35 mg, yield: 74 %). 
White solid. mp: 107-110oC. : +99.4 (c: 1.0g/100 mg, CHCl3). IR (KBr): 2247cm-1. 1H NMR (400 
MHz, CDCl3):δ = 1.17 (d, J=6.4 Hz, 3H), 1.43 (s, 3H), 1.64 (s, 3H), 4.38 (quintet, J=6.4 Hz, 1H), 5.07 (d, 
J=6.4 Hz, 1H), 7.25-7.40 (complex pattern, 6H), 7.56 (m, 4H). 13C NMR (100 MHz, CDCl3): δ =16.75, 
25.63, 27.77, 53.37, 74.39, 80.28, 108.75, 120.96, 127.23, 127.51, 127.98, 128.42, 128.81, 129.27, 137.45, 
140.35. MS: m/z=330 [M+Na+]. Elemental Analysis: Calcd. for C20H21NO2: C, 78.15; H, 6.89; N, 4.56; O, 
10.41; Found: C, 78.26; H, 6.90 
 
Preparation of (3S, 4S)-4-hydroxy-2,2-diphenyl-3-(trimethylsilyloxy)pentanenitrile 6a from 4b. 
(3S, 4S)-4-(benzyloxy)-2,2-diphenyl-3-(trimethylsilyloxy)pentanenitrile 4b (90 mg), Pd/C 10% (90 
mg) and Pd(AcO)2 (40 mg) were mixted into 20 mL of anhydrous MeOH. The reaction mixture was kept 
under H2 (50psi) for 1 hour. Then the reaction mixture was filtered and the solvent was removed to get 
crude product. This crude product was directly mixed with 2 mL of actonitrile and 1 mL of HClaq (1N). The 
reaction was kept at r.t for 30mins. Then the solvent was removed under vacuum to give a colourless oil 
product which showed a superimposable spectral data with the authentic 6a obtained as previously 
described (see above). 
 
Preparation of (3S, 4S)-4-hydroxy-2,2-diphenyl-3-(trimethylsilyloxy)pentanenitrile 6a from 4c 
and 4d 
1ml of 1M HCl was added into a solution of 4c (198 mg, 0.4 mmol) in acetonitrile (6mL). The 
reaction mixture was kept at r.t for 0.5hr. Then the solvent was removed under vacuum to get pure 6a as 
colourless oil (101mg, yield: 87%). Starting from 4d (230 mg, 0.4 mmol) following the same procedure 
above described compound 6a was obtained (95 mg, 82%). 
 
Preparation of (3S, 4S)-4-(benzyloxy)-5-methyl-2,2-diphenyl-3-(trimethylsilyloxy)hexanenitrile 
4e. 
Following Method A, starting from diphenylacetonitrile (193 mg, 1.0 mmol) and (S)-2-(benzyloxy)-3-
methylbutanal 3e (211 mg, 1.1 mmol), (3S, 4S)-4-(benzyloxy)-5-methyl-2,2-diphenyl-3-
(trimethylsilyloxy)hexanenitrile 4e was obtained after flash chromatography (hexane : ether =8:1) (311 mg; 
yield:68%). 
Spectral data for (3S, 4S)-4-(benzyloxy)-5-methyl-2,2-diphenyl-3-(trimethylsilyloxy)hexanenitrile 
4e as follow: 
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White solid; mp: 86-93 oC. : +3.80(c: 1.0g/100 mg, CHCl3). IR (film): 2240 cm-1. 1H NMR (400 
MHz, CDCl3):δ =-0.20 (s, 9H), 0.80 (d, J=6.4 Hz, 3H), 0.93 (d, J=6.4 Hz, 3H), 1.62 (m, 1H), 3.37 (dd, 
J1=4.4 Hz, J2=5.6 Hz, 1H), 4.33 (d, J=11.6 Hz, 1H), 4.47 (d, J=11.6 Hz, 1H), 4.69 (d, J=4.4 Hz, 1H), 7.18-
7.37 (Complex pattern, 11H), 7.49 (m, 2H), 7.75 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =0.42, 17.41, 
20.41, 31.06, 58.57, 73.77, 79.00, 83.39, 121.01, 127.59, 127.86, 127.98, 128.02, 128.54, 128.58, 128.80, 
137.79, 138.22, 139.00. MS (EI): m/z=458 [M+1]. Elemental Analysis: Calcd. for C29H35NO2Si: C, 76.10; 
H, 7.71; N, 3.06; Si, 6.14; Found: C, 76.37; H, 7.74 
 
Preparation of (3S*, 4S*)-4-(benzyloxy)-5,5-dimethyl-2,2-diphenyl-3-
(trimethylsilyloxy)hexanenitrile 4g. 
Following Method A, starting from diphenylacetonitrile (290 mg, 1.5mmol) and 2-(benzyloxy)-3,3-
dimethylbutanal 3g (309 mg, 1.5 mmol), (3S*, 4S*)-4-(benzyloxy)-5,5-dimethyl-2,2-diphenyl-3-
(trimethylsilyloxy)hexanenitrile 4g was obtained after purification by the flash chromatography (hexane : 
ether = 9:1) (459 mg; yield:65%) 
Spectral data for (3S*, 4S*)-4-(benzyloxy)-5,5-dimethyl-2,2-diphenyl-3-
(trimethylsilyloxy)hexanenitrile 4g as follow: 
Colourless oil. IR (film): 2238 cm-1. 1H NMR (400 MHz, CDCl3):δ =-0.16 (s, 9H), 0.97 (s, 9H), 3.30 
(d, J=1.2 Hz, 1H), 3.99 (d, J=11.2 Hz, 1H), 4.18(d, J=11.2 Hz, 1H), 5.02 (d, J=1.2 Hz, 1H), 7.19-7.38 
(Complex pattern, 11H), 7.47 (m, 2H), 7.83 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =1.10, 27.18, 37.01, 
58.96, 73.96, 77.42, 84.06, 122.24, 126.66, 126.75, 127.83, 128.04, 128.28, 128.36, 128.51, 128.74, 129.27, 
136.64, 139.02, 139.66. MS (EI): m/z=472 [M+1]. Elemental Analysis: Calcd. for C30H37NO2Si: C, 76.39; 
H, 7.91; N, 2.97; Si, 5.95; Found: C, 76.52; H, 7.92 
 
Preparation of (R)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-diphenyl-3-
(trimethylsilyloxy)propanenitrile 4h and (S)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-diphenyl-3-
(trimethylsilyloxy)propanenitrile 5h. 
Following Method A, starting from diphenylacetonitrile (290 mg, 1.5 mmol) and (R)-2,2-dimethyl-
1,3-dioxolane-4-carbaldehyde 3h (195 mg, 1.5 mmol), a mixture of (R)-3-((R)-2,2-dimethyl-1,3-dioxolan-
4-yl)-2,2-diphenyl-3-(trimethylsilyloxy)propanenitrile 4h and (S)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-
2,2-diphenyl-3-(trimethylsilyloxy)propanenitrile 5h was obtained after flash chromatography (petroleum 
ether : ether = 5:1) (480 mg in a ratio, determined by 1H NMR, 4h/5h of 9:1). Crystallization 
(CH3CN/MeOH/H2O) allowed to give pure 4h and 5h. 
Spectral data for (R)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-diphenyl-3-
(trimethylsilyloxy)propanenitrile 4h as follow: 
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White solid. mp: 110-114 °C. : -67.1 (c: 1.0g/100 mg, CHCl3). IR (film): 2246 cm-1. 1H NMR (400 
MHz, CDCl3): δ =-0.04 (s, 9H), 1.30 (s, 3H), 1.39 (s, 3H), 3.17 (dd, J1= 8.4 Hz, J2= 9.2 Hz, 1H), 3.28 (dd, 
J1= 5.2 Hz, J2= 8.4 Hz, 1H), 4.15 (m, 1H), 4.58 (d, J= 8.0 Hz, 1H), 7.27-7.45 (m, 8H), 7.64 (d, J1= 7.6 Hz, 
2H). 13C NMR (100 MHz, CDCl3): δ = 0.32, 25.73, 26.56, 57.11, 66.10, 78.35, 78.85, 108.04, 120.78, 
127.54, 127.82, 128.04, 128.38, 128.65, 128.80, 129.05, 129.17, 137.11, 137.20. MS (ESI): m/z= 418 
[M+Na+]. Elemental Analysis: Calcd. for C23H29NO3Si: C, 69.84; H, 7.39; N, 3.54; O, 12.13; Si, 7.10; 
Found: C, 69.92; H, 7.40. 
Spectral data for (S)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-diphenyl-3-
(trimethylsilyloxy)propanenitrile 5h as follow: 
White solid. mp: 100-106 °C. : -21.4 (c: 1.0g/100 mg, CHCl3). IR (film): 2241 cm-1. 1H NMR (400 
MHz, CDCl3): δ =-0.13 (s, 9H), 1.24 (s, 3H), 1.45 (s, 3H), 3.71 (dd, J1= 6.4 Hz, J2= 8.0 Hz, 1H), 3.99 (t, J= 
8.0 Hz, 1H), 4.33 (ddd, J1= 6.8 Hz, J2= 1.2 Hz, J3= 0.4 Hz, 1H), 5.02 (d, J= 1.2 Hz, 1H), 7.30-7.41 (m, 6H), 
7.49-7.54 (m, 4H). 13C NMR (100 MHz, CDCl3): δ = 0.13, 24.60, 26.29, 57.21, 63.76, 76.60, 77.67, 107.71, 
121.22, 127.62, 127.88, 127.99, 128.25, 128.40, 128.85, 129.22, 129.34, 137.68, 137.98. MS (ESI): m/z= 
418 [M+Na+]. Elemental Analysis: Calcd. for C23H29NO3Si: C, 69.84; H, 7.39; N, 3.54; O, 12.13; Si, 7.10; 
Found: C, 69.80; H, 7.39. 
 
Preparation of (3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,2,4-triphenyl-3-
(trimethylsilyloxy)butanenitrile 4i. 
Following Method A, starting from diphenylacetonitrile (193 mg, 1.0 mmol) and (S)-2-(tert-
butyldimethylsilyloxy)-2-phenylacetaldehyde 3i (250 mg, 1.0 mmol), (3S, 4S)-4-(tert-
butyldimethylsilyloxy)-2,2,4-triphenyl-3-(trimethylsilyloxy)butanenitrile 4i was obtained after flash 
chromatography (hexane : ether = 98:2)(402 mg; yield:78%). 
Spectral data for (3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,2,4-triphenyl-3-
(trimethylsilyloxy)butanenitrile 4i as follow: 
White solid; mp: 135-137 oC. : -4.45 (c: 1.1g/100 mg, CHCl3). IR (film): 2247 cm-1. 1H NMR (400 
MHz, CDCl3):δ =-0.49 (s, 9H), -0.46 (s, 3H), -0.28 (s, 3H), 0.91 (s, 9H), 4.77 (d, J=2.4 Hz, 1H), 5.08 (d, 
J=2.4 Hz, 1H), 7.27-7.37 (m, 11H), 7.56 (d, J=8.4 Hz, 2H), 7.75 (d, J=7.6 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ =-4.89, -4.29, 0.35, 18.25, 26.23, 57.72, 75.07, 82.70, 120.63, 127.66, 127.68, 127.79, 127.88, 
128.67, 128.80, 138.96, 138.97, 142.57. MS (EI): m/z=515 [M]. Elemental Analysis: Calcd. for 
C31H41NO2Si2:C, 72.18; H, 8.01; N, 2.72; Si, 10.89; Found: C, 73.00; H, 8.03 
 
Preparation of (3S*, 4S*)-4-(tert-butyldimethylsilyloxy)-4-(4-chlorophenyl)-2,2-diphenyl-3-
(trimethylsilyloxy)butanenitrile 4j. 
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Following Method A, starting from diphenylacetonitrile (232 mg, 1.2 mmol) and 2-((tert-
butyldimethylsilyl)oxy)-2-(4-chlorophenyl)acetaldehyde 3j (341 mg, 1.2 mmol), (3S*,4S*)-4-(tert-
butyldimethylsilyloxy)-4-(4-chlorophenyl)-2,2-diphenyl-3-(trimethylsilyloxy)butanenitrile 4j was obtained 
by the flash chromatography ((petroleum ether :ether = 97:3)(481 mg; yield:73%). 
Spectral data for (3S*, 4S*)-4-(tert-butyldimethylsilyloxy)-4-(4-chlorophenyl)-2,2-diphenyl-3-
(trimethylsilyloxy)butanenitrile 4j as follow: 
White solid. mp:156-163 oC. IR (film): 2251 cm-1. 1H NMR (400 MHz, CDCl3):δ = -0.55 (s, 9H), -
.0.53 (s, 3H), -0.36 (s, 3H), 0.79 (s, 9H), 4.62 (d, J= 2.8 Hz, 1 H), 4.95 (d, J= 2.8 Hz, 1 H), 7.12-7.27 (m, 
10H), 7.42 (d, J= 8.0 Hz, 2H), 7.61(d, J= 7.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ =-4.91, -4.25, -0.27, 
18.21, 26.17, 57.54, 74.94, 82.45, 120.56, 127.68, 127.79, 127.84, 128.01, 128.35, 128.66, 128.79, 129.02, 
133.40, 138.42, 138.74, 140.98. MS: m/z=572 [M+Na+]. Elemental Analysis: Calcd. for C31H40ClNO2Si2: 
C, 67.66; H, 7.33; Cl, 6.44; N, 2.55; O, 5.82; Si, 10.21; Found: C, 67.84; H, 7.35. 
 
Preparation of (3S*, 4S*)-4-(tert-butyldimethylsilyloxy)-4-(4-methoxyphenyl)-2,2-diphenyl-3-
(trimethylsilyloxy)butanenitrile 4k 
Following Method A, starting from diphenylacetonitrile (193mg, 1.0 mmol) and 2-((tert-
butyldimethylsilyl)oxy)-2-(4-methoxyphenyl)acetaldehyde 3k (280mg, 1.0mmol), (3S*,4S*)-4-(tert-
butyldimethylsilyloxy)-4-(4-methoxyphenyl)-2,2-diphenyl-3-(trimethylsilyloxy)butanenitrile 4k was 
obtained after flash chromatography ((petroleum ether :ether =50:1)(371 mg; yield:68%). 
Spectral data for (3S*, 4S*)-4-(tert-butyldimethylsilyloxy)-4-(4-methoxyphenyl)-2,2-diphenyl-3-
(trimethylsilyloxy)butanenitrile 4k as follow: 
White solid; mp: 118-123 oC. IR (film): 2245 cm-1. 1H NMR (400 MHz, CDCl3):δ = -0.46 (s, 9H), -
0.44 (s, 3H), -0.28 (s, 3H), 0.87 (s, 9H), 3.80 (s, 3H), 4.72 (d, J=2.8 Hz, 1H), 5.01 (d, J=2.8 Hz, 1H), 6.81(d, 
J=9.2 Hz, 2H), 7.18 (d, J=8.8 Hz, 2H), 7.24-7.37 (m, 6H), 7.53 (d, J=8.0 Hz, 2H), 7.73  (d, J=8.0 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ = -4.84, -4.26, -0.23, 18.26, 26.24, 55.22, 57.57, 74.94, 82.80, 113.22, 
120.67, 127.69, 127.73, 127.88, 128.22, 128.61, 128.70, 128.81, 129.16, 134.52, 138.68, 139.06, 159.22. 
MS (ESI): m/z=568 [M+Na+]. Elemental Analysis: Calcd. for C32H43NO3Si2: C, 70.41; H, 7.94; N, 2.57; O, 
8.79; Si, 10.29;  Found: C, 70.27; H, 7.2. 
 
Preparation of (3S, 4S)-3-hydroxy-5-methyl-2,2-diphenyl-4-(trimethylsilyloxy)hexanenitrile 8 
(3S, 4S)-4-(benzyloxy)-5-methyl-2,2-diphenyl-3-(trimethylsilyloxy)hexanenitrile 4e (130 mg), Pd/C 
10% (130 mg) and Pd(OAc)2(75mg) were mixted into 15mL of MeOH. The reaction mixture was kept 
under H2 (50psi) for 4 hours. Then the reaction mixture was filtered and the solvent was removed to get 
crude product which was purified by flash chromatography (n-hexane: ether=10:1) to get (3S, 4S)-3-
hydroxy-5-methyl-2,2-diphenyl-4-(trimethylsilyloxy)hexanenitrile 8 (65mg, yield: 63%. ) 
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Colourless oil. : +68.2(c: 1.0g/100 mg, CHCl3). IR (film): 3452, 2239 cm-1. 1H NMR(400 MHz, 
CDCl3):δ =0.17 (s, 9H), 0.6 3(d, J=6.4 Hz, 3H), 0.90 (d, J=6.8 Hz, 3H), 1.57 (m, 1H), 3.73 (dd, J1=1.2 Hz, 
J2=7.6 Hz, 1H), 4.09 (d, J=8.0 Hz, OH), 4.46 (dd, J1=0.8 Hz, J2=8.0 Hz, 1H), 7.27-7.44 (m, 8H), 7.62 (m, 
2H). 13C NMR (100 MHz, CDCl3): δ =0.46, 16.47, 17.44, 33.90, 57.82, 71.14, 73.41, 120.89, 127.52, 
127.57, 127.74, 127.97, 128.29, 128.58, 128.83, 135.73, 135.88, 138.40, 139.12. MS (ESI): m/z=368 
[M+1]. Elemental Analysis: Calcd. for C22H29NO2Si: C, 71.89, H, 7.95, N, 3.81, Si, 7.64, Found: C, 71.96, 
H, 7.96, 
 
Preparation of (3S, 4S)-3,4-dihydroxy-5-methyl-2,2-diphenylhexanenitrile 9 
Following the same procedure for preparing compound 6a, starting from (3S, 4S)-3-hydroxy-5-
methyl-2,2-diphenyl-4-(trimethylsilyloxy)hexanenitrile 8 (45mg,  mmol), (3S,4S)-3,4-dihydroxy-5-methyl-
2,2-diphenylhexanenitrile 9 was obtained as colourless oil (28 mg, yield: 72%). 
: +78.3 (c: 1.0g/100 mg, CHCl3). IR(film): 3400 (b), 2240 cm-1. 1H NMR (400 MHz, CD3OD): δ= 
0.80 (d, J=6.4 Hz, 3H), 0.85 (d, J=6.4 Hz, 3H), 1.72 (octet, J1=6.4 Hz, 1H), 3.00 (dd, J1=6.4 Hz, J2=0.2 Hz, 
1H), 4.65 (d, J=0.2 Hz, 1H), 7.28 (m, 2H), 7.35 (m, 4H), 7.44 (m, 2H), 7.59 (m, 2H). 13C NMR (100 MHz, 
CD3OD): δ =18.78, 19.35, 33.07, 58.55, 74.11, 75.57, 122.67, 128.33, 128.67, 129.03, 129.65, 129.96, 
140.12, 140.53. MS (ESI): m/z= 318 [M+Na+]. Elemental Analysis: Calcd. for C19H21NO2: C, 77.26, H, 
7.17, N, 4.74, Found: C, 77.34, H, 7.18 
 
Preparation of 2-((4S, 5S)-5-isopropyl-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-diphenylacetonitrile 
10 
Following the same procedure for preparing compound 7a, starting from (3S, 4S)-3,4-dihydroxy-5-
methyl-2,2-diphenylhexanenitrile 9 (10mg, 0.07 mmol), 2-[(4S,5S)-5-isopropyl-2,2-dimethyl-1,3-dioxolan-
4-yl]-2,2-diphenylacetonitrile 10 was obtained as white solid (10 mg, yield: 90%). 
mp: 172-174 oC. : +94.8 (c: 1.0g/100 mg, CHCl3). IR (film): 2247 cm-1. 1H NMR (400 MHz, 
CDCl3):δ = 0.37 (m, 1H), 0.69 (d, J=6.8 Hz, 3H,), 0.73 (d, J=6.8 Hz, 3H), 1.47 (s, 3H), 1.48(s, 3H), 4.02 
(dd, J1=2.8 Hz, J2=8.0 Hz, 1H), 4.59 (d, J=7.6 Hz, 1H), 7.28-7.41 (m, 8H), 7.55 (m, 2H). 13C NMR (100 
MHz, CDCl3): δ=14.68, 20.58, 27.23, 27.83, 28.45, 56.28, 79.36, 83.07, 109.64, 120.62, 127.18, 128.04, 
128.39, 129.48, 128.71, 128.89, 137.24, 139.15. MS (ESI): m/z=336 [M+1]. Elemental Analysis: Calcd. for 
C22H25NO2: C, 78.77, H, 7.51, N, 4.18, O, 9.54, Found: C, 79.01, H, 7.53 
 
Preparation of (3S, 4S)-3,4-dihydroxy-2,2,4-triphenylbutanenitrile 11 
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Following the same procedure for preparing compound 6a, starting from (3S,4S)-4-(tert-
butyldimethylsilyloxy)-2,2,4-triphenyl-3-(trimethylsilyloxy)butanenitrile 4i (100 mg,  0.35 mmol), (3S, 
4S)-3,4-dihydroxy-2,2,4-triphenylbutanenitrile 11 was obtained as colourless oil (62 mg, yield: 97%). 
: +66.73(c: 1.1g/100 mg, CHCl3). IR (film): 3420 (b), 2239 cm-1. 1H NMR (400 MHz, CDCl3): δ 
=2.63 (bs, OH), 3.50 (bm, OH), 4.55 (d, J=8.0 Hz, 1H), 4.65 (bs, 1H), 7.04-7.45 (complex pattern, 17h). 
13C NMR (100 MHz, CDCl3): 57.18, 71.23, 77.60, 121.06, 125.73, 127.36, 127.85, 128.03, 128.30, 128.57, 
128.86, 129.20, 138.05, 138.38, 141.65. MS (ESI): m/z = 352 [M+Na+]. Elemental Analysis: Calcd. for 
C22H19NO2: C, 80.22; H, 5.81; N, 4.25; O, 9.71. Found: C, 80.44; H, 5.83 
 
Preparation of 2-[(4S, 5S)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-yl]-2,2-diphenylacetonitrile 12 
Following the same procedure for preparing compound 7a, starting from (3S, 4S)-3,4-dihydroxy-2,2,4-
triphenylbutanenitrile 11 (55 mg, 0.17 mmol), 2-[(4S,5S)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-yl]-2,2-
diphenylacetonitrile 12 was obtained as white solid (54 mg, yield:86%) 
mp: 218-220 oC. : +52.30 (c: 1.0g/100 mg, CHCl3). IR (film): 2238 cm-1. 1H NMR (400 MHz, 
C6D6): δ =1.51 (s, 3H), 1.65 (s, 3H), 4.89 (d, J=8.0 Hz, 1H), 5.21 (d, J=8.0 Hz, 1H), 6.64-7.12 (complex 
pattern, 13H), 7.56 (m, 2H). 13C NMR (100 MHz, CDCl3): 27.00, 27.95, 55.76, 81.47, 84.44, 110.42, 
120.21, 127.10, 127.35, 127.76, 127.86, 128.02, 128.06, 128.19, 128.46, 128.76, 135.94, 136.83, 139.19. 
MS (ESI): m/z = 369 [M]. Elemental Analysis: Calcd. for C25H23NO2: C, 81.27; H, 6.27; N, 3.79; O, 8.66. 
Found: C, 81.41; H, 6.28; 
 
Preparation of (3S*, 4S*)-3-hydroxy-5,5-dimethyl-2,2-diphenyl-4-
(trimethylsilyloxy)hexanenitrile 13 
Starting from (3S*, 4S*)-4-(benzyloxy)-5,5-dimethyl-2,2-diphenyl-3-(trimethylsilyloxy)hexanenitrile 
4g (120 mg, 0.25 mmol), Pd/C (10%) (120mg) and Pd(OAc)2 (35mg) were mixed in 20mL of anhydrous 
MeOH. The reaction mixture was kept under H2 (50 Psi) for 1 hr. After the reaction completed, it was 
filtered and concentrated under vacuum. (3S*, 4S*)-3-hydroxy-5,5-dimethyl-2,2-diphenyl-4-
(trimethylsilyloxy)hexanenitrile 13 was obtained after flash chromatography (cyclohexane: ether=4:1) (95 
mg, yield: 98% ) 
Colourless oil. IR (film): 3445, 2239 cm-1. 1H NMR (400 MHz, CDCl3): δ= 0.27 (s, 9H), 0.65 (s, 9H), 
3.57 (d, J=1.2 Hz, 1H), 4.25 (d, J=7.6 Hz, 1H, OH), 4.53 (dd, J1=1.2 Hz, J2=7.2 Hz, 1H), 7.23-7.40 
(complex pattern, 8H), 7.62 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =1.21, 25.84, 35.50, 58.04, 70.79, 
77.20, 121.49, 127.77, 128.00, 128.07, 128.56, 128.64, 128.71, 138.26, 138.45. MS (ESI): m/z=382 [M+1]. 
Elemental Analysis: Calcd. for C23H31NO2Si: C, 72.39; H, 8.19; N, 3.67; O, 8.39; Si, 7.36, Found: C, 
72.63; H, 8.22 
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Preparation of (3S*, 4S*)-3,4-dihydroxy-5,5-dimethyl-2,2-diphenylhexanenitrile 14 
(3S*, 4S*)-3-hydroxy-5,5-dimethyl-2,2-diphenyl-4-(trimethylsilyloxy)hexanenitrile 13  (107 mg,  
0.28mmol) was mixed with 2 mL of acetone and PPTS (104 mg,0.56mmol). The reaction mixture was kept 
at r.t. for 24hrs. Then it was filtered and concentrated under vacuum to get the crude product which was 
purified by Lichroprep® (RP-18, 40-63 μm) chromatography (MeOH: H2O= 70:30) to get pure (3S*, 4S*)-
3,4-dihydroxy-5,5-dimethyl-2,2-diphenylhexanenitrile 14 (82 mg, yield: 95% ) 
White solid. mp: 63-70 oC. IR (film): 3440 (b), 2242 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.82 (s, 
9H), 1.99 (d, J=5.2 Hz, 1H, OH), 3.50 (d, J=4.4 Hz, 1H), 3.85(d, J=8.0 Hz, 1H, OH), 4.70 (d, J=8.4 Hz, 
1H), 7.28-7.48 (complex pattern, 8H), 7.60 (d, J=7.6 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ=25.84, 
35.01, 58.08, 71.28, 75.27, 121.84, 127.86, 128.18, 128.23, 128.91, 129.04, 138.10, 138.17. MS (ESI): 
m/z=310 [M+1]. Elemental Analysis: Calcd. for C20H23NO2: C, 77.64; H, 7.49; N, 4.53; O, 10.34; Found: 
C, 77.89; H, 7.49; 
 
Preparation of (R)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-hydroxy-2,2-diphenylpropanenitrile 15 
and (S)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-hydroxy-2,2-diphenylpropanenitrile 16 
A crude mixture of 4h and 5h (150 mg, 0.38 mmol, ratio 4h: 5h=1:9) was dissolved into 5 mL of 
CH2Cl2/acetonitrile (9:1), KF (22mg, 0.38 mmol) and HFaq (50%, 1 ml) were added into the solution. The 
reaction was kept at r.t. for 1hr.  Then it was decomposed with 3mL of NaHCO3 and extracted with CH2Cl2 
(15mL ×3). The organic phase was washed with NH4Cl and brine, dried with Na2SO4 and removed under 
vacuum to get the crude product which was purified after flash chromatography (Cyclohexane : ether =3:2) 
to get pure (S)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-hydroxy-2,2-diphenylpropanenitrile  15 (60 mg, 
yield: 49%) and (R)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-hydroxy-2,2-diphenylpropanenitrile 16 (6 
mg, yield:5%).  
15: White solid. mp: 104-108 oC. :-103.6 (c: 0.5g/100 mg, CHCl3). IR (KBr):  3431, 2252 cm-1. 1H 
NMR (400 MHz, CDCl3): δ =1.32 (s, 3H), 1.45 (s, 3H), 3.21 (dd, J1=6.0 Hz, J2 =8.8 Hz, 1H), 3.39 (d, 
J=5.2 Hz, 1H, OH), 3.46 (dd, J1=6.0 Hz, J2 =8.8 Hz, 1H), 4.16 (q, J=6.0 Hz, 1H) , 4.45 (t, J=5.2 Hz, 1H), 
7.31-7.41 (m, 8H), 7.57 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =25.32, 26.57, 57.09, 67.07, 74.25, 75.27, 
109.97, 120.41, 127.52, 128.25, 128.67, 128.94, 129.27, 137.45, 138.54. MS (ESI): m/z=346 [M+Na+]. 
Elemental Analysis: Calcd. for C20H21NO3: C, 74.28; H, 6.55; N, 4.33; O, 14.84;  Found: C, 74.13; H, 6.54. 
16: White solid. mp: 137-139 oC. : +67.6 (c: 0.5 g/100 mg, CHCl3). IR (KBr):  3439, 2252 cm-1. 
1H NMR (400 MHz, CDCl3): δ =1.25 (s, 3H) , 1.40 (s, 3H), 2.56 (d, J=3.2 Hz, 1H, OH), 3.87 (dd, J1=6.0 
Hz, J2 =8.4 Hz, 1H), 3.99 (dt, J1=2.8 Hz, J2=6.4 Hz, 1H), 4.14 (dd, J1=6.8 Hz, J2 =8.4 Hz, 1H), 4.90 (t, 
J=2.8 Hz, 1H), 7.33-7.42 (m, 8H), 7.57 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =25.28, 26.44, 55.26, 
63.68, 74.23, 76.11, 108.50, 120.46, 127.25, 127.88, 128.47, 128.53, 129.06, 129.35, 137.52, 137.71. MS: 
m/z=346 [M+Na+]. Elemental Analysis: Calcd. for C20H21NO3: C, 74.28; H, 6.55; N, 4.33; O, 14.84;  
Found: C, 74.21; H, 6.54. 
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Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-p-tolyl-3-
(trimethylsilyloxy)pentanenitrile 17a/18a (identified as the corresponding monohydroxy derivatives 
17a1 and 18a1 see below) 
BuLi(1.0 mmol, 0.4 mL of 2.5M in n-hexane ) was added into a solution of diisopropyl ethyl amine 
(1.1 mmol, 0.155 mL) in THF (3 mL) at -78℃. Then a solution of 2-phenyl-2-p-tolylacetonitrile (2c) (207 
mg, 1.0 mmol) in THF (1 mL) was dropped into the base solution at -78℃. The color of the reaction 
became yellow. After 5mins, a solution of TMSCl (0.14 mL, 1.1 mmol) in THF (1 mL) was added to the 
reaction. The reaction mixture was allowed to reach r.t.. (S)-2-(Benzyloxy)propanal 3b (180 mg, 1.1 mmol) 
in THF (1 mL) was added at r.t. After the reaction was completed (t.l.c. test), the solvent was removed. The 
crude  product so obtained was dissolved into 1 mL of  1 N HClaq and 5 mL of acetonitrile. The resulting 
homogeneous solution was kept at r.t. for 30 mins and neutralized with iced satured solution of  NaHCO3to 
adjust the pH at 6.0. The solvent  was removed under vacuum,  the  residue dissolved in 10 mL of water 
and extracted with ether (20 mL × 3). The organic phase was dried with anhydrous Na2SO4, the solvent  
removed under vacuum. The residue was purified by flash chromatography (silica gel, hexane/ether 4/1) to 
get an inseparable mixture of products 17a1 and 18a1 in 58% overall yields (214 mg) and in a ratio of 50/50 
as determined by HPLC and 1H NMR spectra. The inseparable diastereomeric mixture arising from flash 
chromatography was crystalyzed from ACN:H2O=99:1 allowing the separation of a pure isomer to which 
has been attributed, arbitrarly, the structure 17a1 while the 18a1 remained in the mother liquorin mixture 
with 17a1. Because an easily retro reaction takes place no further efforts were made to isolate pure 18a1 and 
its spectral data were deducted from the mixture. 
17a1: White solid; mp: 95-98oC. : +99.5 (c: 1.0g/100 mg, CHCl3). IR (film): 2238 cm-1. 1H NMR 
(400 MHz, CD3OD): δ =1.20 (d, J=6.8 Hz, 3H), 2.30 (s, 3H), 3.37 (dq, J1=2.0 Hz, J2=6.4 Hz, 1H), 4.17 (d, 
J=11.6 Hz, 1H), 4.45 (d, J=11.6 Hz, 1H), 4.48 (d, J=1.6 Hz, 1H), 7.13(d, J=11.6 Hz, 2H), 7.24-7.40 
(complex pattern, 10H), 7.56 (m,2H). 13C NMR (100 MHz, CD3OD): δ =16.80, 20.95, 57.81, 72.00, 74.77, 
78.05, 122.82, 128.23, 128.33, 128.43, 128.62, 128.87, 128.94, 129.09, 129.14, 129.56, 129.87, 130.20, 
130.50, 137.20, 138.95, 139.48, 141.97. MS (EI): m/z=357 [M-CH3+H]. Elemental Analysis: Calcd. for 
C25H25NO2: C, 80.83; H, 6.78; N, 3.77; O, 8.61; Found: C, 81.03; H, 6.80. 
18a1: IR (film): 2238 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.19 (d, J=6.8 Hz, 3H), 2.26 (s, 3H), 3.65 
(d, J= 9.6 Hz, 1H, OH), 3.53 (dq, J1=2.0 Hz, J2=6.4 Hz, 1H), 4.38 (dd, J1=2.0 Hz, J2=9.6 Hz, 1H), 4.41 (d, 
J=10.8 Hz, 1H), 4.52 (d, J=10.8 Hz, 1H), 7.16 (d, J=7.6 Hz, 2H), 7.29-7.40 (complex pattern, 10H), 7.46 
(m, 2H). 13C NMR (100 MHz, CDCl3): δ =17.95, 20.98, 56.68, 71.22, 72.67, 77.50, 121.00, 127.25, 127.81, 
127.94, 128.09, 128.19, 128.57, 129.00, 129.72, 136.28, 137.48, 137.87, 139.45. MS (EI): m/z=357 [M-
CH3+H]. 
 
Preparation of (2S, 3S, 4S) /(2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-m-tolyl-3-
(trimethylsilyloxy)pentanenitrile 17b/18b (identified as the corresponding monohydroxydertivatives 
17b1 and 18b1(see below) 
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Following the same procedure of 17a1/18a1, starting from 2-phenyl-2-m-tolylacetonitrile (207 mg, 1.0 
mmol) and (S)-2-(benzyloxy)propanal 3b (180 mg, 1.1 mmol), an inseparable mixture of (2S, 3S, 4S)-4-
(benzyloxy)-2-phenyl-2-m-tolyl-3-(trimethylsilyloxy)pentanenitrile 17b1 and (2R, 3S, 4S)-4-(benzyloxy)-2-
phenyl-2-m-tolyl-3-(trimethylsilyloxy)pentanenitrile 18b1 was obtained (288mg, ratio:52/48, overall yield: 
65%) after column chromatography on silica gel (hexane/ether: 6/1). Spectral data were deducted from the 
mixture and the major set of signals arbitrarly attributed to 18b1.  
17b1: Colorless oil. IR(film): 2238 cm-1. 1H NMR (400 MHz, (CD3)2SO/D2O): δ =1.13 (d, J=6.4 Hz, 
3H), 2.17 (s, 3H), 3.14 (dq, J1=6.0 Hz, J2=1.2 Hz, 1H), 3.85 (d, J=12.0 Hz, 1H), 4.36 (d, J=12.0 Hz, 1H), 
4.58 (d, J=1.2 Hz, 1H), 7.11 (m, 1H), 7.18-7.38 (complex pattern, 13H). 13C NMR (100 MHz, 
(CD3)2SO/D2O): δ= 16.09, 21.48, 56.56, 70.19, 74.90, 75.67, 122.07, 125.02, 127.38, 128.56, 127.85, 
128.20, 128.28, 128.51, 128.85, 129.06, 138.29, 138.76, 139.26, 141.15. MS (EI): m/z=357 [M-CH3+H]. 
18b1: Colorless oil. IR(film): 2238 cm-1. 1HNMR (400 MHz, (CD3)2SO/D2O): δ =1.13 (d, J=6.0 
Hz,3H), 2.28 (s, 3H), 3.14 (dq, J1=6.0 Hz, J2=1.2 Hz, 1H), 3.89 (d, J=12.0 Hz, 1H), 4.33(d, J=12.0 Hz, 1H), 
4.56 (d, J=1.2 Hz, 1H), 7.08(m, 2H), 7.23-7.38 (complex pattern, 10H), 7.54 (d, J=7.6 Hz, 2H). 13C NMR 
(100 MHz, (CD3)2SO/D2O): δ=16.01, 21.30, 56.59, 70.25, 74.10, 75.67, 121.98, 124.27, 127.03, 127.44, 
127.74, 127.90, 128.26, 128.34, 128.76, 128.92, 138.04, 138.70, 139.13, 140.99. MS (EI): m/z=357 [M-
CH3+H]. 
 
Preparation of (2S, 3S, 4S) /(2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-o-tolyl-3-
(trimethylsilyloxy)pentanenitrile 17c/18c 
Following the same procedure of Method A, starting from 2-phenyl-2-o-tolylacetonitrile2e (207 mg, 
1.0 mmol) and (S)-2-(benzyloxy)propanal 3b (180 mg, 1.1 mmol), (2S, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-
o-tolyl-3-(trimethylsilyloxy)pentanenitrile 17c and (2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-o-tolyl-3-
(trimethylsilyloxy)pentanenitrile 18c were obtained by the flash chromatography (n-hexane: ether= 98:2) 
(239mg, ratio:70/30, overall yield: 54%). The stereo attribution at each isomer was determined by X-Ray 
analysis of the corresponding acetonide 20 . 
17c: White solid; mp: 61-65 oC. : + 96.90 (c: 1.0g/100 mg, CHCl3). IR(film): 2237 cm-1. 1H NMR 
(400 MHz, CDCl3): δ =-0.03 (s, 9H), 1.20 (d, J=6.4 Hz, 3H), 2.13 (s, 3H), 3.75 (m, 1H), 4.35 (d, J=12.0 Hz, 
1H), 4.39 (d, J=4.0 Hz, 1H), 4.58 (d, J=12.0 Hz, 1H), 7.14-7.39 (complex pattern, 12H), 7.95 (m, 2H). 13C 
NMR (100 MHz, CDCl3): δ =0.69, 18.78, 21.53, 55.68, 70.98, 75.33, 82.58, 121.06, 125.34, 127.18,127.42, 
127.63, 128.14, 128.26, 128.41, 128.73, 132.82, 135.68, 138.29, 138.43, 138.75. MS (EI): m/z=443 [M]. 
Elemental Analysis: Calcd. for C28H33NO2Si: C, 75.80; H, 7.50; N, 3.16; O, 7.21; Si, 6.33; Found: C, 
76.00; H, 7.52. 
18c: Colorless oil. : -57.90 (c: 1.0g/100 mg, CHCl3). IR (film): 2237cm1. 1H NMR (400 MHz, 
CDCl3): δ=-0.11 (s, 9H), 1.18 (d, J=6.0 Hz, 3H), 2.20 (s, 3H), 3.85 (dq, J1=4.4 Hz, J2=6.0 Hz, 1H), 4.35 (d, 
J=12.0 Hz, 1H), 4.46 (d, J=12.0 Hz, 1H), 4.63 (d, J=4.4 Hz, 1H), 7.12-7.32 (complex pattern, 11H), 7.42 
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(m, 2H), 7.52 (m,1H). 13C NMR (100 MHz, CDCl3): δ =0.32, 18.20, 21.77, 55.48, 71.11, 76.47, 80.45, 
120.89, 125.41, 127.21,127.53, 127.55, 128.03, 128.07, 128.28, 128.59, 133.04, 135.97, 137.65, 138.44, 
138.58. MS (EI): m/z=443[M]. Elemental Analysis: Calcd. for C28H33NO2Si: C, 75.80; H, 7.50; N, 3.16; O, 
7.21; Si, 6.33; Found: C, 75.94; H, 7.51. 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-(4-bromophenyl)-2-phenyl-3-
(trimethylsilyloxy)pentanenitrile 17d/18d 
Following the same procedure of Method A, starting from 2-(4-bromophenyl)-2-phenylacetonitrile 2f 
(271 mg, 1.0 mmol) and (S)-2-(benzyloxy)propanal 3b (164 mg, 1.0 mmol), a mixture of (2S, 3S, 4S)-4-
(benzyloxy)-2-(4-bromophenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 17d and (2R, 3S, 4S)-4-
(benzyloxy)-2-(4-bromophenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 18d was obtained after flash 
chromatography (n-hexane: ether= 9:1) (274mg, ratio:45/55, Overall yield: 54%). No further efforts to 
isolate pure 17d from 18d were taken. To 17d was arbitrarly attributed the stereochemistry reported and its 
spectral data were deducted from the mixture reporting the major set of signals. 
17d: colorless oil. IR(film): 2239 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.00 (s, 9H), 1.3 (d, J=6.4 Hz, 
3H), 3.90 (dq, J1=4.4 Hz, J2=6.4 Hz, 1H), 4.45(d, J=11.6 Hz, 1H), 4.60 (d, J=11.6 Hz, 1H), 4.66(d, J=4.0 
Hz, 1H), 7.36-7.62 (complex pattern, 10H), 7.67 (m, 2H), 7.80(m, 2H). 13C NMR (100 MHz, CDCl3): δ 
=0.00, 17.10, 58.99, 70.87, 75.94, 81.50, 121.91, 127.14, 127.49, 127.79, 127.93, 128.57, 129.22, 131.52, 
136.63, 137.59, 138.02, 144.75.MS (EI): m/z=530 [M+Na+]. Elemental Analysis: Calcd. for 
C27H30BrNO2Si: C, 63.77; H, 5.95; Br, 15.71; N, 2.75; O, 6.29; Si, 5.52, Found: C, 63.71; H, 5.94. 
18d: colorless oil. IR(film): 2239 cm-1. 1H NMR (400 MHz,CDCl3): δ =0.01 (s, 9H),1.35 (d, J=6.0 Hz, 
3H), 3.83 (dq, J1= 4.4 Hz, J2=6.0 Hz, 1H), 4.44 (d, J=12.0 Hz, 1H), 4.65 (d, J=12.0 Hz, 1H), 4.68 (d, J=4.4 
Hz, 1H),7.36-7.62 (complex pattern, 12H), 7.85(m, 2H). 13C NMR (100 MHz, CDCl3): δ =0.00, 16.79, 
58.95, 70.52, 75.35, 81.01, 121.10, 127.12,127,47, 127.49, 128.79, 127.93, 128.57, 129.22, 131.39, 136.63, 
137.59, 138.02, 144.75. MS (EI): m/z=530 [M+Na+]. 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-(4-methoxyphenyl)-2-phenyl-3-
(trimethylsilyloxy)pentanenitrile 17e/18e 
Following the same procedure of Method A, starting from 2-(4-methoxyphenyl)-2-phenylacetonitrile 
2g (223 mg, 1.0 mmol)and (S)-2-(benzyloxy)propanal 3b (164 mg, 1.0 mmol), (2S, 3S, 4S)-4-(benzyloxy)-
2-(4-methoxyphenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 17e and (2R, 3S, 4S)-4-(benzyloxy)-2-
(4-methoxyphenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 18e were obtained after flash 
chromatography (petroleum ether : ether= 9:1) (298mg, ratio:50/50, overall yield:65 %) 
17e: White solid. Mp: 65-71 oC. :+15.89 (c:8.75 g/100 mL, CHCl3). IR (film): 2242 cm-1. 1H NMR 
(400 MHz,CDCl3): δ =-0.01 (s, 9H), 1.32 (d, J=6.4 Hz, 3H), 3.84 (dq, J1=6.4 Hz, J2=4.4 Hz, 1H), 3.98 (s, 
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3H), 4.46 (d, J=12.0 Hz, 1H), 4.58 (d, J=12.0 Hz, 1H), 4.65 (d, J=4.4 Hz, 1H),7.00 (d, J=9.6 Hz, 2H), 7.38-
7.54 (m, 8H), 7.60 (m, 2H), 7.81 (m, 2H). 13C NMR (100 MHz,CDCl3): δ =0.17, 17.27, 55.29, 56.19, 71.00, 
76.26, 81.73, 113.79, 121.81, 127.62,127.68, 128.07, 128.62 , 129.55, 138.44, 139.24 , 159.12. MS (EI): 
m/z= 459 [M]. Elemental Analysis: Calcd. for C28H33NO3Si: C, 73.16; H, 7.24; N, 3.05; O, 10.44; Si, 6.11, 
Found: C, 73.26; H, 7.25. 
18e: Colorless oil. : + 3.5(c: 1.0g/100 mg, CHCl3). IR (film): 2242 cm-1. 1H NMR (400 MHz, 
CDCl3): δ =-0.17 (s, 9H), 1.13 (d, J=6.4 Hz, 3H), 3.70 (dq, J1=6.4 Hz, J2=4.0 Hz, 1H), 3.79 (s, 3H), 4.32 (d, 
J=12.4 Hz, 1H), 4.42 (d, J=12.4 Hz, 1H), 4.50 (d, J=4.0 Hz, 1H), 6.85 (d, J=9.2 Hz, 2H), 7.22-7.41 
(complex pattern, 10H), 7.65 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =0.19, 17.35, 55.30, 56.61, 71.00, 
75.90, 81.35, 113.97, 121.60, 127.21, 127.71, 127.75, 128.00, 128.08, 128.54, 128.80, 130.63, 138.42, 
138.52, 158.98. MS (EI): m/z=459 [M]. Elemental Analysis: Calcd. for C28H33NO3Si: C, 73.16; H, 7.24; N, 
3.05; O, 10.44; Si, 6.11, Found: C, 73.30; H, 7.25 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-(4-(trifluoromethyl)phenyl)-3-
(trimethylsilyloxy)pentanenitrile 17f/18f 
Following the same procedure of Method A, starting from 2-phenyl-2-(4-
(trifluoromethyl)phenyl)acetonitrile 2h (261 mg, 1.0 mmol) and (S)-2-(benzyloxy)propanal 3b (164 mg, 
1.0 mmol), a mixture of (2S, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-(4-(trifluoromethyl)phenyl)-3-
(trimethylsilyloxy)pentanenitrile 17f and (2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-(4-
(trifluoromethyl)phenyl)-3-(trimethylsilyloxy)pentanenitrile 18f was obtained after flash chromatography 
(petroleum ether : AcOEt=14:1) (303mg, ratio:40/60, yield: 61 %). No further efforts to isolate pure 17f 
from 18f  were taken. To 17f was arbitrarly attributed the stereochemistry reported and its spectral data 
were deducted from the mixture reporting the major set of signals. 
17f: IR(film): 2239 cm-1. 1H NMR (400 MHz, CDCl3): δ =-0.10 (s, 9H), 1.25 (d, J=6.4 Hz, 3H), 3.87 
(dq, J1=4.4 Hz, J2=6.4 Hz, 1H), 4.36 (d, J=11.6 Hz, 1H), 4.52 (d, J=11.6 Hz, 1H), 4.63 (d, J=4.4 Hz, 1H), 
7.25-7.53 (complex pattern, 9H), 7.66 (m, 3H), 7.97 (d, J=8.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 
=0.27, 17.44, 57.11, 70.75, 71.22, 76.24, 81.91, 121.26, 125.54, 125.70, 127.55, 127.85, 128.28, 128.37, 
129.00, 129.07, 130.46, 137.30, 138.10, 138.23, 141.98. MS (EI): m/z=497 [M]. Elemental Analysis: Calcd. 
for C28H30F3NO2Si: C, 67.58; H, 6.08; F, 11.45; N, 2.81; O, 6.43; Si, 5.64, Found: C, 67.66; H, 6.09. 
18f: IR(film): 2239 cm-1. 1H NMR (400 MHz, CDCl3): δ =-0.08 (s, 9H), 1.29 (d, J=6.4 Hz, 3H), 3.74 
(dq, J1=4.0 Hz, J2=6.4 Hz, 1H), 4.32 (d, J=12.0 Hz, 1H), 4.57 (d, J=12.0 Hz, 1H), 4.66 (d, J=4.0 Hz, 1H), 
7.25-7.53 (complex pattern, 9H), 7.66 (m, 3H), 7.79 (m, 2H). 13C NMR (100 MHz, CDCl3): δ = 0.27, 16.97, 
57.09, 70.75, 71.22, 75.62, 81.45, 121.12, 125.54, 125.70, 127.55, 127.85, 128.28, 128.37, 129.00, 129.07, 
130.43, 137.30, 138.10, 138.23, 141.97. MS (EI): m/z=497 [M]. 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-(4-nitrophenyl)-2-phenyl-3-
(trimethylsilyloxy)pentanenitrile 17g/18g 
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Following the same procedure of Method A, starting from 2-(4-nitrophenyl)-2-phenylacetonitrile 2i 
(238 mg, 1.0 mmol) and (S)-2-(benzyloxy)propanal 3b (164 mg, 1.0 mmol), ((2S, 3S, 4S) -4-(benzyloxy)-2-
(4-nitrophenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 17g and (2R, 3S, 4S)-4-(benzyloxy)-2-(4-
nitrophenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 18g  were obtained by the flash chromatography 
(petroleum ether : AcOEt=10:1) (270mg, ratio:36/64, yield: 57%) 
17g: Colorless oil. : +26.08 (c: 1.3g/100 mg, CHCl3). IR (film): 2243cm-1. 1H NMR (400 
MHz,CDCl3): δ =-0.17 (s, 9H), 1.19 (d, J=6.4 Hz, 3H), 3.87 (dq, J1=6.4 Hz, J2=4.0 Hz, 1H), 4.22 (d, 
J=12.0 Hz, 1H), 4.42 (d, J=12.0 Hz, 1H), 4.54 (d, J=4.0Hz, 1H), 7.12 (m, 2H), 7.24 (m, 3H), 7.35 (m, 5H), 
7.93 (d, J=9.2 Hz, 2H), 8.15 (d, J=9.2 Hz, 2H). 13C NMR (100 MHz,CDCl3): δ =0.00, 17.06, 56.75, 70.90, 
75.81, 81.89, 120.75, 123.13, 127.23, 127.48,127.55, 127.88, 128.27, 128.84, 129.52, 137.54, 137.64, 
144.67, 145.05. MS (EI): m/z=475 [M+H]. Elemental Analysis: Calcd. for C27H30N2O4Si: C, 68.33; H, 
6.37; N, 5.90; O, 13.48; Si, 5.92, Found: C, 68.13; H, 6.35. 
18g: White solid. mp: 130-133 oC. : +18.47 (c: 1.1g/100 mg, CHCl3). IR (film): 2242 cm-1. 1H 
NMR (400 MHz, CDCl3): δ =-0.12 (s, 9H), 1.26 (d, J=6.4 Hz, 3H), 3.66 (dq, J1=6.4 Hz, J2=4.0 Hz, 1H), 
4.21 (d, J=12.0 Hz, 1H), 4.52 (d, J=12.0 Hz, 1H), 4.62 (d, J=4.0 Hz, 1H), 7.26 (m, 4H), 7.42 (m, 4H), 7.66 
(d, J=8.8 Hz, 2H), 7.71 (d, J=8.0 Hz, 2H), 8.13 (d, J=8.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ =0.15, 
16.57, 57.11, 70.49, 75.46, 81.10, 120.68, 123.57, 127.46, 127.65, 127.74, 127.97, 128.13, 128.56, 128.84, 
129.00, 136.69, 137.74, 145.64, 146.05. MS (EI): m/z=475 [M+H]. Elemental Analysis: Calcd. for 
C27H30N2O4Si: C, 68.33; H, 6.37; N, 5.90; O, 13.48; Si, 5.92, Found: C, 68.26; H, 6.36. 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-(pyridin-3-yl)-3-
(trimethylsilyloxy)pentanenitrile 17h/18h 
Following the same procedure of Method A, starting from 2-phenyl-2-(pyridin-3-yl)acetonitrile 2j 
(194 mg, 1.0 mmol) and (S)-2-(benzyloxy)propanal 3b (164 mg, 1.0 mmol), (2S, 3S, 4S)-4-(benzyloxy)-2-
phenyl-2-(pyridin-3-yl)-3-(trimethylsilyloxy)pentanenitrile 17h and (2R, 3S, 4S)-4-(benzyloxy)-2-phenyl-
2-(pyridin-3-yl)-3-(trimethylsilyloxy)pentanenitrile 18h were obtained after flash chromatography (n-
hexane : ether=3:2) (288mg, ratio:65/35, yield: 67%) 
17h: Colorless oil. : +18.40 (c: 1.0g/100 mg, CHCl3). IR (film): 2240 cm-1. 1H NMR (400 MHz, 
CDCl3): δ =-0.04 (s, 9H), 1.28 (d, J=6.4 Hz, 3H), 3.90 (dq, J1=6.4 Hz, J2=4.0 Hz, 1H), 4.38 (d, J=11.6 Hz, 
1H), 4.55 (d, J=11.6 Hz, 1H), 4.67 (d, J=4.0 Hz, 1H), 7.31-7.58 (complex pattern, 11H), 8.19 (m, 1H), 8.67 
(dd, J1=1.2 Hz, J2=4.4 Hz, 1H), 9.13 (m, 1H). 13C NMR (100 MHz, CDCl3): δ =0.17, 17.27, 55.48, 71.04, 
75.92, 81.58, 120.62, 1223.15, 127.31, 127.66, 128.11, 128.26, 128.96, 133.89, 136.28, 137.78, 138.08, 
148.95, 149.42. MS (EI): m/z= 430 [M]. Elemental Analysis: Calcd. for C26H30N2O2Si: C, 72.52; H, 7.02; 
N, 6.51; O, 7.43; Si, 6.52, Found: C, 72.72; H, 7.04. 
 18h: White solid. mp: 59-64 oC. : +12.80 (c: 1.1g/100 mg, CHCl3). IR (film):  2242 cm-1. 1H 
NMR (400 MHz, CDCl3): δ =-0.04 (s, 9H), 1.33 (d, J=6.0 Hz, 3H), 3.78 (dq, J1=6.0 Hz, J2 =4.4 Hz, 1H), 
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4.35 (d, J=11.6 Hz, 1H), 4.59 (d, J=11.6 Hz, 1H), 4.68(d, J=4.4 Hz,1H), 7.31-7.58 (complex pattern, 11H), 
7.83 (d, J=7.6 Hz, 2H), 7.91 (m, 1H), 8.63 (dd, J1=1.2 Hz, J2=4.8 Hz, 1H), 8.85 (d, J=2.0 Hz, 1H). 13C 
NMR (100 MHz, CDCl3): δ =0.09, 16.83, 55.41, 70.70, 75.75, 81.28, 120.66, 123.30, 127.36, 127.65, 
128.10, 128.13, 128.33, 128.86, 134.76, 135.47, 136.64, 137.99, 148.77, 148.88. MS (EI): m/z= 430 [M]. 
Elemental Analysis: Calcd. for C26H30N2O2Si: C, 72.52; H, 7.02; N, 6.51; O, 7.43; Si, 6.52, Found: C, 
72.69; H, 7.04. 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(benzyloxy)-2-(2-chlorophenyl)-2-phenyl-3-
(trimethylsilyloxy)pentanenitrile 17i/18i 
Following the same procedure of Method A, starting from 2-(2-chlorophenyl)-2-phenylacetonitrile 2k 
(227 mg, 1.0 mmol) and (S)-2-(benzyloxy)propanal 3b (164 mg, 1.0 mmol), (2S, 3S, 4S)-4-(benzyloxy)-2-
(2-chlorophenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 17i and  (2R, 3S, 4S)-4-(benzyloxy)-2-(2-
chlorophenyl)-2-phenyl-3-(trimethylsilyloxy)pentanenitrile 18i were obtained by the flash chromatography 
(n-hexane : toluene=1:1) (203mg, ratio:80/20, yield: 44%). The absolute configuration of the isomer 17i 
was established by X-Ray analysis. 
17i: White solid. mp: 75-80 oC. : +73.50 (c: 1.0g/100 mg, CHCl3). IR (film):  2240 cm-1. 1H NMR 
(400 MHz, CDCl3): δ =-0.11 (s, 9H), 1.21 (d, J=6.4 Hz, 3H), 3.92 (dq, J1=6.4 Hz, J2=3.2 Hz, 1H) , 4.33 (d, 
J=11.6 Hz, 1H), 4.40 (d, J=3.2 Hz, 1H), 4.55 (d, J=11.6 Hz, 1H), 7.20-7.36 (complex pattern, 13H), 8.16(m, 
1H). 13C NMR (100 MHz, CDCl3): δ = 0.46, 18.95, 56.32, 71.20, 75.33, 82.67, 120.25, 126.05, 127.23, 
127.52, 127.67, 128.11, 128.20, 128.27, 129.27, 131.46, 131.62, 134.89, 137.82, 138.46. MS (EI): m/z= 
448 [M-CH3]. Elemental Analysis: Calcd. for C27H30ClNO2Si: C, 69.88; H, 6.52; Cl, 7.64; N, 3.02; O, 
6.90; Si, 6.05, Found: C, 69.74; H, 6.51. 
18i: Colorless oil. : +46.90 (c: 1.8g/100 mg, CHCl3). IR (film): 2240 cm-1. 1H NMR (400 MHz, 
CDCl3): δ =-0.04 (s, 9H), 1.21 (d, J=6.4 Hz, 3H), 3.58 (dq, J1=6.4 Hz, J2=4.0 Hz, 1H), 4.14 (d, J=11.6 Hz, 
1H), 4.42 (d, J=11.6 Hz, 1H), 5.10 (d, J=4.0 Hz, 1H), 7.14-7.38 (complex pattern, 11H), 7.54 (m, 1H), 7.64 
(d, J=6.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ =0.45, 16.99, 56.38, 70.79,76.53, 78.51, 120.63, 126.64, 
127.18, 127.38, 128.00, 128.08, 128.30, 129.07, 129.28, 131.77, 131.93, 133.31, 135.90,136.79, 138.46. 
MS (EI): m/z= 448 [M-CH3]. Elemental Analysis: Calcd. for C27H30ClNO2Si: C, 69.88; H, 6.52; Cl, 7.64; 
N, 3.02; O, 6.90; Si, 6.05, Found: C, 70.00; H, 6.53. 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,4-diphenyl-2-m-tolyl-3-
(trimethylsilyloxy)butanenitrile 17j/18j 
Following the same procedure of A, starting from2-phenyl-2-m-tolylacetonitrile 2d (207 mg, 1.0 
mmol)and (S)-2-(tert-butyldimethylsilyloxy)-2-phenylacetaldehyde 3i (250 mg, 1.0 mmol), a mixture 
products 17j and 18j was obtained by the flash chromatography (cyclohexane: ether=99:1) (429mg, 
ratio:50/50, yield: 85%) 
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17j: IR(film): 2245 cm-1. 1H NMR (400 MHz, CD3OD): δ =-0.59 (s, 9H), -0.55 (s, 3H), -0.38 (s, 3H), 
0.06 (s, 9H), 2.32(s, 3H), 4.95 (d, J=2.0 Hz, 1H), 5.16 (d, J=1.6 Hz, 1H), 7.06 (d, J=11.6 Hz, 1H), 7.20-
7.45 (complex pattern, 9H), 7.53 (m, 2H), 7.74 (m, 2H). 13C NMR (100 MHz, CDCl3): δ = -4.85, -4.28, -
0.36, 18.16, 21.44, 26.90, 57.68, 74.85, 82.46, 120.62, 124.44, 127.62, 127.68, 127.74, 128.33, 128.49, 
128.61, 128.79, 138.29, 138.85, 138.97, 142.74. MS (EI): m/z=529 [M]. Elemental Analysis: Calcd. for 
C32H43NO2Si2: C, 72.54; H, 8.18; N, 2.64; O, 6.04; Si, 10.60;  Found: C, 72.74; H, 8.20. 
18j:(50%) IR(film): 2245 cm-1. 1H NMR (400 MHz, CD3OD): δ =-0.59 (s, 9H), -0.54 (s, 3H), -0.38 (s, 
3H), 0.06 (s, 9H), 2.36 (s, 3H), 4.93 (d, J=2.0 Hz, 1H), 5.15 (d, J=1.2 Hz, 1H), 7.13 (d, J=11.6 Hz, 1H), 
7.20-7.45 (complex pattern, 9H), 7.53 (m, 2H), 7.74 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =-4.94, -4.27, 
-0.35, 18.25, 21.53, 26.23, 57.77, 74.95, 82.60, 120.68, 124.56, 127.66, 127.71, 127.86,  128.42, 128.56, 
128.67, 138.54, 138.85, 138.97, 142.74. MS (EI): m/z=529 [M] 
 
Preparation of (2S, 3S, 4S)/(2R, 3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,4-diphenyl-2-(pyridin-3-
yl)-3-(trimethylsilyloxy)butanenitrile 17k/18k 
Following the same procedure of Method A, starting from 2-phenyl-2-(pyridin-3-yl)acetonitrile 2j 
(194 mg, 1.0 mmol) and (S)-2-(tert-butyldimethylsilyloxy)-2-phenylacetaldehyde 3i (250 mg, 1.0 mmol), 
(2S, 3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,4-diphenyl-2-(pyridin-3-yl)-3-(trimethylsilyloxy)butanenitrile 
17k and (2R, 3S, 4S)-4-(tert-butyldimethylsilyloxy)-2,4-diphenyl-2-(pyridin-3-yl)-3-
(trimethylsilyloxy)butanenitrile 18k were obtained by the flash chromatography (CH2Cl2 : ether=99:1) 
(197mg, ratio:80/20, yield: 40%). The absolute configuration of the isomer 17k was established by X-Ray 
analysis. 
17k: White solid. mp:104-107oC. : + 3.1(c: 1.0g/100 mg, CHCl3). IR (film):  2246 cm-1. 1H NMR 
(400 MHz, CDCl3): δ =-0.47 (s, 9H),  -0.41 (s, 3H), -0.27 (s, 3H), 0.86 (s, 9H), 4.71 (d, J= 2.4 Hz, 1H), 
5.13 (d, J= 2.4 Hz, 1H), 7.23-7.45 (complex patern, 11H), 8.05 (m, 1H), 8.51 (dd, J1= 1.6 Hz, J2= 4.8 Hz, 
1H), 9.05 (d, J= 2.1 Hz, 1H). 13C NMR (50M, CDCl3): δ =-4.89, -4.37, -0.32, 18.21, 26.15, 55.49, 75.69, 
83.37, 120.14, 123.20, 127.61, 127.84, 127.96, 128.25, 128.98, 136.40, 138.48, 141.74, 148.57, 149.51. 
MS (ESI): m/z= 517 [M+H]. Elemental Analysis: Calcd. for C30H40N2O2Si2: C, 69.72; H, 7.80; N, 5.42; O, 
6.19; Si, 10.87;  Found: C, 69.80; H, 7.81. 
18k: White solid. mp: 88-92 oC. : + 18.3 (c: 1.0g/100 mg, CHCl3). IR (film): 2246 cm-1. 1H NMR 
(400 MHz, CDCl3): δ =-0.39 (s, 3H),  -0.38 (s, 9H), -0.27 (s, 3H), 0.87 (s, 9H), 4.77 (d, J= 2.8 Hz, 1H), 
5.08 (d, J= 2.8 Hz, 1H), 7.21-7.41 (m, 11H), 7.67 (m, 2H), 7.96 (m, 1H), 8.52 (m, 1H), 8.79 (s, 1H). 13C 
NMR (100 MHz, CDCl3): δ =-4.69, -4.17, -0.18, 18.30, 26.20, 58.02, 76.24, 82.33, 119.80, 124.02, 127.76, 
127,81, 128.07, 128.25, 128.45, 128.77, 129.13, 136.20, 137.82, 141.16, 148.72, 149.50. MS (ESI): m/z= 
517 [M+1]. Elemental Analysis: Calcd. for C30H40N2O2Si2: C, 69.72; H, 7.80; N, 5.42; O, 6.19; Si, 10.87; 
Found: C, 69.51; H, 7.77. 
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Prearation of  (2S, 3S, 4S)-3,4-dihydroxy-2-phenyl-2-o-tolylpentanenitrile 19 
(2S, 3S, 4S)-4-(benzyloxy)-2-phenyl-2-o-tolyl-3-(trimethylsilyloxy)pentanenitrile 17c (120 mg) and 
Pd/C 10% (120 mg) were mixted into 10 mL of anhydrous MeOH. The reaction mixture was kept under H2 
(50psi) for overnight. Then the reaction mixture was filtered and concentrated to get crude product which 
was purified by flash chromatography (cyclohexane : ether= 3:2) to give pure compound 19 (45 mg, yield: 
59%).  
colourless oil. : +126.18 (c: 1.1g/100 mg, CHCl3). IR (film): 3444 (b), 2241 cm-1. 1H NMR (400 
MHz, CDCl3): δ =1.10 (d, J=6.8 Hz, 3H), 2.07 (s, 3H), 2.13 (d, J=4.8 Hz, 1H, OH), 3.69 (d, J=8.4 Hz, 1H, 
OH), 3.76 (m, 1H), 4.27 (dd, J1=1.2 Hz, J2=8.4 Hz, 1H), 7.13 (d, J=7.6 Hz, 1H), 7.25-7.37 (complex 
pattern, 7H), 7.80 (d, J=8.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ = 21.07, 21.68, 55.53, 65.18, 76.68, 
120.25, 126.06, 127.05, 128.06, 128.42, 129.03, 133.09, 136.05, 136.99, 138.36. MS (ESI): m/z=281  [M]. 
Elemental Analysis: Calcd. for C18H19NO2: C, 76.84; H, 6.81; N, 4.98; O, 11.37, Found: C, 76.85; H, 6.81. 
 
Prearation of  (S)-2-phenyl-2-o-tolyl-2-((4S,5S)-2,2,5-trimethyl-1,3-dioxolan-4-yl)acetonitrile 20 
Following the same procedure for preparing compound 7a, starting from (2S, 3S, 4S)-3,4-dihydroxy-2-
phenyl-2-o-tolylpentanenitrile 19 (23 mg, 0.08 mmol), PPTS (41mg, 0.16mmol) and 2,2-dimethoxypropane 
(1 mL) compound 20 was obtained (24 mg, yield: 92 %) as white solid.  
mp: 95-99°C. : +126.94 (c: 1.6 g/100 mg, CHCl3). IR (film): 2239 cm-1. 1H NMR (400 MHz, 
CDCl3): δ =0.34 (d, J=5.2 Hz, 3H), 1.54 (s, 3H), 1.57 (s, 3H), 2.07 (s, 3H), 4.27 (dq, J1=5.2 Hz, J2=7.6 Hz, 
1H), 4.34 (d, J=8.0 Hz, 1H), 7.13 (d, J=7.2 Hz, 1H) , 7.26-7.37 (complex pattern, 7H), 7.82 (dd, J1=7.6 Hz, 
J2=0.8 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ =18.41, 20.89, 26.85, 27.94, 54.46, 74.78, 84.73, 109.24, 
119.01, 126.12, 127.13, 127.63, 128.40, 128.52, 129.00, 132.76, 135.78, 136.17, 137.95. MS (EI): m/z= 
321 [M]. Elemental Analysis: Calcd. for C21H23NO2: C, 78.47; H, 7.21; N, 4.36; O, 9.96, Found: C, 78.49; 
H, 7.21. 
 
4.3.2 Experimental data for the preparation of α-cyano-β-carboxyamides (Section B.) 
Method A; Typical Procedure 
2,2-Diphenylacetonitrile (21a) (193 mg, 1.0 mmol) in THF (2 mL) was added dropwise to a solution 
of n-BuLi (0.52 mL of a 2.5 M solution in n-hexane, 1.3 mmol) in THF (3 mL) at –78 °C. After 15 min, a 
solution of isocyanate 22a (164 mg, 1.1 mmol) in toluene (4 mL) was added dropwise at the same 
temperature. The resulting mixture was stirred at –78 °C for 2 h and then allowed to warm to r.t. over 6 h. 
Next, the reaction mixture was added dropwise to ice-cold sat. NH4Claq (10 mL), and then extracted with 
EtOAc (3 × 20 mL). The combined organic phase was dried (Na2SO4), filtered and concentrated under 
vacuum. The crude residue was purified by flash chromatography (cyclohexane–Et2O, 4:1) to give malonic 
amide 23a (120 mg, 35%) as a white solid. 
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Method B; Typical Procedure 
2,2-Diphenylacetonitrile (21a) (193 mg, 1.0 mmol) in THF (1 mL)was added dropwise to a solution of 
n-BuLi (0.44 mL of a 2.5 M solution inn-hexane, 1.1 mmol) in THF (3 mL) at –78 °C. Next, a solution of 
TMSCl (120 mg, 1.1 mmol) in THF (1 mL) was added dropwise at–78 °C. After 15 min, a solution of 
isocyanate 22a (164 mg, 1.1 mmol)in toluene (1 mL) was added dropwise at –78 °C and the mixture 
allowed to warm to r.t. over 6–8 h. The reaction mixture was quenched by its addition to ice-cold sat. 
NH4Cl solution (10 mL), and then extracted with EtOAc (3 × 20 mL). The combined organic phase was 
dried (Na2SO4), filtered and concentrated under vacuum. The crude residue was purified by flash 
chromatography (cyclohexane–Et2O, 4:1) to give malonamide 23a (221 mg, 65%). 
 
Method C; Typical Procedure 
2,2-Diphenylacetonitrile (21a) (193 mg, 1.0 mmol) in THF (1 mL)was added dropwise to a solution of 
LDA (1.3 mmol), previously prepared from n-BuLi (0.52 mL of a 2.5 M solution in n-hexane, 1.3 
mmol)and diisopropyl ethyl amine (131 mg, 1.3 mmol) in THF (3 mL) at –78 °C. After 15 min, a solution 
of TMSCl (120 mg, 1.1 mmol) in THF (1 mL) was added dropwise to –78 °C. The resulting mixture was 
stirred for a further 15 min and then the solvent was removed in vacuo. The residue was dissolved in 
toluene (6 mL) at –78 °C and the isocyanate 22a (164 mg, 1.1 mmol) in toluene (2 mL) was added 
dropwise at the same temperature. The reaction temperature was maintained at –78 °C for 2 h and then 
allowed to warm to r.t. over 6–8 h. The reaction mixture was quenched by its addition to ice-cold 
sat.NH4Cl solution (10 mL), and then extracted with EtOAc (3 × 20 mL).The combined organic phase was 
dried (Na2SO4), filtered and concentrated under vacuum. The crude residue was purified by silica gel 
column chromatography (cyclohexane–EtOAc, 95:5) to give 23a (243 mg, 71%). 
 
Method D; Typical Procedure 
A solution of n-BuLi (0.40 mL of a 2.5 M solution in n-hexane, 1.0 mmol) was added dropwise to a 
solution of ethyl amine (101 mg, 1.0 mmol) in THF (3 mL) at –78 °C. After 5 min, a solution of 2,2-
diphenylacetonitrile (21a) (193 mg, 1.0 mmol) in THF (1 mL) was added dropwise at –78 °C, followed by 
a solution of TBDMSCl (166 mg, 1.1 mmol) in THF (1 mL) at the same temperature. The mixture was 
stirred for 20 min at –78 °C and then allowed to warm to r.t. The solvent was removed in vacuo and the 
residue dissolved in anhydrous toluene (3 mL). After cooling to –78 °C, a solution of isocyanate 22a (164 
mg, 1.1 mmol) in toluene (1 mL) was added dropwise at –78 °C. The resulting mixture was stirred at –
78 °C for 6–8 h, then allowed to warm to r.t. and stirred at this temperature for 2 d. The reaction mixture 
was quenched by its addition to ice-cold sat. NH4Cl solution (10 mL), and then extracted with EtOAc (3 × 
20 mL). The combined organic phase was dried (Na2SO4), filtered and concentrated under vacuum. The 
starting nitrile 21a (117 mg, 61%) was recovered by flash chromatography (cyclohexane–Et2O, 4:1). No 
trace of the target amide 23a was evident in the crude reaction mixture according to TLC, 1H NMR and 
HPLC analyses. 
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2-Cyano-N-(4-methoxyphenyl)-2,2-diphenylacetamide (23a) 
mp：119–122 °C. IR (KBr): 2243, 1692 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.80 (s, 3 H), 6.86–
6.90 (m, 2 H), 7.41–7.49 (complex pattern, 12 H), 7.78 (bs, 1 H, NH). 13C NMR (100 MHz, CDCl3): δ = 
55.66, 60.36, 114.42, 120.47, 122.17, 128.39, 129.24, 129.31, 129.82, 136.25, 157.14, 163.71. GC–MS: 
m/z = 342 [M]+. Elemental Analysis: Calcd for C22H18N2O2: C, 77.17; H, 5.30. Found: C, 77.32; H, 5.31. 
 
2-(4-Bromophenyl)-2-cyano-N-(4-methoxyphenyl)-2-phenylacetamide (23b) 
Starting from 2-(4-bromophenyl)-2-phenylacetonitrile (21b) (272 mg, 1.0 mmol) and isocyanate 22a 
(164 mg, 1.1 mmol), following Method C, malonamide 23b was obtained, after flash chromatography 
(cyclohexane–EtOAc, 4:1), as a light-yellow solid (273 mg, 65%). 
mp：147–153 °C. IR (KBr): 2241, 1667 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.81 (s, 3 H), 6.85–
6.91 (m, 2 H), 7.33–7.41 (m, 2 H), 7.40–7.50 (complex pattern, 7 H), 7.54–7.58 (m, 2 H), 7.85 (bs, 1 H, 
NH). 13C NMR (100 MHz, CDCl3): δ = 55.60, 59.57, 114.38, 120.02, 122.29, 123.58, 128.18, 129.42, 
129.61, 130.10, 132.28, 135.33, 135.73, 157.48, 163.19. LC–MS: m/z = 421 [M + 1]+. Elemental Analysis: 
Calcd for C22H17BrN2O2: C, 62.72; H, 4.07. Found: C, 62.82; H, 4.08. 
 
2-Cyano-N-(4-methoxyphenyl)-2-phenyl-2-(m-tolyl)acetamide (23c) 
Starting from 2-phenyl-2-(m-tolyl)acetonitrile (21c) (207 mg, 1.0mmol) and isocyanate 22a (164 mg, 
1.1 mmol), following Method C, malonamide 23c was obtained, after flash chromatography (cyclohexane–
EtOAc, 12:1), as a white solid (206 mg, 58%). 
mp：133–134 °C. IR (KBr): 2241, 1663 cm–1.  1H NMR (400 MHz, CDCl3): δ = 2.31 (s, 3 H), 3.73 (s, 
3 H), 6.79–6.82 (m, 2 H), 7.15–7.17 (m, 2 H), 7.24 (d, J = 7.2 Hz, 2 H), 7.34–7.41 (complex pattern, 7 H), 
7.71(bs, 1 H, NH). 13C NMR (100 MHz, CDCl3): δ = 21.65, 55.62, 60.36, 114.37, 120.52, 122.14, 125.40, 
128.39, 128.91, 129.14, 129.15, 129.23, 129.85, 130.02, 136.07, 136.31, 139.25, 157.37, 163.80. LC–MS: 
m/z = 357 [M + 1]+. Elemental Analysis: Calcd for C23H20N2O2: C, 77.51; H, 5.66. Found: C, 77.63; H, 
5.67. 
 
2-Cyano-N-(4-methoxyphenyl)-2-phenyl-2-(o-tolyl)acetamide (23d) 
Starting from 2-phenyl-2-(o-tolyl)acetonitrile (21d) (207 mg, 1.0mmol) and isocyanate 22a (164 mg, 
1.1 mmol), following Method C, malonamide 23d was obtained, after flash chromatography (cyclohexane: 
EtOAc, 12:1), as a light-yellow solid (228 mg, 64%). 
mp：125–129 °C. IR (KBr): 2245, 1686 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.37 (s, 3 H), 3.79 (s, 
3 H), 6.87 (d, J = 8.8 Hz, 2 H), 6.95 (d, J = 8.0 Hz, 1 H), 7.17–7.19 (m, 1 H), 7.26–7.30 (m, 2 H), 7.39–
7.55 (complex pattern, 7 H), 7.69 (bs, 1 H, NH). 13C NMR (100 MHz, CDCl3): δ = 21.09, 55.66, 59.81, 
114.45, 119.60, 122.10, 126.69, 128.23, 129.13, 129.33, 129.48, 129.51,129.87, 132.82, 134.55, 135.08, 
137.98, 157.43, 163.94. LC–MS: m/z = 357 [M + 1]+. Elemental Analysis: Calcd for C23H20N2O2: C, 77.51; 
H, 5.66. Found: C, 77.62; H, 5.67. 
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2-Cyano-N-(4-methoxyphenyl)-2-phenyl-2-(p-tolyl)acetamide (23e) 
Starting from 2-phenyl-2-(p-tolyl)acetonitrile (21e) (207 mg, 1.0mmol) and isocyanate 22a (164 mg, 
1.1 mmol), following Method C, malonamide 23e was obtained, after flash chromatography (cyclohexane–
EtOAc, 9:1), as a light-yellow solid (267 mg, 75%). 
mp：107–113 °C. IR (KBr): 2242, 1671 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.23 (s, 3 H), 3.63 (s, 
3 H), 6.72–6.79 (m, 2 H), 7.07–7.09 (m, 2 H), 7.18–7.20 (m, 2 H), 7.25–7.32 (complex pattern, 7 H), 7.64 
(bs, 1 H, NH). 13C NMR (100 MHz, CDCl3): δ = 21.17, 55.57, 60.08, 114.32, 120.47, 122.12, 128.19, 
128.31, 129.09, 129.19, 129.85, 129.94, 133.24, 136.38, 139.24, 157.31, 163.90. LC–MS: m/z = 357 [M + 
1]+. Elemental Analysis: Calcd for C23H20N2O2: C, 77.51; H, 5.66. Found: C, 77.61; H, 5.67. 
 
2-Cyano-N,2-bis(4-methoxyphenyl)-2-phenylacetamide (23f) 
Starting from 2-(4-methoxyphenyl)-2-phenylacetonitrile (21f) (224mg, 1.0 mmol) and isocyanate 22a 
(164 mg, 1.1 mmol), following Method B, malonamide 23f was obtained, after flash chromatography 
(cyclohexane–EtOAc, 4:1), as a white solid (260 mg, 70%). 
mp：116–120 °C. IR (KBr): 2243, 1666 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.80 (s, 3 H), 3.83 (s, 
3 H), 6.87 (d, J = 8.8 Hz, 2 H), 6.95 (d, J = 8.8 Hz, 2 H), 7.36–7.49 (complex pattern, 9 H), 7.79 (bs, 1 H, 
NH). 13C NMR (100 MHz, CDCl3): δ = 55.50, 55.60, 114.35, 114.59, 120.54, 122.12, 128.09, 128.26, 
129.12, 129.23, 129.64, 129.85, 136.51, 157.34, 160.11, 164.03. LC–MS: m/z = 373 [M + 1]+. Elemental 
Analysis: Calcd for C23H20N2O3: C, 74.18; H, 5.41. Found: C, 74.33; H, 5.42. 
 
2-(2-Chlorophenyl)-2-cyano-N-(4-methoxyphenyl)-2-phenylacetamide (23g) 
Starting from 2-(2-chlorophenyl)-2-phenylacetonitrile (21g) (227mg, 1.0 mmol) and isocyanate 22a 
(164 mg, 1.1 mmol), following Method B, malonamide 2g was obtained, after flash chromatography 
(cyclohexane–EtOAc, 10:1), as a yellow solid (256 mg, 68%). 
mp：167–169 °C. IR (KBr): 2242, 1670 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.80 (s, 3 H), 6.77 
(dd, J1 =1.2 Hz, J2 = 7.6 Hz, 1 H), 6.87–6.89 (m, 2 H), 7.20 (dt, J1 = 1.2 Hz, J2 = 7.2 Hz, 1 H), 7.37 (dt, J1 
= 1.2 Hz, J2 = 7.2Hz, 1 H), 7.42–7.45 (m, 2 H), 7.50–7.54 (m, 4 H),7.68–7.70 (m, 2 H), 7.94 (bs, 1 H, NH). 
13C NMR (100 MHz, CDCl3): δ = 55.61, 59.08, 114.39, 118.80, 122.42, 127.19, 128.31, 129.61, 129.66, 
129.92, 130.64, 131.01, 133.57, 134.78, 157.40, 163.12. GC–MS: m/z = 376 [M]+. Elemental Analysis: 
Calcd for C22H17ClN2O2: C, 70.12; H, 4.55. Found: C, 70.26; H, 4.56. 
 
2-Cyano-N-(4-methoxyphenyl)-2-phenyl-2-(pyridin-3-yl)acetamide(23h) 
Starting from 2-phenyl-2-(pyridin-3-yl)acetonitrile (21h) (194 mg,1.0 mmol) and isocyanate 22a (164 
mg, 1.1 mmol), following Method B, malonamide 23h was obtained, after flash chromatography 
(cyclohexane :EtOAc, 4:1), as a white solid (274 mg, 80%). 
mp：111–115 °C. IR (KBr): 2246, 1697 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.80 (s, 3 H), 6.86–
6.90 (m, 2 H), 7.34 (dd, J1 = 4.8 Hz, J2 = 7.6 Hz, 1 H), 7.45 (m, 7 H), 7.75 (m, 1 H), 8.16 (bs, 1 H, NH), 
Chapter 4 
99 
 
8.62 (dd, J1 = 1.6 Hz, J2 = 4.8 Hz, 1 H), 8.67 (d, J = 2.0 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 55.46, 
57.76, 114.26, 119.39, 122.30, 123.44, 127.88, 129.44, 132.39, 135.00, 136.10, 149.19,149.97, 157.42, 
162.71. GC–MS: m/z = 344 [M + 1]+. Elemental Analysis: Calcd for C21H17N23O2: C, 73.45; H, 4.99. 
Found: C, 73.56; H, 5.00. 
 
2-Cyano-N,2,2-triphenylacetamide (23i) 
Starting from 2,2-diphenylacetonitrile (21a) (193 mg, 1.0 mmol) and isocyanate 22b (131 mg, 1.1 
mmol), following Method C, malonamide 23i was obtained, after flash chromatography (cyclohexane : 
EtOAc, 4:1), as a white solid (228 mg, yield 73%). 
mp：119–122 °C. IR (KBr): 2246, 1703 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.22 (m, 1 H), 7.34–
7.43 (m, 2 H), 7.43–7.53 (complex pattern, 12 H), 7.85 (bs, 1 H, NH). 13C NMR (100 MHz, CDCl3): δ = 
60.56, 120.31, 120.37, 125.71, 128.40, 129.31, 129.33, 129.35, 136.12, 136.78, 163.85, 178.88. LC–MS: 
m/z = 313 [M + 1]+. Elemental Analysis: Calcd for C21H16N2O: C, 80.75; H, 5.16. Found: C, 80.83; H, 5.17. 
 
N-Benzyl-2-cyano-2,2-diphenylacetamide (23j) 
Starting from 2,2-diphenylacetonitrile (21a) (193 mg, 1 mmol) and isocyanate 22c (146 mg, 1.1 
mmol), following Method B, malonamide 23j was obtained, after flash chromatography (cyclohexane: 
EtOAc, 4:1), as a white solid (164 mg, 50%). 
mp：131–132 °C. IR (KBr): 2247, 1665 cm–1. 1H NMR (400 MHz, CDCl3): δ = 4.44 (d, J = 6.0 Hz, 2 
H, CH2), 6.64 (bs, 1 H, NH), 7.23–7.43 (complex pattern, 15 H).13C NMR (100 MHz, CDCl3): δ = 44.84, 
59.61, 120.45, 127.81, 127.99, 128.31, 128.97, 129.05, 129.14, 136.31, 137.09, 165.84. LC–MS: m/z = 327 
[M + 1]+. Elemental Analysis: Calcd for C22H18N2O: C, 80.96; H, 5.56. Found: C, 80.88; H, 5.55. 
 
2-Cyano-2,2-diphenyl-N-(1-phenylethyl)acetamide (23k) 
Starting from 2,2-diphenylacetonitrile (21a) (193 mg, 1 mmol) and isocyanate 22d (162 mg, 1.1 
mmol), following Method B, malonamide 23k was obtained, after flash chromatography 
(cyclohexane:EtOAc=4:1), as a white solid (265 mg, 78%). 
mp：92–95 °C.IR (KBr): 2239, 1663 cm–1. 1H NMR (400 MHz, CDCl3): δ = 1.54 (d, J = 6.8 Hz, 3 H), 
5.17 (quintet, J = 7.2 Hz, 1 H, CH), 6.54 (d, J = 7.6 Hz, 1 H, NH), 7.25–7.40 (complex pattern, 15 H). 13C 
NMR (100 MHz, CDCl3): δ = 21.67, 50.53, 120.53, 126.12, 127.82, 128.24, 128.29, 128.90, 128.98, 
129.05, 129.10, 136.31,136.38, 142.13, 164.87. GC–MS: m/z = 340 [M]+. Elemental Analysis: Calcd for 
C23H20N2O: C, 81.15; H, 5.92. Found: C, 81.03; H5.91. 
 
N-Benzyl-2-cyano-2-(4-methoxyphenyl)-2-phenylacetamide (23l) 
Starting from 2-(4-methoxyphenyl)-2-phenylacetonitrile (21f) (224mg, 1.0 mmol) and isocyanate 22c 
(146 mg, 1.1 mmol), following Method B, malonamide 23l was obtained, after flash chromatography 
(cyclohexane–EtOAc, 4:1), as a white solid (144 mg, 40%). 
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mp: 132–134 °C. IR (KBr): 2242, 1658 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.82 (s, 3 H), 4.53 (d, 
J = 5.6 Hz, 2 H, CH2), 6.63 (bs, 1 H, NH), 6.90–6.92 (m, 2 H), 7.23–7.42 (complex pattern, 12 H). 13C 
NMR (100 MHz, CDCl3): δ = 44.79, 55.48, 58.98, 114.46, 120.58, 127.79, 127.95, 128.21, 128.94, 128.96, 
129.10, 129.57, 136.61, 137.15, 159.99, 166.16. LC–MS: m/z = 357 [M + 1]+. Elemental Analysis: Calcd 
for C23H20N2O2: C, 77.51; H, 5.66. Found: C, 77.28; H, 5.65. 
 
2-Cyano-N-(2-methylphenyl)-2-phenyl-2-(pyridin-3-yl)acetamide (23m) 
Starting from 2-phenyl-2-(pyridin-3-yl)acetonitrile (21h) (194 mg,1.0 mmol) and 1-isocyanato-2-
methylbenzene (22e) (133 mg, 1.1mmol), following Method B, malonamide 23m was obtained, after flash 
chromatography (CH2Cl2–Et2O, 5:1), as a white solid (1723mg, 53%). 
mp: 230–235 °C. IR (neat): 2238, 1698 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.15 (s, 3 H), 7.14–
7.27 (m,3 H), 7.35–7.38 (m, 1 H), 7.47–7.54 (m, 5 H),7.79–7.85 (m, 2 H), 7.98 (bs, 1 H, NH), 8.65 (dd, J1 
= 1.2 Hz,J2 = 4.0 Hz, 1 H), 8.73 (dd, J1 = 1.5 Hz, J2 = 0.4 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 
17.28, 58.10, 119.39, 122.64, 123.52, 126.39, 126.98, 127.88, 129.41, 129.57, 129.61, 130.71, 132.34, 
134.37, 135.03, 136.09, 149.24, 150.08, 162.90. LC–MS: m/z = 328 [M + 1]+ . Elemental Analysis: Calcd 
for C21H17N23O: C, 77.04; H, 5.23. Found: C, 77.26; H, 5.24. 
 
2-Cyano-N,2,2-tris(4-methoxyphenyl)acetamide (23n) 
Starting from 2,2-bis(4-methoxyphenyl)acetonitrile (21i) (253 mg,1.0 mmol) and isocyanate 22a (164 
mg, 1.1 mmol), following Method B, malonamide 23n was obtained, after flash chromatography 
(cyclohexane–EtOAc, 4:1), as a white solid (244 mg, 61%). 
mp: 133–135 °C.IR (KBr): 2241, 1666 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.80 (s, 3 H), 3.83 (s, 6 
H), 6.85–6.88 (m, 2 H), 6.92–6.95 (m, 4 H), 7.36–7.43 (complex pattern, 6 H), 7.74 (bs, 1 H, NH). 13C 
NMR (100 MHz, CDCl3): δ = 55.53, 55.63, 59.14, 114.38, 114.59, 120.71, 122.08, 128.43, 129.58, 129.93, 
157.34, 160.09,164.37.LC–MS: m/z = 403 [M + 1]+. Elemental Analysis: Calcd for C24H22N2O4: C, 71.63; 
H, 5.51. Found: C, 71.87; H, 5.52. 
 
4.3.3 Experimental data for the preparation of γ-hydroxy nitriles (Section C.) 
The diastereomeric ratios reported into Tables 5 and 6 have been calculated by HPLC (Agilent, 
Poroshell 120. SB-C18. 2.7m, 3.0 × 100 mm) and 1H NMR on the crude reaction mixture taking into 
account the doubtless peaks of each diatereomer. 
Preparation of 4-hydroxy-2,2-diphenylpentanenitrile 32a 
Method A: diphenylacetonitrile (290 mg, 1.5 mmol) in THF (1mL) was added into a solution of 
LiN(SiMe3)2 (1.5mmol, 1.5 mL of 1.0 M in n-hexane) in THF (5 mL) at -78oC under nitrogen atmosphere. 
After 10mins, diethyl aluminium choloride (1.5 mmol, 1.5 mL of 1.0 M in n-hexane) was added to the 
reaction. This reaction mixture was kept at -78oC for 30mins. A solution of 2-methyloxirane (87 mg, 1.5 
mmol) in THF (1 mL) was added. The reaction was kept at -78 oC for 30mins. Then it was left 
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spontaneously to reach r.t and kept overnight. The reaction was decomposed by saturated NH4Claq and 
potassium sodium tartrate tetrahydrate and kept stirring for 1hr at r.t.. It was extracted by AcOEt 
(3×15mL). The organic phase was collected, dried and concentrated under vacuum to get the crude 
mixture which was purified by the flash chromatography (cyclohexane: AcOEt= 4:1) to give pure product 
32a ( 218 mg, yield: 58%). 
White solid. mp: 88-92 oC. IR(film): 2244 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.25 (d, J=6.0 Hz, 
3H), 1.61 (bs, 1H, OH), 2.51(dd, J1= 2.8 Hz, J2=14.4 Hz, 1H), 2.68 (dd, J1= 7.6 Hz, J2=14.0 Hz, 1H), 3.98 
(m, 1H), 7.29-7.45 (complex pattern, 10H). 13C NMR (100 MHz, CDCl3): δ = 24.39, 48.17, 49.53, 65.27, 
122.63, 126.91, 126.95, 128.01, 128.09, 128.98, 129.01, 139.89, 140.36.  MS (ESI): m/z=252 [M+1]. 
 
Preparation of (2S*, 4R*)-4-hydroxy-2-methyl-2-phenylpentanenitrile 32b and (2R*, 4R*)-4-
hydroxy-2-methyl-2-phenylpentanenitrile 32c 
Preparation of diethylaluminium ketene imine 25a 
Diethylaluminium ketene imine 25a was prepared according the same literature procedure for the 
preparation of silylketene imines.54,99 In detail, α-methyl acetonitriles (197 mg, 1.5 mmol) was added into a 
solution of LiN(SiMe3)2 (1.5mmol, 1.5 mL of 1.0 M in n-hexane) in THF (5 mL) at -78oC under nitrogen 
atmosphere. After 10mins, a solution of diethyl aluminium choloride (1.5 mmol, 1.5 mL of 1.0 M in n-
hexane) was added to the reaction mixture. A sample of the resulting keteneimine 25a was characterized by 
its IR spectra. The IR spectra indicated that there is a strong absorption at 2087 cm-1 which is the 
characteristic signal of the cumulene absorption.  
Following Method A, to the solution of keteneimine 25a which was prepared as described above, a 
solution of 2-methyloxirane (87 mg, 1.5 mmol) in THF (1 mL) was added at -78 oC. The reaction was kept 
at -78 oC for 30mins. Then the reaction was left spontaneously to reach r.t and kept overnight. The reaction 
was decomposed by saturated NH4Claq and potassium sodium tartrate tetrahydrate, this mixture was kept 
stirring for 1hr and extracted by AcOEt (3X15mL). The organic phase was collected, dried and 
concentrated under vacuum to get the crude mixture which was purified by the flash chromatography 
(cyclohexane: AcOEt= 2:1) to give a inseparable mixture of product 32b and 33b (170 mg, ratio: 50:50, 
total yield: 60%). Spectral data were deducted from the mixture and arbitrarly attributed to 32b and 33b 
32b: IR(film): 2237 cm-1.1H NMR (400 MHz, CDCl3): δ =1.15(d, J=6.4 Hz, 3H), 1.68 (bs, 1H, OH), 
1.79 (s, 3H), 1.98 (dd, J1= 2.8 Hz, J2= 13.6 Hz, 1H), 2.16(dd, J1=8.8 Hz, J2=13.6 Hz, 1H), 3.85 (m, 1H), 
7.31-7.53(complex pattern, 5H). 13C NMR (100 MHz, CDCl3): δ =24.37, 28.21, 40.89, 50.52, 65.58, 
123.70, 125.61, 127.98, 129.15, 139.93. MS (ESI): m/z=190 [M+1]. 
33b: IR(film): 2237 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.23(d, J=6.4 Hz, 3H), 1.68 (bs, 1H, OH), 
1.80 (s, 3H), 2.04 (dd, J1= 3.6 Hz, J2= 13.6 Hz, 1H), 2.16(dd, J1=4.0 Hz, J2=13.6 Hz, 1H), 3.99 (m, 1H), 
7.31-7.53(complex pattern, 5H). 13C NMR (100 MHz,CDCl3): δ =24.82, 28.94, 40.96, 50.83, 65.58, 123.89, 
125.63, 128.19, 129.28, 140.23. MS (ESI): m/z=190 [M+1]. 
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Method B: α-methyl acetonitriles (197 mg, 1.5 mmol) in toluene (1mL) was added into a solution of 
LiN(SiMe3)2 (1.5mmol, 1.5 mL of 1.0 M in n-hexane) in toluene (5 mL) at -78oC under nitrogen 
atmosphere. After 10mins, diethyl aluminium choloride (1.5 mmol, 1.5 mL of 1.0 M in n-hexane) was 
added to the reaction. This reaction mixture was kept at -78oC for 30mins and filtered. The filtrate was 
added to a solution of 2-methyloxirane (87 mg, 1.5 mmol) in toluene (1 mL) at -78 oC and kept for 30mins 
at this temperature. Then the reaction was left spontaneously to reach r.t for overnight. It was decomposed 
by saturated NH4Claq and potassium sodium tartrate tetrahydrate, kept stirring for 1hr at r.t. and extracted 
by AcOEt (3×15mL). The organic phase was collected, dried and concentrated under vacuum to get the 
crude mixture which was purified by the flash chromatography (cyclohexane: AcOEt= 2:1) to give a 
inseparable mixture of product 32b and 33b (113 mg, ratio: 40:60, total yield: 40%). 
 
Method C: α-methyl acetonitriles (197 mg, 1.5 mmol) in THF (1mL) was added into a solution of 
LiN(SiMe3)2 (1.5mmol, 1.5 mL of 1.0 M in n-hexane) in THF (3 mL) at -78oC under nitrogen atmosphere. 
After 10mins, diethyl aluminium choloride (1.5 mmol, 1.5 mL of 1.0 M in n-hexane) was added to the 
reaction. The reaction was diluted with 20mL of toluene, kept at -78oC for 30mins and filtered. (S,S)-N,N-
bis(3,5-di-tertbutylsalicylidene)-1,2-cyclohexanediamino aluminium chloride (135mg) in THF (1ml) was 
added into the filtrate at -78oC and kept for 10mins. A solution of 2-methyloxirane (87 mg, 1.5 mmol) in 
toluene (1 mL) was added at -78 oC. The reaction was at -50oC for overnight. It was decomposed by 
saturated NH4Claq and potassium sodium tartrate tetrahydrate, kept stirring for 1hr at r.t. and extracted by 
AcOEt (3X15mL). The organic phase was collected, dried and concentrated under vacuum to get the crude 
mixture which was purified by the flash chromatography (cyclohexane: AcOEt= 2:1) to give a inseparable 
mixture of product 32b and 33b (141 mg, ratio: 40:60, total yield: 50%). 
 
Preparation of (2S*)-2-((2S*)-2-hydroxycyclohexyl)-2-phenylpropanenitrile 32c and (2R*)-2-
((2S*)-2-hydroxycyclohexyl)-2-phenylpropanenitrile 33c 
 α-methyl acetonitriles (197 mg, 1.5 mmol) in THF (1mL) was added into a solution of LiN(SiMe3)2 
(1.5mmol, 1.5 mL of 1.0 M in n-hexane) in THF (3 mL) at -78oC under nitrogen atmosphere. After 10mins, 
diethyl aluminium choloride (1.5 mmol, 1.5 mL of 1.0 M in n-hexane) was added to the reaction. The 
reaction was kept at r.t. for 1hr and concentrated. 10ml of toluene was added to the residue and filtered. 
The filtrate was added into a solution of 7-oxabicyclo[4.1.0]heptanes (147 mg, 1.5 mmol) in toluene (1 mL) 
at -78 oC. Then the reaction was left spontaneously to reach r.t for overnight. It was decomposed by 
saturated NH4Claq and potassium sodium tartrate tetrahydrate, kept stirring for 1hr at r.t. and extracted by 
AcOEt (3×15mL). The organic phase was collected, dried and concentrated under vacuum to get the crude 
mixture which was purified by the flash chromatography (cyclohexane: AcOEt= 4:1) to give an inseparable 
mixture of product 32c and 33c (113 mg, ratio: 50:50, total yield: 33%). Spectral data were deducted from 
the mixture and arbitrarly attributed to 32c and 33c. 
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32c: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.90-1.44 (comlex pattern, 8H), 1.83 (s, 
3H), 1.92(m, 1H), 3.53 (m, 1H), 7.30-7.55 (complex pattern, 5H). 13C NMR (100 MHz, CDCl3): δ = 21.08, 
24.64, 24.87, 25.60, 25.91, 27.33, 28.07, 37.55, 53.01, 72.91, 123.45, 126.16, 127.64, 127.92, 128.52, 
128.97, 140.50. MS (ESI): m/z=230 [M+1]. 
33c: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.90-1.44 (comlex pattern, 8H), 1.85 (s, 
3H), 1.92(m, 1H), 3.68 (dt, J1=4.4 Hz, J2=14.4 Hz, 1H), 7.30-7.55 (complex pattern, 5H). 13C NMR (100 
MHz, CDCl3): δ = 21.08, 24.67, 24.88, 25.66, 26.43, 27.93, 36.54, 45.44, 53.26, 73.33, 123.99, 126.43, 
127.89, 128.30, 128.87, 128.96, 141.01. MS (ESI): m/z=230 [M+1]. 
 
Preparation of (2S*, 4R*)-4-hydroxy-2-methyl-2,4-diphenylbutanenitrile 32d and (2R*, 4R*)-4-
hydroxy-2-methyl-2,4-diphenylbutanenitrile 33d 
Following Method A, stating from  α-methyl acetonitriles (197 mg, 1.5 mmol), 2-phenyloxirane (180 
mg, 1.5 mmol), (2S*, 4R*)-4-hydroxy-2-methyl-2,4-diphenylbutanenitrile 32d and (2R*, 4R*)-4-hydroxy-
2-methyl-2,4-diphenylbutanenitrile 33d were obtained after flash chromatography (cyclohexane : AcOEt 
=4:1) (184 mg, ratio:32d/33d=25/75, total yield: 49%) 
32d: whilte solid. mp: 78-82 oC. IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.50 (s, 3H), 
1.58 (bs, 1H, OH), 3.24 (dd, J1= 4.8 Hz, J2= 10.0 Hz, 1H), 3.68 (dd, J1=4.4 Hz, J2=11.6 Hz, 1H), 4.25 (t, 
J=10.4 Hz, 1H), 7.35-7.51 (complex pattern, 8H) 7.57 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =27.26, 
45.19, 57.50, 63.16, 122.01, 125.77, 128.31, 128.50, 129.13, 129.25, 129.57, 136.80, 139.73. MS (ESI): 
m/z=252 [M+1]. 
33d: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.52 (bs, 1H, OH), 1.88 (s, 3H), 3.25 (dd, 
J1= 5.2 Hz, J2= 9.2 Hz, 1H), 4.14 (dd, J1=11.6 Hz, J2=9.6 Hz, 1H), 4.25 (dd, J1=6.0 Hz, J2=11.6 Hz, 1H), 
7.00 (m, 2H), 7.17-7.28 (complex pattern, 8H). 13C NMR (100 MHz, CDCl3): δ =25.83, 45.20, 57.62, 
63.17, 122.78, 126.48,127.94, 127.97, 128.48, 128.54, 129.53, 136.49, 138.58. MS (ESI): m/z=252 [M+1]. 
 
Preparation of (2S*, 4R*)-5-tert-butoxy-4-hydroxy-2-methyl-2-phenylpentanenitrile 32e and 
(2R*, 4R*)-5-tert-butoxy-4-hydroxy-2-methyl-2-phenylpentanenitrile 33e 
Following Method A, stating from  α-methyl acetonitriles (197 mg, 1.5 mmol), 2-(tert-
butoxymethyl)oxirane (195 mg, 1.5 mmol), an inseparable mixture of products 32e and 33e was obtained 
after flash chromatography (cyclohexane : AcOEt=4:1) (164 mg, ratio: 50:50, total yield: 42%) Spectral 
data were deducted from the mixture and arbitrarly attributed to 32e and 33e. 
32e: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.40 (s, 9H), 1.82 (s, 3H), 1.95 (dd, J1= 3.2 
Hz, J2= 14.4 Hz, 1H), 2.14 (dd, J1=8.4 Hz, J2=14.4 Hz, 1H), 2.56 (bs, 1H, OH), 3.09 (dd, J1=7.2 Hz, J2=8.8 
Hz, 1H), 3.22 (dd, J1=8.8 Hz, J2=11.2 Hz, 1H),3,79 (m, 1H), 7.32 (m, 1H), 7.40 (m, 2H), 7.50 (m, 2H). 13C 
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NMR (100 MHz, CDCl3): δ =27.58, 28.60, 41.04, 45.33, 65.65, 68.33, 73.42, 123.65, 125.63, 127.91, 
129.03, 140.51. MS (ESI): m/z=262 [M+1]. 
33e: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =1.64 (s, 9H), 1.81 (s, 3H), 2.03 (dd, J1= 4.0 
Hz, J2= 14.4 Hz, 1H), 2.21 (dd, J1=7.6 Hz, J2=14.4 Hz, 1H), 2.38 (bs, 1H, OH), 3.22 (dd, J1=8.8 Hz, J2=4.0 
Hz, 1H), 3.36 (dd, J1=3.6 Hz, J2=8.8 Hz, 1H), 3.73 (m, 1H), 7.32 (m, 1H), 7.40 (m, 2H), 7.50 (m, 2H). 13C 
NMR (100 MHz, CDCl3): δ =27.54, 27.61, 40.46, 45.24, 65.75, 67.92, 73.50, 123.99, 125.82, 127.96, 
129.05, 140.03. MS (ESI): m/z=262 [M+1]. 
 
Preparation of (2S*, 4R*)-5-(2-ethyldodecyloxy)-4-hydroxy-2-methyl-2-phenylpentanenitrile 32f 
and (2R*, 4R*)-5-(2-ethyldodecyloxy)-4-hydroxy-2-methyl-2-phenylpentanenitrile 33f 
Following Method A, stating from  α-methyl acetonitriles (131 mg, 1.0 mmol), 2-((2-
ethyldodecyloxy)methyl)oxirane (186 mg, 1.0 mmol), an inseparable mixture of products 32f and 33f was 
obtained after flash chromatography (cyclohexane : AcOEt=8:1) (200 mg, ratio: 50:50, total yield: 50%) 
Spectral data were deducted from the mixture and arbitrarly attributed to 32f and 33f. 
32f: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.87 (t, J=7.6 Hz, 3H), 0.89 (m, 3H), 
1,29(m, 8H), 1.46(m, 1H), 1.81(s, 3H), 2.05 (dd, J1= 4.0 Hz, J2= 14.4 Hz, 1H), 2.20 (bs, 1H, OH), 2.21 (dd, 
J1=7.2 Hz, J2=14.4 Hz, 1H), 3.29 (m, 3H), 3.41 (m, 1H), 3.83 (m, 1H), 7.32 (m, 1H), 7.41 (m, 2H), 7.51 (m, 
2H). 13C NMR (100 MHz, CDCl3): δ =11.24, 14.23, 23.20, 27.79, 29.23, 30.65, 39.76, 40.53, 45.22 67.73, 
74.38, 74.67, 123.89, 125.79, 128.06, 129.11, 140.43. MS (ESI): m/z=424 [M+Na]. 
33f: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.88 (m, 6H), 1.29 (m, 8H), 1.59 (m, 1H), 
1.83 (s, 3H), 2.05 (dd, J1= 2.8 Hz J2= 14.8 Hz, 1H), 2.13 (dd, J1=7.6 Hz, J2=14.8 Hz, 1H), 2.42 (bs, 1H, 
OH), 3.15 (m, 1H), 3.29 (m, 3H), 3.83 (m, 1H), 7.32 (m, 1H), 7.41 (m, 2H), 7.51 (m, 2H). 13C NMR (100 
MHz, CDCl3): δ =11.21, 14.23, 23.98, 28.66, 29.23, 30.72, 39.76, 41.02, 45.17, 68.07, 74.38, 74.83, 123.66, 
125.63, 128.00, 129.13, 139.98. MS (ESI): m/z=424 [M+Na]. 
 
Preparation of (2S*, 4S*)-4-hydroxy-2-methyl-2-phenyltetradecanenitrile 32g and (2R*, 4S*)-4-
hydroxy-2-methyl-2-phenyltetradecanenitrile 33g 
Following Method A, stating from  α-methyl acetonitriles (131 mg, 1.0 mmol), 2-decyloxirane (184 
mg, 1.0 mmol), an inseparable mixture of products 32g and 33g was obtained after flash chromatography 
(cyclohexane : AcOEt=8:1) (158 mg, ratio: 50:50, total yield: 50%) Spectral data were deducted from the 
mixture and arbitrarly attributed to 32g and 33g. 
32g: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.89 (t, J=7.6 Hz, 3H), 1.20-1.45 (m, 18H), 
1.79 (s, 3H), 2.05 (dd, J1=2.8 Hz, J2= 14.4 Hz, 1H), 2.14 (dd, J1=8.4 Hz, J2=14.4 Hz, 1H), 3.81 (m, 1H), 
7.33 (m, 1H), 7.41 (m, 2H), 7.51 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =14.23, 22.79, 25.39, 27.95, 
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28.94, 29.42, 29.58, 29.66, 29.69, 32.01, 38.13, 41.08, 49.52, 123.77, 125.60, 127.91, 129.10, 140.17. MS 
(ESI): m/z=316 [M+1]. 
33g: IR(film): 2236 cm-1. 1H NMR (400 MHz, CDCl3): δ =0.89 (t, J=7.6 Hz, 3H), 1.20-1.45 (m, 18H), 
1.80 (s, 3H), 1.99 (dd, J1=2.4 Hz, J2= 14.8 Hz, 1H), 2.11 (dd, J1=6.8 Hz, J2=14.8 Hz, 1H), 3.62 (m, 1H), 
7.33 (m, 1H), 7.41 (m, 2H), 7.48 (m, 2H). 13C NMR (100 MHz, CDCl3): δ =14.23, 22.79, 25.33, 27.95, 
28.94, 29.56, 29.62, 29.67, 29.70, 32.01, 38.48, 40.98, 49.00, 123.97, 125.65, 128.13, 129.23, 140.37. MS 
(ESI): m/z= 316 [M+1]. 
 
Preparation of (2S*, 4S*)-4-hydroxy-2-methyl-2-phenyloctanenitrile 32h and (2R*, 4S*)-4-
hydroxy-2-methyl-2-phenyloctanenitrile 33h 
 α-methyl acetonitriles (197 mg, 1.5 mmol) in THF (1mL) was added into a solution of LiN(SiMe3)2 
(1.5mmol, 1.5 mL of 1.0 M in n-hexane) in THF (3 mL) at -78oC under nitrogen atmosphere. After 10mins, 
diethyl aluminium choloride (1.5 mmol, 1.5 mL of 1.0 M in n-hexane) was added to the reaction. The 
reaction was kept at r.t. for 20mins and concentrated. 20ml of CH2Cl2 was added to the residue and filtered. 
The filtrate was cooled to -78 oC. A solution of 2-butyloxirane (150 mg, 1.5 mmol) in CH2Cl2 (1 mL) was 
added at -78 oC. Then the reaction was left spontaneously to reach r.t for overnight. It was decomposed by 
saturated NH4Claq and potassium sodium tartrate tetrahydrate, kept stirring for 1hr at r.t. and extracted by 
AcOEt (3X15mL). The organic phase was collected, dried and concentrated under vacuum to get the crude 
mixture which was purified by the flash chromatography (cyclohexane: AcOEt= 6:1) to give an inseparable 
mixture of products 32h and 33h (107 mg, ratio: 50:50, total yield: 31%). Spectral data were deducted from 
the mixture and arbitrarly attributed to 32h and 33h. 
32h: IR(film): 2237cm-1. 1H NMR (400 MHz, CDCl3): δ =0.86 (t, J=7.2 Hz, 3H), 1.22-1.49 (m, 6H), 
1.80(s, 3H), 1.99 (dd, J1=2.4 Hz, J2= 14.8 Hz, 1H), 2.11 (dd, J1=9.2 Hz, J2=14.8 Hz, 1H), 3.63 (m, 1H), 
7.28-7.53 (complex pattern, 5H). 13C NMR (100 MHz, CDCl3): δ = 14.09, 22.62, 27.46, 28.91, 38.15, 
40.97, 48.98, 69.27, 123.76, 125.58, 127.89, 128.10, 129.08, 140.36. MS(ESI) m/z= 232 [M+1]. 
33h: IR(film): 2237cm-1. 1H NMR (400 MHz, CDCl3): δ =0.89 (t, J=8.0 Hz, 3H), 1.22-1.49 (m, 6H), 
1.79 (s, 3H), 2.05 (dd, J1=2.8 Hz, J2= 14.4 Hz, 1H), 2.11 (dd, J1=8.2 Hz, J2=14.4 Hz, 1H), 3.81 (m, 1H), 
7.28-7.53 (complex pattern, 5H). 13C NMR (100 MHz, CDCl3): δ = 14.05, 22.62, 27.52, 27.91, 37.77, 
41.04, 49.47, 69.27, 123.95, 125.63, 128.09, 129.21, 140.16. MS(ESI) m/z= 232 [M+1]. 
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